-------------
sentence: Close observation of the patient is recommended when a beta-blocker is administered to patients receiving catecholamine-depleting drugs such as reserpine, because of possible additive effects and the production of hypotension and/or marked bradycardia, which may produce vertigo, syncope, or postural hypotension.
entities: beta-blocker / reserpine
ddi: advise
>>> match: recommend_administer
-------------
sentence: Phase II clinical trial data, where IRESSA and vinorelbine have been used concomitantly, indicate that IRESSA may exacerbate the neutropenic effect of vinorelbine.
entities: IRESSA / vinorelbine
ddi: effect
>>> match: indicate_exacerbate
-------------
sentence: Our data suggest that TAM significantly potentiates the reduction in cell number induced by 1,25(OH)2D3 alone.
entities: TAM / 1,25(OH)2D3
ddi: effect
>>> match: suggest_potentiate
-------------
sentence: Several studies indicate that olanzapine has benefits against symptoms of aggression and agitation, while other studies strongly support the effectiveness of olanzapine in the treatment of depressive symptomatology.
entities: olanzapine / olanzapine
ddi: null
>>> match: indicate_have
-------------
sentence: Pharmacoeconomic analyses indicate that olanzapine does not significantly increase, and may even decrease, the overall direct treatment costs of schizophrenia, compared with haloperidol.
entities: olanzapine / haloperidol
ddi: null
>>> match: indicate_increase
-------------
sentence: In vitro studies with human liver microsomes showed that terbinafine does not inhibit the metabolism of tolbutamide, ethinylestradiol, ethoxycoumarin, and cyclosporine.
entities: terbinafine / tolbutamide
ddi: null
>>> match: show_inhibit
-------------
sentence: In vitro studies with human liver microsomes showed that terbinafine does not inhibit the metabolism of tolbutamide, ethinylestradiol, ethoxycoumarin, and cyclosporine.
entities: terbinafine / ethinylestradiol
ddi: null
>>> match: show_inhibit
-------------
sentence: In vitro studies with human liver microsomes showed that terbinafine does not inhibit the metabolism of tolbutamide, ethinylestradiol, ethoxycoumarin, and cyclosporine.
entities: terbinafine / ethoxycoumarin
ddi: null
>>> match: show_inhibit
-------------
sentence: In vitro studies with human liver microsomes showed that terbinafine does not inhibit the metabolism of tolbutamide, ethinylestradiol, ethoxycoumarin, and cyclosporine.
entities: terbinafine / cyclosporine
ddi: null
>>> match: show_inhibit
-------------
sentence: In vivo drug-drug interaction studies conducted in normal volunteer subjects showed that terbinafine does not affect the clearance of antipyrine or digoxin.
entities: terbinafine / antipyrine
ddi: null
>>> match: show_affect
-------------
sentence: In vivo drug-drug interaction studies conducted in normal volunteer subjects showed that terbinafine does not affect the clearance of antipyrine or digoxin.
entities: terbinafine / digoxin
ddi: null
>>> match: show_affect
-------------
sentence: Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when midazolam is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of azole antimycotics, protease inhibitors, calcium channel antagonists, and macrolide antibiotics).
entities: midazolam / azole antimycotics
ddi: advise
>>> match: advise_administer
-------------
sentence: Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when midazolam is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of azole antimycotics, protease inhibitors, calcium channel antagonists, and macrolide antibiotics).
entities: midazolam / protease inhibitors
ddi: advise
>>> match: advise_administer
-------------
sentence: Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when midazolam is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of azole antimycotics, protease inhibitors, calcium channel antagonists, and macrolide antibiotics).
entities: midazolam / calcium channel antagonists
ddi: advise
>>> match: advise_administer
-------------
sentence: Drug Interactions: Inhibitors of CYP3A4 Isozymes: Caution is advised when midazolam is administered concomitantly with drugs that are known to inhibit the cytochrome P450 3A4 enzyme system (ie, some drugs in the drug classes of azole antimycotics, protease inhibitors, calcium channel antagonists, and macrolide antibiotics).
entities: midazolam / macrolide antibiotics
ddi: advise
>>> match: advise_administer
-------------
sentence: Resveratrol (5-35 micromol/l) induced concentration-dependent relaxation of mesenteric arteries preconstricted with noradrenaline (8 micromol/l) or KCl (125 mmol/l) from both lean and dietary-obese rats.
entities: noradrenaline / KCl
ddi: null
>>> match: induce_preconstrict
-------------
sentence: An inhibitor of CYP2C8 (such as gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (such as rifampin) may decrease the AUC of rosiglitazone.
entities: gemfibrozil / rosiglitazone
ddi: mechanism
>>> match: decrease_increase
-------------
sentence: An inhibitor of CYP2C8 (such as gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (such as rifampin) may decrease the AUC of rosiglitazone.
entities: gemfibrozil / rifampin
ddi: null
>>> match: decrease_increase
-------------
sentence: Valproate: The addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics, but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8%, which resulted in an increase of approximately 40% in the free tiagabine concentration.
entities: valproate / tiagabine
ddi: mechanism
>>> match: have_decrease
-------------
sentence: This indicates that tiagabine does not cause induction or inhibition of the hepatic microsomal enzyme systems responsible for the metabolism of antipyrine.
entities: tiagabine / antipyrine
ddi: null
>>> match: indicate_cause
-------------
sentence: METHODS: Clinical studies, case reports, and commentaries and editorials concerning sildenafil published in the international literature between January 1999 and August 2000 were identified through searches of MEDLINE, PREMEDLINE, and International Pharmaceutical Abstracts, using the terms sildenafil, Viagra, and erectile dysfunction.
entities: sildenafil / sildenafil
ddi: null
>>> match: report_identify
-------------
sentence: METHODS: Clinical studies, case reports, and commentaries and editorials concerning sildenafil published in the international literature between January 1999 and August 2000 were identified through searches of MEDLINE, PREMEDLINE, and International Pharmaceutical Abstracts, using the terms sildenafil, Viagra, and erectile dysfunction.
entities: sildenafil / Viagra
ddi: null
>>> match: report_identify
-------------
sentence: However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.
entities: theophylline / caffeine
ddi: null
>>> match: show_elevate
-------------
sentence: However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.
entities: theophylline / anticoagulant
ddi: null
>>> match: show_elevate
-------------
sentence: However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.
entities: theophylline / warfarin
ddi: null
>>> match: show_elevate
-------------
sentence: However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.
entities: theophylline / cyclosporine
ddi: null
>>> match: show_elevate
-------------
sentence: However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.
entities: caffeine / anticoagulant
ddi: null
>>> match: show_elevate
-------------
sentence: However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.
entities: caffeine / warfarin
ddi: null
>>> match: show_elevate
-------------
sentence: However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.
entities: caffeine / cyclosporine
ddi: null
>>> match: show_elevate
-------------
sentence: However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.
entities: anticoagulant / cyclosporine
ddi: null
>>> match: show_elevate
-------------
sentence: However, the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline, interfere with the metabolism of caffeine, and enhance the effects of the oral anticoagulant warfarin and its derivatives, and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly.
entities: warfarin / cyclosporine
ddi: null
>>> match: show_elevate
-------------
sentence: Amiodarone or Verapamil: The risk of myopathy/rhabdomyolysis is increased when either amiodarone or verapamil is used concomitantly with a closely related member of the HMG-CoA reductase inhibitor class (see WARNINGS, Myopathy/Rhabdomyolysis).
entities: amiodarone / HMG-CoA reductase inhibitor class
ddi: effect
>>> match: increase_use
-------------
sentence: Amiodarone or Verapamil: The risk of myopathy/rhabdomyolysis is increased when either amiodarone or verapamil is used concomitantly with a closely related member of the HMG-CoA reductase inhibitor class (see WARNINGS, Myopathy/Rhabdomyolysis).
entities: verapamil / HMG-CoA reductase inhibitor class
ddi: effect
>>> match: increase_use
-------------
sentence: It is recommended that in patients taking anticoagulants, prothrombin time be determined before starting lovastatin and frequently enough during early therapy to insure that no significant alteration of prothrombin time occurs.
entities: anticoagulants / lovastatin
ddi: advise
>>> match: recommend_determine
-------------
sentence: Azithromycin had no significant impact on the Cmax and AUC of zidovudine, although it significantly decreased the zidovudine tmax by 44% and increased the intracellular exposure to phosphorylated zidovudine by 110%.
entities: zidovudine / zidovudine
ddi: null
>>> match: have_decrease
-------------
sentence: Based on the results of these studies, it is concluded that azithromycin may be safely coadministered with both zidovudine and dideoxyinosine.
entities: azithromycin / zidovudine
ddi: null
>>> match: conclude_coadminister
-------------
sentence: Based on the results of these studies, it is concluded that azithromycin may be safely coadministered with both zidovudine and dideoxyinosine.
entities: azithromycin / dideoxyinosine
ddi: null
>>> match: conclude_coadminister
-------------
sentence: Since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable to avoid giving tetracyclines in conjunction with penicillin.
entities: tetracyclines / penicillin
ddi: advise
>>> match: avoid_give
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).
entities: Ritalin / coumarin anticoagulants
ddi: mechanism
>>> match: show_inhibit
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).
entities: Ritalin / anticonvulsants
ddi: mechanism
>>> match: show_inhibit
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).
entities: Ritalin / phenobarbital
ddi: mechanism
>>> match: show_inhibit
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).
entities: Ritalin / diphenylhydantoin
ddi: mechanism
>>> match: show_inhibit
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).
entities: Ritalin / primidone
ddi: mechanism
>>> match: show_inhibit
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).
entities: Ritalin / phenylbutazone
ddi: mechanism
>>> match: show_inhibit
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).
entities: Ritalin / tricyclic drugs
ddi: mechanism
>>> match: show_inhibit
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).
entities: Ritalin / imipramine
ddi: mechanism
>>> match: show_inhibit
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).
entities: Ritalin / clomipramine
ddi: mechanism
>>> match: show_inhibit
-------------
sentence: Human pharmacologic studies have shown that Ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).
entities: Ritalin / desipramine
ddi: mechanism
>>> match: show_inhibit
-------------
sentence: Although there are no study data to evaluate the possibility, nitric oxide donor compounds, including sodium nitroprusside and nitroglycerin, may have an additive effect with INOmax on the risk of developing methemoglobinemia.
entities: nitric oxide donor compounds / INOmax
ddi: effect
>>> match: be_evaluate
-------------
sentence: Although there are no study data to evaluate the possibility, nitric oxide donor compounds, including sodium nitroprusside and nitroglycerin, may have an additive effect with INOmax on the risk of developing methemoglobinemia.
entities: sodium nitroprusside / INOmax
ddi: effect
>>> match: be_evaluate
-------------
sentence: Although there are no study data to evaluate the possibility, nitric oxide donor compounds, including sodium nitroprusside and nitroglycerin, may have an additive effect with INOmax on the risk of developing methemoglobinemia.
entities: nitroglycerin / INOmax
ddi: effect
>>> match: be_evaluate
-------------
sentence: When oxandrolone therapy is initiated in a patient already receiving treatment with warfarin, the INR or prothrombin time (PT) should be monitored closely and the dose of warfarin adjusted as necessary until a stable target INR or PT has been achieved.
entities: oxandrolone / warfarin
ddi: advise
>>> match: monitor_initiate
-------------
sentence: When oxandrolone therapy is initiated in a patient already receiving treatment with warfarin, the INR or prothrombin time (PT) should be monitored closely and the dose of warfarin adjusted as necessary until a stable target INR or PT has been achieved.
entities: oxandrolone / warfarin
ddi: null
>>> match: achieve_monitor
-------------
sentence: When oxandrolone therapy is initiated in a patient already receiving treatment with warfarin, the INR or prothrombin time (PT) should be monitored closely and the dose of warfarin adjusted as necessary until a stable target INR or PT has been achieved.
entities: warfarin / warfarin
ddi: null
>>> match: achieve_monitor
-------------
sentence: The possibility of hypotensive effects can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with perindopril.
entities: diuretic / perindopril
ddi: effect
>>> match: minimize_discontinue
-------------
sentence: Digoxin: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with ACEON    Tablets, but an effect of digoxin on the plasma concentration of perindopril/perindoprilat has not been excluded.
entities: ACEON / digoxin
ddi: null
>>> match: show_coadminister
-------------
sentence: Digoxin: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with ACEON    Tablets, but an effect of digoxin on the plasma concentration of perindopril/perindoprilat has not been excluded.
entities: ACEON / perindopril
ddi: null
>>> match: show_coadminister
-------------
sentence: Digoxin: A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with ACEON    Tablets, but an effect of digoxin on the plasma concentration of perindopril/perindoprilat has not been excluded.
entities: ACEON / perindoprilat
ddi: null
>>> match: show_coadminister
-------------
sentence: Pharmacokinetic studies show that there are no significant alterations in pharmacokinetic parameters of zidovudine or rifabutin to warrant dosage adjustment when megestrol acetate is administered with these drugs.
entities: zidovudine / megestrol acetate
ddi: null
>>> match: be_warrant
-------------
sentence: Pharmacokinetic studies show that there are no significant alterations in pharmacokinetic parameters of zidovudine or rifabutin to warrant dosage adjustment when megestrol acetate is administered with these drugs.
entities: rifabutin / megestrol acetate
ddi: null
>>> match: be_warrant
-------------
sentence: When warfarin is co-administered with nevirapine, anticoagulation levels should be monitored frequently.
entities: warfarin / nevirapine
ddi: advise
>>> match: monitor_administer
-------------
sentence: Nevirapine and ketoconazole should not beadministered concomitantly becausedecreases in ketoconazole plasmaconcentrations may reduce the efficacy of the drug.
entities: Nevirapine / ketoconazole
ddi: null
>>> match: reduce_beadminister
-------------
sentence: Nevirapine and ketoconazole should not beadministered concomitantly becausedecreases in ketoconazole plasmaconcentrations may reduce the efficacy of the drug.
entities: ketoconazole / ketoconazole
ddi: null
>>> match: reduce_beadminister
-------------
sentence: Methadone levels may be decreased; increased dosages may be required to prevent symptoms of opiate withdrawal. Methadone maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly.
entities: Methadone / nevirapine
ddi: advise
>>> match: decrease_maintain
-------------
sentence: Nevirapine and rifampin should not beadministered concomitantly becausedecreases in nevirapine plasmaconcentrations may reduce the efficacy ofthe drug.
entities: Nevirapine / nevirapine
ddi: null
>>> match: reduce_beadminister
-------------
sentence: Nevirapine and rifampin should not beadministered concomitantly becausedecreases in nevirapine plasmaconcentrations may reduce the efficacy ofthe drug.
entities: rifampin / nevirapine
ddi: null
>>> match: reduce_beadminister
-------------
sentence: It is recommended that if CASODEX is started in patients already receiving coumarin anticoagulants, prothrombin times should be closely monitored and adjustment of the anticoagulant dose may be necessary.
entities: CASODEX / coumarin anticoagulants
ddi: advise
>>> match: monitor_start
-------------
sentence: It is recommended that if CASODEX is started in patients already receiving coumarin anticoagulants, prothrombin times should be closely monitored and adjustment of the anticoagulant dose may be necessary.
entities: CASODEX / anticoagulant
ddi: advise
>>> match: recommend_monitor
-------------
sentence: It is recommended that if CASODEX is started in patients already receiving coumarin anticoagulants, prothrombin times should be closely monitored and adjustment of the anticoagulant dose may be necessary.
entities: coumarin anticoagulants / anticoagulant
ddi: null
>>> match: recommend_monitor
-------------
sentence: Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain narcotic analgesics such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and antihistamines.
entities: AKINETON / narcotic analgesics
ddi: effect
>>> match: occur_administer
-------------
sentence: Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain narcotic analgesics such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and antihistamines.
entities: AKINETON / meperidine
ddi: effect
>>> match: occur_administer
-------------
sentence: Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain narcotic analgesics such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and antihistamines.
entities: AKINETON / phenothiazines
ddi: effect
>>> match: occur_administer
-------------
sentence: Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain narcotic analgesics such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and antihistamines.
entities: AKINETON / antipsychotics
ddi: effect
>>> match: occur_administer
-------------
sentence: Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain narcotic analgesics such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and antihistamines.
entities: AKINETON / tricyclic antidepressants
ddi: effect
>>> match: occur_administer
-------------
sentence: Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain narcotic analgesics such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and antihistamines.
entities: AKINETON / antiarrhythmics
ddi: effect
>>> match: occur_administer
-------------
sentence: Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain narcotic analgesics such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and antihistamines.
entities: AKINETON / quinidine
ddi: effect
>>> match: occur_administer
-------------
sentence: Drug Interactions: The central anticholinergic syndrome can occur when anticholinergic agents such as AKINETON are administered concomitantly with drugs that have secondary anticholinergic actions, e.g., certain narcotic analgesics such as meperidine, the phenothiazines and other antipsychotics, tricyclic antidepressants, certain antiarrhythmics such as the quinidine salts, and antihistamines.
entities: AKINETON / antihistamines
ddi: effect
>>> match: occur_administer
-------------
sentence: Human pharmacokinetics data indicate that oral ketoconazole potently inhibits the metabolism of cisapride resulting in an eight-fold increase in the mean AUC of cisapride.
entities: ketoconazole / cisapride
ddi: mechanism
>>> match: indicate_inhibit
-------------
sentence: Human pharmacokinetics data indicate that oral ketoconazole potently inhibits the metabolism of cisapride resulting in an eight-fold increase in the mean AUC of cisapride.
entities: ketoconazole / cisapride
ddi: null
>>> match: indicate_inhibit
-------------
sentence: In vitro data suggest that itraconazole also markedly inhibits the biotransformation system mainly responsible for the metabolism of cisapride;
entities: itraconazole / cisapride
ddi: mechanism
>>> match: suggest_inhibit
-------------
sentence: When Itraconazole was coadministered with phenytoin, rifampin, or H2antagonists, reduced plasma concentrations of itraconazole were reported.
entities: Itraconazole / phenytoin
ddi: mechanism
>>> match: report_coadminister
-------------
sentence: When Itraconazole was coadministered with phenytoin, rifampin, or H2antagonists, reduced plasma concentrations of itraconazole were reported.
entities: Itraconazole / rifampin
ddi: mechanism
>>> match: report_coadminister
-------------
sentence: When Itraconazole was coadministered with phenytoin, rifampin, or H2antagonists, reduced plasma concentrations of itraconazole were reported.
entities: Itraconazole / itraconazole
ddi: null
>>> match: report_coadminister
-------------
sentence: The physician is advised to monitor the plasma concentrations of itraconazole when any of these drugs is taken concurrently, and to increase the dose of Itraconazole if necessary.
entities: itraconazole / Itraconazole
ddi: null
>>> match: advise_monitor
-------------
sentence: It has been reported that Itraconazole enhances the anticoagulant effect of coumarin-like drugs.
entities: Itraconazole / coumarin
ddi: effect
>>> match: report_enhance
-------------
sentence: The results from a study in which eight HIV-infected individuals were treated with zidovudine, 8 +/- 0.4 mg/kg/day, showed that the pharmacokinetics of zidovudine were not affected during concomitant administration of Itraconazole, 100 mg b.i.d.
entities: zidovudine / Itraconazole
ddi: null
>>> match: show_affect
-------------
sentence: However, because some quinolones have been reported to enhance the anticoagulant effects of warfarin or its derivatives in patients, the prothrombin time or other suitable coagulation test should be closely monitored if a quinolone antimicrobial is administered concomitantly with warfarin or its derivatives.
entities: quinolones / warfarin
ddi: effect
>>> match: monitor_report
-------------
sentence: However, because some quinolones have been reported to enhance the anticoagulant effects of warfarin or its derivatives in patients, the prothrombin time or other suitable coagulation test should be closely monitored if a quinolone antimicrobial is administered concomitantly with warfarin or its derivatives.
entities: quinolone antimicrobial / warfarin
ddi: advise
>>> match: monitor_administer
-------------
sentence: Population pharmacokinetic analyses revealed that MTX, NSAIDs, corticosteroids, and TNF blocking agents did not influence abatacept clearance.
entities: MTX / abatacept
ddi: null
>>> match: reveal_influence
-------------
sentence: Population pharmacokinetic analyses revealed that MTX, NSAIDs, corticosteroids, and TNF blocking agents did not influence abatacept clearance.
entities: NSAIDs / abatacept
ddi: null
>>> match: reveal_influence
-------------
sentence: Population pharmacokinetic analyses revealed that MTX, NSAIDs, corticosteroids, and TNF blocking agents did not influence abatacept clearance.
entities: corticosteroids / abatacept
ddi: null
>>> match: reveal_influence
-------------
sentence: Population pharmacokinetic analyses revealed that MTX, NSAIDs, corticosteroids, and TNF blocking agents did not influence abatacept clearance.
entities: TNF blocking agents / abatacept
ddi: null
>>> match: reveal_influence
-------------
sentence: There is insufficient experience to assess the safety and efficacy of ORENCIA administered concurrently with anakinra, and therefore such use is not recommended.
entities: ORENCIA / anakinra
ddi: advise
>>> match: be_administer
-------------
sentence: The possibility of hypotensive effects can be minimized by either discontinuing the diuretic or increasing salt intake prior to initiation of treatment with fosinopril sodium.
entities: diuretic / fosinopril sodium
ddi: effect
>>> match: minimize_discontinue
-------------
sentence: Antacids: In a clinical pharmacology study, coadministration of an antacid (aluminum hydroxide, magnesium hydroxide, and simethicone) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone, suggesting that antacids may impair absorption of fosinopril.
entities: antacids / fosinopril
ddi: mechanism
>>> match: suggest_impair
-------------
sentence: When amiodarone is added to flecainide therapy, plasma flecainide levels may increase two-fold or more in some patients, if flecainide dosage is not reduced.
entities: amiodarone / flecainide
ddi: mechanism
>>> match: increase_add
-------------
sentence: Drugs that inhibit cytochrome P450IID6, such as quinidine , might increase the plasma concentrations of flecainide in patients that are on chronic flecainide therapy;
entities: flecainide / flecainide
ddi: null
>>> match: inhibit_increase
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir).
entities: Sanctura / Sanctura
ddi: null
>>> match: eliminate_conduct
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir).
entities: Sanctura / digoxin
ddi: null
>>> match: eliminate_conduct
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir).
entities: Sanctura / procainamide
ddi: null
>>> match: eliminate_conduct
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir).
entities: Sanctura / pancuronium
ddi: null
>>> match: eliminate_conduct
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir).
entities: Sanctura / morphine
ddi: null
>>> match: eliminate_conduct
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir).
entities: Sanctura / vancomycin
ddi: null
>>> match: eliminate_conduct
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir).
entities: Sanctura / metformin
ddi: null
>>> match: eliminate_conduct
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir).
entities: Sanctura / tenofovir
ddi: null
>>> match: eliminate_conduct
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir).
entities: Sanctura / digoxin
ddi: mechanism
>>> match: conduct_have
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir).
entities: Sanctura / procainamide
ddi: mechanism
>>> match: conduct_have
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir).
entities: Sanctura / pancuronium
ddi: mechanism
>>> match: conduct_have
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir).
entities: Sanctura / morphine
ddi: mechanism
>>> match: conduct_have
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir).
entities: Sanctura / vancomycin
ddi: mechanism
>>> match: conduct_have
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir).
entities: Sanctura / metformin
ddi: mechanism
>>> match: conduct_have
-------------
sentence: Drugs Eliminated by Active Tubular Secretion: Although studies to assess drug-drug interactions with Sanctura have not been conducted, Sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir).
entities: Sanctura / tenofovir
ddi: mechanism
>>> match: conduct_have
-------------
sentence: To investigate the effects of antimicrobial combinations of GL with four kinds of antibiotics (ampicillin, cefazolin, oxytetracycline and chloramphenicol), the fractional inhibitory concentration index (FICI) was determined by checkerboard assay for each strain.
entities: GL / ampicillin
ddi: null
>>> match: determine_investigate
-------------
sentence: To investigate the effects of antimicrobial combinations of GL with four kinds of antibiotics (ampicillin, cefazolin, oxytetracycline and chloramphenicol), the fractional inhibitory concentration index (FICI) was determined by checkerboard assay for each strain.
entities: GL / cefazolin
ddi: null
>>> match: determine_investigate
-------------
sentence: To investigate the effects of antimicrobial combinations of GL with four kinds of antibiotics (ampicillin, cefazolin, oxytetracycline and chloramphenicol), the fractional inhibitory concentration index (FICI) was determined by checkerboard assay for each strain.
entities: GL / oxytetracycline
ddi: null
>>> match: determine_investigate
-------------
sentence: To investigate the effects of antimicrobial combinations of GL with four kinds of antibiotics (ampicillin, cefazolin, oxytetracycline and chloramphenicol), the fractional inhibitory concentration index (FICI) was determined by checkerboard assay for each strain.
entities: GL / chloramphenicol
ddi: null
>>> match: determine_investigate
-------------
sentence: To investigate the effects of antimicrobial combinations of GL with four kinds of antibiotics (ampicillin, cefazolin, oxytetracycline and chloramphenicol), the fractional inhibitory concentration index (FICI) was determined by checkerboard assay for each strain.
entities: antibiotics / ampicillin
ddi: null
>>> match: determine_investigate
-------------
sentence: To investigate the effects of antimicrobial combinations of GL with four kinds of antibiotics (ampicillin, cefazolin, oxytetracycline and chloramphenicol), the fractional inhibitory concentration index (FICI) was determined by checkerboard assay for each strain.
entities: antibiotics / cefazolin
ddi: null
>>> match: determine_investigate
-------------
sentence: To investigate the effects of antimicrobial combinations of GL with four kinds of antibiotics (ampicillin, cefazolin, oxytetracycline and chloramphenicol), the fractional inhibitory concentration index (FICI) was determined by checkerboard assay for each strain.
entities: antibiotics / oxytetracycline
ddi: null
>>> match: determine_investigate
-------------
sentence: To investigate the effects of antimicrobial combinations of GL with four kinds of antibiotics (ampicillin, cefazolin, oxytetracycline and chloramphenicol), the fractional inhibitory concentration index (FICI) was determined by checkerboard assay for each strain.
entities: antibiotics / chloramphenicol
ddi: null
>>> match: determine_investigate
-------------
sentence: Synergism was observed when GL was combined with cefazolin against Bacillus subtilis and Klebsiella oxytoca.
entities: GL / cefazolin
ddi: effect
>>> match: observe_combine
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;
entities: anticoagulant / adrenocortical steroids
ddi: effect
>>> match: report_diminish
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / adrenocortical steroids
ddi: effect
>>> match: report_diminish
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / alcohol
ddi: effect
>>> match: report_diminish
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / antacids
ddi: effect
>>> match: report_diminish
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / antihistamines
ddi: effect
>>> match: report_diminish
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / barbiturates
ddi: effect
>>> match: report_diminish
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / carbamazepine
ddi: effect
>>> match: report_diminish
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / chloral hydrate
ddi: effect
>>> match: report_diminish
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / chlordiazepoxide
ddi: effect
>>> match: report_diminish
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / cholestyramine
ddi: effect
>>> match: report_diminish
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / vitamin K
ddi: effect
>>> match: report_diminish
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / diuretics
ddi: effect
>>> match: report_diminish
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / ethchlorvynol
ddi: effect
>>> match: report_diminish
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / glutethimide
ddi: effect
>>> match: report_diminish
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / griseofulvin
ddi: effect
>>> match: report_diminish
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / haloperidol
ddi: effect
>>> match: report_diminish
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / meprobamate
ddi: effect
>>> match: report_diminish
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / contraceptives
ddi: effect
>>> match: report_diminish
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / paraldehyde
ddi: effect
>>> match: report_diminish
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / primidone
ddi: effect
>>> match: report_diminish
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / ranitidine
ddi: effect
>>> match: report_diminish
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / rifampin
ddi: effect
>>> match: report_diminish
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / vitamin C
ddi: effect
>>> match: report_diminish
-------------
sentence: Drugs that have been reported to diminish oral anticoagulant response, ie, decreased prothrom-bin time response, in man significantly include: adrenocortical steroids;alcohol*;antacids;antihistamines;barbiturates;carbamazepine;chloral hydrate*;chlordiazepoxide;cholestyramine;diet high in vitamin K;diuretics*;ethchlorvynol;glutethimide;griseofulvin;haloperidol;meprobamate;oral contraceptives;paraldehyde;primidone;ranitidine*;rifampin;unreliable prothrombin time determinations;vitamin C;warfarin sodium under-dosage.
entities: anticoagulant / warfarin sodium
ddi: effect
>>> match: report_diminish
-------------
sentence: Because oral anticoagulants may interfere with the hepatic metabolism of phenytoin, toxic levels of the anticonvulsant may occur when an oral anticoagulant and phenytoin are administered concurrently.
entities: anticoagulants / phenytoin
ddi: mechanism
>>> match: occur_interfere
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: aspirin / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: aspirin / melatonin
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: aspirin / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: aspirin / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: NSAIDs / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: NSAIDs / melatonin
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: NSAIDs / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: NSAIDs / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / melatonin
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: fluvoxamine / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: fluvoxamine / melatonin
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: fluvoxamine / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: fluvoxamine / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / melatonin
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: beta blockers / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: beta blockers / melatonin
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: beta blockers / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: beta blockers / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / melatonin
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: fluoxetine / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: fluoxetine / melatonin
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: fluoxetine / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: fluoxetine / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: progestin / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: progestin / melatonin
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: progestin / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: progestin / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / melatonin
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: progestin / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: progestin / melatonin
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: progestin / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: progestin / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: benzodiazepenes / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: benzodiazepenes / melatonin
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: benzodiazepenes / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: benzodiazepenes / corticosteroids
ddi: null
>>> match: interact_result
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: corticosteroids / melatonin
ddi: null
>>> match: result_interfere
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: corticosteroids / corticosteroids
ddi: null
>>> match: result_interfere
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: corticosteroids / corticosteroids
ddi: null
>>> match: result_interfere
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: melatonin / corticosteroids
ddi: null
>>> match: result_interfere
-------------
sentence: Melatonin may interact with the following drugs: aspirin and other NSAIDs (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).
entities: corticosteroids / corticosteroids
ddi: null
>>> match: result_interfere
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin.
entities: sodium carboxymethylcellulose / sodium fluorescein
ddi: null
>>> match: evaluate_conjugate
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin.
entities: sodium carboxymethylcellulose / NaFlu
ddi: null
>>> match: evaluate_conjugate
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin.
entities: sodium carboxymethylcellulose / bacitracin
ddi: null
>>> match: evaluate_conjugate
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin.
entities: sodium carboxymethylcellulose / insulin
ddi: null
>>> match: evaluate_conjugate
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin.
entities: NaCMC / sodium fluorescein
ddi: null
>>> match: evaluate_conjugate
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin.
entities: NaCMC / NaFlu
ddi: null
>>> match: evaluate_conjugate
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin.
entities: NaCMC / bacitracin
ddi: null
>>> match: evaluate_conjugate
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin.
entities: NaCMC / insulin
ddi: null
>>> match: evaluate_conjugate
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin.
entities: carboxymethylcellulose-cysteine / sodium fluorescein
ddi: null
>>> match: evaluate_conjugate
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin.
entities: carboxymethylcellulose-cysteine / NaFlu
ddi: null
>>> match: evaluate_conjugate
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin.
entities: carboxymethylcellulose-cysteine / bacitracin
ddi: null
>>> match: evaluate_conjugate
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin.
entities: carboxymethylcellulose-cysteine / insulin
ddi: null
>>> match: evaluate_conjugate
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin.
entities: CMC-Cys / sodium fluorescein
ddi: null
>>> match: evaluate_conjugate
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin.
entities: CMC-Cys / NaFlu
ddi: null
>>> match: evaluate_conjugate
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin.
entities: CMC-Cys / bacitracin
ddi: null
>>> match: evaluate_conjugate
-------------
sentence: The purpose of this study was to evaluate the effect of sodium carboxymethylcellulose (NaCMC) and carboxymethylcellulose-cysteine (CMC-Cys) conjugates on the intestinal permeation of sodium fluorescein (NaFlu) and model peptide drugs, bacitracin and insulin.
entities: CMC-Cys / insulin
ddi: null
>>> match: evaluate_conjugate
-------------
sentence: Preliminary animal and human studies have shown that small quantities of systemically administered leucovorin enter the CSF primarily as 5-methyltetrahydro-folate and, in humans, remain 1 to 3 orders of magnitude lower than the usual methotrexate concentrations following intrathecal administration.
entities: leucovorin / methotrexate
ddi: null
>>> match: show_enter
-------------
sentence: When other potent parental antihypertensive drugs, such as diazoxide, are used in combination with hydralazine, patients should be continuously observed for several hours for any excessive fall in blood pressure.
entities: antihypertensive drugs / hydralazine
ddi: effect
>>> match: observe_use
-------------
sentence: When other potent parental antihypertensive drugs, such as diazoxide, are used in combination with hydralazine, patients should be continuously observed for several hours for any excessive fall in blood pressure.
entities: diazoxide / hydralazine
ddi: null
>>> match: observe_use
-------------
sentence: Anticholinesterases: Concurrent use of procaine hydrochloride and anticholinesterase agents may result in increased systemic toxicity since anticholinesterases inhibit the breakdown of procaine hydrochloride.
entities: anticholinesterases / procaine hydrochloride
ddi: mechanism
>>> match: result_inhibit
-------------
sentence: However, if Argatroban is to be initiated after cessation of heparin therapy, allow sufficient time for heparins effect on the aPTT to decrease prior to initiation of Argatroban therapy.
entities: Argatroban / heparin
ddi: null
>>> match: allow_initiate
-------------
sentence: Medications can interfere with folate utilization, including: anticonvulsant medications (such as phenytoin, and primidone) metformin (sometimes prescribed to control blood sugar in type 2 diabetes) sulfasalazine (used to control inflammation associated with Crohns disease and ulcerative colitis) triamterene (a diuretic) Methotrexate There has been concern about the interaction between vitamin B12 and folic acid.
entities: triamterene / vitamin B12
ddi: null
>>> match: use_control
-------------
sentence: Medications can interfere with folate utilization, including: anticonvulsant medications (such as phenytoin, and primidone) metformin (sometimes prescribed to control blood sugar in type 2 diabetes) sulfasalazine (used to control inflammation associated with Crohns disease and ulcerative colitis) triamterene (a diuretic) Methotrexate There has been concern about the interaction between vitamin B12 and folic acid.
entities: triamterene / folic acid
ddi: null
>>> match: use_control
-------------
sentence: Medications can interfere with folate utilization, including: anticonvulsant medications (such as phenytoin, and primidone) metformin (sometimes prescribed to control blood sugar in type 2 diabetes) sulfasalazine (used to control inflammation associated with Crohns disease and ulcerative colitis) triamterene (a diuretic) Methotrexate There has been concern about the interaction between vitamin B12 and folic acid.
entities: diuretic / vitamin B12
ddi: null
>>> match: use_control
-------------
sentence: Medications can interfere with folate utilization, including: anticonvulsant medications (such as phenytoin, and primidone) metformin (sometimes prescribed to control blood sugar in type 2 diabetes) sulfasalazine (used to control inflammation associated with Crohns disease and ulcerative colitis) triamterene (a diuretic) Methotrexate There has been concern about the interaction between vitamin B12 and folic acid.
entities: diuretic / folic acid
ddi: null
>>> match: use_control
-------------
sentence: Medications can interfere with folate utilization, including: anticonvulsant medications (such as phenytoin, and primidone) metformin (sometimes prescribed to control blood sugar in type 2 diabetes) sulfasalazine (used to control inflammation associated with Crohns disease and ulcerative colitis) triamterene (a diuretic) Methotrexate There has been concern about the interaction between vitamin B12 and folic acid.
entities: Methotrexate / vitamin B12
ddi: null
>>> match: use_control
-------------
sentence: Medications can interfere with folate utilization, including: anticonvulsant medications (such as phenytoin, and primidone) metformin (sometimes prescribed to control blood sugar in type 2 diabetes) sulfasalazine (used to control inflammation associated with Crohns disease and ulcerative colitis) triamterene (a diuretic) Methotrexate There has been concern about the interaction between vitamin B12 and folic acid.
entities: Methotrexate / folic acid
ddi: null
>>> match: use_control
-------------
sentence: It is better to avoid prescribing isoenzyme CYP 2D6 inhibitors to women treated with tamoxifen for breast cancer, especially SSRI antidepressants such as paroxetine and fluoxetine.
entities: tamoxifen / SSRI antidepressants
ddi: advise
>>> match: avoid_prescribe
-------------
sentence: It is better to avoid prescribing isoenzyme CYP 2D6 inhibitors to women treated with tamoxifen for breast cancer, especially SSRI antidepressants such as paroxetine and fluoxetine.
entities: tamoxifen / paroxetine
ddi: advise
>>> match: avoid_prescribe
-------------
sentence: It is better to avoid prescribing isoenzyme CYP 2D6 inhibitors to women treated with tamoxifen for breast cancer, especially SSRI antidepressants such as paroxetine and fluoxetine.
entities: tamoxifen / fluoxetine
ddi: advise
>>> match: avoid_prescribe
-------------
sentence: The following drug interactions have been identified involving NIZORAL Tablets and other drugs metabolized by the cytochrome P450 3A4 enzyme system: Ketoconazole tablets inhibit the metabolism of terfenadine, resulting in an increased plasma concentration of terfenadine and a delay in the elimination of its acid metabolite.
entities: NIZORAL / Ketoconazole
ddi: null
>>> match: involve_metabolize
-------------
sentence: The following drug interactions have been identified involving NIZORAL Tablets and other drugs metabolized by the cytochrome P450 3A4 enzyme system: Ketoconazole tablets inhibit the metabolism of terfenadine, resulting in an increased plasma concentration of terfenadine and a delay in the elimination of its acid metabolite.
entities: NIZORAL / terfenadine
ddi: null
>>> match: involve_metabolize
-------------
sentence: The following drug interactions have been identified involving NIZORAL Tablets and other drugs metabolized by the cytochrome P450 3A4 enzyme system: Ketoconazole tablets inhibit the metabolism of terfenadine, resulting in an increased plasma concentration of terfenadine and a delay in the elimination of its acid metabolite.
entities: NIZORAL / terfenadine
ddi: null
>>> match: involve_metabolize
-------------
sentence: The following drug interactions have been identified involving NIZORAL Tablets and other drugs metabolized by the cytochrome P450 3A4 enzyme system: Ketoconazole tablets inhibit the metabolism of terfenadine, resulting in an increased plasma concentration of terfenadine and a delay in the elimination of its acid metabolite.
entities: Ketoconazole / terfenadine
ddi: mechanism
>>> match: metabolize_inhibit
-------------
sentence: The following drug interactions have been identified involving NIZORAL Tablets and other drugs metabolized by the cytochrome P450 3A4 enzyme system: Ketoconazole tablets inhibit the metabolism of terfenadine, resulting in an increased plasma concentration of terfenadine and a delay in the elimination of its acid metabolite.
entities: Ketoconazole / terfenadine
ddi: null
>>> match: metabolize_inhibit
-------------
sentence: Pharmacokinetic data indicate that oral ketoconazole inhibits the metabolism of astemizole, resulting in elevated plasma levels of astemizole and its active metabolite desmethylastemizole which may prolong QT intervals.
entities: ketoconazole / astemizole
ddi: effect
>>> match: indicate_inhibit
-------------
sentence: Pharmacokinetic data indicate that oral ketoconazole inhibits the metabolism of astemizole, resulting in elevated plasma levels of astemizole and its active metabolite desmethylastemizole which may prolong QT intervals.
entities: ketoconazole / astemizole
ddi: null
>>> match: indicate_inhibit
-------------
sentence: Pharmacokinetic data indicate that oral ketoconazole inhibits the metabolism of astemizole, resulting in elevated plasma levels of astemizole and its active metabolite desmethylastemizole which may prolong QT intervals.
entities: ketoconazole / desmethylastemizole
ddi: null
>>> match: indicate_inhibit
-------------
sentence: Pharmacokinetic data indicate that oral ketoconazole inhibits the metabolism of astemizole, resulting in elevated plasma levels of astemizole and its active metabolite desmethylastemizole which may prolong QT intervals.
entities: astemizole / astemizole
ddi: null
>>> match: indicate_inhibit
-------------
sentence: Pharmacokinetic data indicate that oral ketoconazole inhibits the metabolism of astemizole, resulting in elevated plasma levels of astemizole and its active metabolite desmethylastemizole which may prolong QT intervals.
entities: astemizole / desmethylastemizole
ddi: null
>>> match: indicate_inhibit
-------------
sentence: Human pharmacokinetics data indicate that oral ketoconazole potently inhibits the metabolism of cisapride resulting in a mean eight-fold increase in AUC of cisapride.
entities: ketoconazole / cisapride
ddi: mechanism
>>> match: indicate_inhibit
-------------
sentence: Human pharmacokinetics data indicate that oral ketoconazole potently inhibits the metabolism of cisapride resulting in a mean eight-fold increase in AUC of cisapride.
entities: ketoconazole / cisapride
ddi: null
>>> match: indicate_inhibit
-------------
sentence: Dosage adjustment may be required if cyclosporine, tacrolimus, or methylprednisolone are given concomitantly with NIZORAL  Tablets.
entities: cyclosporine / NIZORAL
ddi: null
>>> match: require_give
-------------
sentence: Dosage adjustment may be required if cyclosporine, tacrolimus, or methylprednisolone are given concomitantly with NIZORAL  Tablets.
entities: tacrolimus / NIZORAL
ddi: null
>>> match: require_give
-------------
sentence: Dosage adjustment may be required if cyclosporine, tacrolimus, or methylprednisolone are given concomitantly with NIZORAL  Tablets.
entities: methylprednisolone / NIZORAL
ddi: null
>>> match: require_give
-------------
sentence: Also, there were no clinically significant differences in adverse events when loratadine was administered with or without ketoconazole.
entities: loratadine / ketoconazole
ddi: null
>>> match: be_administer
-------------
sentence: Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels.
entities: antacids / piroxicam
ddi: null
>>> match: administer_have
-------------
sentence: Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels.
entities: Nonsteroidal anti-inflammatory agents / lithium
ddi: mechanism
>>> match: administer_report
-------------
sentence: Plasma levels of piroxicam are depressed to approximately 80% of their normal values when FELDENE is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . Nonsteroidal anti-inflammatory agents, including FELDENE, have been reported to increase steady state plasma lithium levels.
entities: FELDENE / lithium
ddi: mechanism
>>> match: administer_report
-------------
sentence: It is recommended that plasma lithium levels be monitored when initiating, adjusting and discontinuing FELDENE.
entities: lithium / FELDENE
ddi: advise
>>> match: recommend_monitor
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.
entities: ketoconazole / paricalcitol
ddi: mechanism
>>> match: demonstrate_double
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.
entities: ketoconazole / paricalcitol
ddi: null
>>> match: demonstrate_double
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.
entities: ketoconazole / ketoconazole
ddi: null
>>> match: demonstrate_double
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.
entities: paricalcitol / paricalcitol
ddi: null
>>> match: double_know
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.
entities: paricalcitol / ketoconazole
ddi: null
>>> match: double_know
-------------
sentence: A multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol AUC0-   . Since paricalcitol is partially metabolized by CYP3A and ketoconazole le is known to be a strong inhibitor of cytochrome P450 3A enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong P450 3A inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.
entities: paricalcitol / ketoconazole
ddi: null
>>> match: know_metabolize
-------------
sentence: It has been reported that sulfamethoxazole may prolong the prothrombin time in patients who are receiving the anticoagulant warfarin.
entities: sulfamethoxazole / anticoagulant
ddi: null
>>> match: report_prolong
-------------
sentence: It has been reported that sulfamethoxazole may prolong the prothrombin time in patients who are receiving the anticoagulant warfarin.
entities: sulfamethoxazole / warfarin
ddi: effect
>>> match: report_prolong
-------------
sentence: If NovoLog is mixed with NPH human insulin, NovoLog should be drawn into the syringe first.
entities: NovoLog / NPH human insulin
ddi: null
>>> match: draw_mix
-------------
sentence: The possibility of hypotensive effects with captopril can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with captopril (captopril tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).
entities: diuretic / captopril
ddi: null
>>> match: minimize_discontinue
-------------
sentence: The possibility of hypotensive effects with captopril can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with captopril (captopril tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).
entities: diuretic / captopril
ddi: null
>>> match: minimize_discontinue
-------------
sentence: The possibility of hypotensive effects with captopril can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with captopril (captopril tablets, USP) or initiating therapy with small doses (6.25 or 12.5 mg).
entities: captopril / captopril
ddi: null
>>> match: minimize_discontinue
-------------
sentence: Inhibitors Of Endogenous Prostaglandin Synthesis It has been reported that indomethacin may reduce the antihypertensive effect of captopril, especially in cases of low renin hypertension.
entities: indomethacin / captopril
ddi: effect
>>> match: report_reduce
-------------
sentence: Loop Diuretics: Furosemide administered concurrently with captopril does not alter the pharmacokinetics of captopril in renally impaired hypertensive patients.
entities: Furosemide / captopril
ddi: null
>>> match: alter_administer
-------------
sentence: Although ibuprofen (400 mg qid) can be administered with ALIMTA in patients with normal renal function (creatinine clearance    80 mL/min), caution should be used when administering ibuprofen concurrently with ALIMTA to patients with mild to moderate renal insufficiency (creatinine clearance from 45 to 79 mL/min).
entities: ibuprofen / ALIMTA
ddi: null
>>> match: use_administer
-------------
sentence: Patients with mild to moderate renal insufficiency should avoid taking NSAIDs with short elimination half-lives for a period of 2 days before, the day of, and 2 days following administration of ALIMTA.
entities: NSAIDs / ALIMTA
ddi: advise
>>> match: avoid_take
-------------
sentence: However, the antagonism of the theophylline-induced anxiogenic effects by CGS21680 was only observed in the time spent in the light zone, and DPCPX-induced anxiogenic effects were neither reversed by CGS 21680 nor by CPA.
entities: DPCPX / CGS 21680
ddi: null
>>> match: observe_reverse
-------------
sentence: However, the antagonism of the theophylline-induced anxiogenic effects by CGS21680 was only observed in the time spent in the light zone, and DPCPX-induced anxiogenic effects were neither reversed by CGS 21680 nor by CPA.
entities: DPCPX / CPA
ddi: null
>>> match: observe_reverse
-------------
sentence: Warfarin: When healthy subjects were administered Starlix 120 mg three times daily before meals for four days in combination with a single dose of warfarin 30 mg on day 2, there were no alterations in the pharmacokinetics of either agent.
entities: Starlix / warfarin
ddi: null
>>> match: be_administer
-------------
sentence: Concomitant administration of naproxen and aspirin is not recommended because naproxen is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations and peak plasma levels.
entities: naproxen / aspirin
ddi: advise
>>> match: recommend_displace
-------------
sentence: Caution should be used if naproxen is administered concomitantly with methotrexate.
entities: naproxen / methotrexate
ddi: advise
>>> match: use_administer
-------------
sentence: Naproxen, naproxen sodium and other NSAIDs have been reported to reduce the tubular secretion of methotrexate in an animal model, possibly increasing the toxicity of methotrexate.
entities: methotrexate / methotrexate
ddi: null
>>> match: report_reduce
-------------
sentence: These data indicate that levetiracetam does not influence the plasma concentration of other AEDs and that these AEDs do not influence the pharmacokinetics of levetiracetam.
entities: levetiracetam / AEDs
ddi: null
>>> match: indicate_influence
-------------
sentence: These data indicate that levetiracetam does not influence the plasma concentration of other AEDs and that these AEDs do not influence the pharmacokinetics of levetiracetam.
entities: levetiracetam / AEDs
ddi: null
>>> match: indicate_influence
-------------
sentence: These data indicate that levetiracetam does not influence the plasma concentration of other AEDs and that these AEDs do not influence the pharmacokinetics of levetiracetam.
entities: levetiracetam / levetiracetam
ddi: null
>>> match: indicate_influence
-------------
sentence: These data indicate that levetiracetam does not influence the plasma concentration of other AEDs and that these AEDs do not influence the pharmacokinetics of levetiracetam.
entities: AEDs / AEDs
ddi: null
>>> match: indicate_influence
-------------
sentence: These data indicate that levetiracetam does not influence the plasma concentration of other AEDs and that these AEDs do not influence the pharmacokinetics of levetiracetam.
entities: AEDs / levetiracetam
ddi: null
>>> match: indicate_influence
-------------
sentence: These data indicate that levetiracetam does not influence the plasma concentration of other AEDs and that these AEDs do not influence the pharmacokinetics of levetiracetam.
entities: AEDs / levetiracetam
ddi: null
>>> match: influence_influence
-------------
sentence: Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of carbamazepine, valproate, topiramate, or lamotrigine.
entities: Levetiracetam / carbamazepine
ddi: null
>>> match: recommend_have
-------------
sentence: Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of carbamazepine, valproate, topiramate, or lamotrigine.
entities: Levetiracetam / valproate
ddi: null
>>> match: recommend_have
-------------
sentence: Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of carbamazepine, valproate, topiramate, or lamotrigine.
entities: Levetiracetam / topiramate
ddi: null
>>> match: recommend_have
-------------
sentence: Dose adjustment is not recommended.Levetiracetam had no effect on plasma concentrations of carbamazepine, valproate, topiramate, or lamotrigine.
entities: Levetiracetam / lamotrigine
ddi: null
>>> match: recommend_have
-------------
sentence: If ZEMURON    is administered following administration of succinylcholine, it should not be given until recovery from succinylcholine has been observed.
entities: ZEMURON / succinylcholine
ddi: advise
>>> match: give_administer
-------------
sentence: Therefore, caution should be used when administering nitazoxanide concurrently with other highly plasma protein-bound drugs with narrow therapeutic indices, as competition for binding sites may occur (e.g., warfarin).
entities: nitazoxanide / warfarin
ddi: mechanism
>>> match: use_occur
-------------
sentence: These results suggest that exposure to environmental lead may alter the biological and behavioral responsiveness of an animal to alcohol.
entities: lead / alcohol
ddi: effect
>>> match: suggest_alter
-------------
sentence: Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and insulin.
entities: dexamethasone / transferrin
ddi: null
>>> match: modify_affect
-------------
sentence: Although neither dexamethasone nor retinyl acetate affected the proliferation of prostatic epithelium in RPMI1640 containing transferrin alone, they modify the mitogenic effect of EGF and insulin.
entities: retinyl acetate / transferrin
ddi: null
>>> match: modify_affect
-------------
sentence: These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.
entities: dexamethasone / insulin
ddi: effect
>>> match: suggest_regulate
-------------
sentence: These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.
entities: dexamethasone / EGF
ddi: effect
>>> match: suggest_regulate
-------------
sentence: These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.
entities: retinyl acetate / insulin
ddi: effect
>>> match: suggest_regulate
-------------
sentence: These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.
entities: retinyl acetate / EGF
ddi: effect
>>> match: suggest_regulate
-------------
sentence: These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.
entities: glucocorticoids / insulin
ddi: effect
>>> match: suggest_regulate
-------------
sentence: These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.
entities: glucocorticoids / EGF
ddi: effect
>>> match: suggest_regulate
-------------
sentence: These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.
entities: retinoids / insulin
ddi: effect
>>> match: suggest_regulate
-------------
sentence: These results suggest that both dexamethasone and retinyl acetate, and possibly other glucocorticoids and retinoids, may regulate the proliferation of prostate epithelium by a dose-dependent modification of the activity of insulin and EGF.
entities: retinoids / EGF
ddi: effect
>>> match: suggest_regulate
-------------
sentence: Amphotericin B injection and potassium-depleting agents: When corticosteroids are administered concomitantly with potassium-depleting agents (e.g., amphotericin B, diuretics), patients should be observed closely for development of hypokalemia.
entities: corticosteroids / amphotericin B
ddi: advise
>>> match: observe_administer
-------------
sentence: Amphotericin B injection and potassium-depleting agents: When corticosteroids are administered concomitantly with potassium-depleting agents (e.g., amphotericin B, diuretics), patients should be observed closely for development of hypokalemia.
entities: corticosteroids / diuretics
ddi: advise
>>> match: observe_administer
-------------
sentence: Ketoconazole: Ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60%, leading to increased risk of corticosteroid side effects.
entities: corticosteroids / corticosteroid
ddi: null
>>> match: report_decrease
-------------
sentence: When Mefloquine is taken concurrently with oral live typhoid vaccines, attenuation of immunization cannot be excluded.
entities: Mefloquine / live typhoid vaccines
ddi: effect
>>> match: exclude_take
-------------
sentence: The possibility of hypotensive effects with Lotensin can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with Lotensin.
entities: diuretic / Lotensin
ddi: advise
>>> match: minimize_discontinue
-------------
sentence: Other No clinically important pharmacokinetic interactions occurred when Lotensin was administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.
entities: Lotensin / hydrochlorothiazide
ddi: null
>>> match: occur_administer
-------------
sentence: Other No clinically important pharmacokinetic interactions occurred when Lotensin was administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.
entities: Lotensin / chlorthalidone
ddi: null
>>> match: occur_administer
-------------
sentence: Other No clinically important pharmacokinetic interactions occurred when Lotensin was administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.
entities: Lotensin / furosemide
ddi: null
>>> match: occur_administer
-------------
sentence: Other No clinically important pharmacokinetic interactions occurred when Lotensin was administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.
entities: Lotensin / digoxin
ddi: null
>>> match: occur_administer
-------------
sentence: Other No clinically important pharmacokinetic interactions occurred when Lotensin was administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.
entities: Lotensin / propranolol
ddi: null
>>> match: occur_administer
-------------
sentence: Other No clinically important pharmacokinetic interactions occurred when Lotensin was administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.
entities: Lotensin / atenolol
ddi: null
>>> match: occur_administer
-------------
sentence: Other No clinically important pharmacokinetic interactions occurred when Lotensin was administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.
entities: Lotensin / naproxen
ddi: null
>>> match: occur_administer
-------------
sentence: Other No clinically important pharmacokinetic interactions occurred when Lotensin was administered concomitantly with hydrochlorothiazide, chlorthalidone, furosemide, digoxin, propranolol, atenolol, naproxen, or cimetidine.
entities: Lotensin / cimetidine
ddi: null
>>> match: occur_administer
-------------
sentence: Thus, the results suggest that cypermethrin exposure of rats results in free radical-mediated tissue damage, as indicated by elevated cerebral and hepatic lipid peroxidation, which was prevented by allopurinol and Vitamin E.
entities: cypermethrin / allopurinol
ddi: effect
>>> match: suggest_result
-------------
sentence: Thus, the results suggest that cypermethrin exposure of rats results in free radical-mediated tissue damage, as indicated by elevated cerebral and hepatic lipid peroxidation, which was prevented by allopurinol and Vitamin E.
entities: cypermethrin / Vitamin E
ddi: effect
>>> match: suggest_result
-------------
sentence: Studies in rats have shown that neomycin administration attenuates certain types of adrenocortical steroid dependent hypertension, including ACTH hypertension.
entities: neomycin / ACTH
ddi: effect
>>> match: show_attenuate
-------------
sentence: Preliminary data which suggest that dapsone may inhibit the anti-inflammatory activity of Lamprene have not been confirmed.
entities: dapsone / Lamprene
ddi: effect
>>> match: suggest_inhibit
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: cholestyramine / digitalis
ddi: mechanism
>>> match: interfere_pose
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: cholestyramine / cholestyramine
ddi: null
>>> match: interfere_pose
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: cholestyramine / resin
ddi: null
>>> match: interfere_pose
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: resin / digitalis
ddi: null
>>> match: interfere_pose
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: resin / cholestyramine
ddi: null
>>> match: interfere_pose
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: resin / resin
ddi: null
>>> match: interfere_pose
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: digitalis / cholestyramine
ddi: null
>>> match: pose_filtrate
-------------
sentence: Cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation, The discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin.
entities: digitalis / resin
ddi: null
>>> match: pose_filtrate
-------------
sentence: Ethanol decreases the elimination of abacavir causing an increase in overall exposure . The addition of methadone has no clinically significant effect on the pharmacokinetic properties of abacavir.
entities: methadone / abacavir
ddi: null
>>> match: decrease_have
-------------
sentence: Although not studied systematically in clinical trials, no drug interactions were observed when vecuronium, pancuronium, or atracurium were administered following varying degrees of recovery from single doses or infusions of NIMBEX.
entities: vecuronium / NIMBEX
ddi: null
>>> match: observe_administer
-------------
sentence: Although not studied systematically in clinical trials, no drug interactions were observed when vecuronium, pancuronium, or atracurium were administered following varying degrees of recovery from single doses or infusions of NIMBEX.
entities: pancuronium / NIMBEX
ddi: null
>>> match: observe_administer
-------------
sentence: Although not studied systematically in clinical trials, no drug interactions were observed when vecuronium, pancuronium, or atracurium were administered following varying degrees of recovery from single doses or infusions of NIMBEX.
entities: atracurium / NIMBEX
ddi: null
>>> match: observe_administer
-------------
sentence: Isoflurane or enflurane administered with nitrous oxide/oxygen to achieve 1.25 MAC [Minimum Alveolar Concentration] may prolong the clinically effective duration of action of initial and maintenance doses of NIMBEX and decrease the required infusion rate of NIMBEX.
entities: NIMBEX / NIMBEX
ddi: null
>>> match: administer_prolong
-------------
sentence: When phenytoin or other hepatic enzyme inducers such as rifampin and phenobarbital have been taken concurrently with Mexitil   , lowered Mexitil    plasma levels have been reported.
entities: phenytoin / Mexitil
ddi: mechanism
>>> match: lower_take
-------------
sentence: When phenytoin or other hepatic enzyme inducers such as rifampin and phenobarbital have been taken concurrently with Mexitil   , lowered Mexitil    plasma levels have been reported.
entities: rifampin / Mexitil
ddi: mechanism
>>> match: lower_take
-------------
sentence: When phenytoin or other hepatic enzyme inducers such as rifampin and phenobarbital have been taken concurrently with Mexitil   , lowered Mexitil    plasma levels have been reported.
entities: phenobarbital / Mexitil
ddi: mechanism
>>> match: lower_take
-------------
sentence: Mexitil    does not alter serum digoxin levels but magnesium-aluminum hydroxide, when used to treat gastrointestinal symptoms due to Mexitil   , has been reported to lower serum digoxin levels.
entities: Mexitil / digoxin
ddi: null
>>> match: use_treat
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed.
entities: Theophylline / Mexitil
ddi: null
>>> match: observe_return
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed.
entities: Theophylline / Mexitil
ddi: mechanism
>>> match: observe_return
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed.
entities: Mexitil / Mexitil
ddi: null
>>> match: observe_return
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed.
entities: Mexitil / theophylline
ddi: null
>>> match: observe_monitor
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed.
entities: Mexitil / Mexitil
ddi: null
>>> match: observe_monitor
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed.
entities: theophylline / theophylline
ddi: null
>>> match: observe_monitor
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed.
entities: theophylline / Mexitil
ddi: null
>>> match: observe_monitor
-------------
sentence: This increase was observed at the first test point which was the second day after starting Mexitil   . Theophylline plasma levels returned to pre-Mexitil    values within 48 hours after discontinuing Mexitil   . If Mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the Mexitil    dose is changed.
entities: theophylline / Mexitil
ddi: null
>>> match: observe_monitor
-------------
sentence: There was a small decrease in the clearance of cetirizine caused by a 400-mg dose of theophylline;
entities: cetirizine / theophylline
ddi: mechanism
>>> match: be_cause
-------------
sentence: The possibility of hypotensive effects with PRINIVIL can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with PRINIVIL.
entities: diuretic / PRINIVIL
ddi: effect
>>> match: minimize_discontinue
-------------
sentence: When a diuretic is added to the therapy of a patient receiving PRINIVIL, an additional antihypertensive effect is usually observed.
entities: diuretic / PRINIVIL
ddi: effect
>>> match: observe_add
-------------
sentence: Studies with ACE inhibitors in combination with diuretics indicate that the dose of the ACE inhibitor can be reduced when it is given with a diuretic.
entities: ACE inhibitor / diuretic
ddi: advise
>>> match: indicate_reduce
-------------
sentence: Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE inhibitors, including lisinopril.
entities: NSAIDs / ACE inhibitors
ddi: effect
>>> match: suggest_diminish
-------------
sentence: Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE inhibitors, including lisinopril.
entities: NSAIDs / lisinopril
ddi: effect
>>> match: suggest_diminish
-------------
sentence: In a study in 36 patients with mild to moderate hypertension where the antihypertensive effects of PRINIVIL alone were compared to PRINIVIL given concomitantly with indomethacin, the use of indomethacin was associated with a reduced antihypertensive effect, although the difference between the two regimens was not significant.
entities: PRINIVIL / PRINIVIL
ddi: null
>>> match: associate_compare
-------------
sentence: In a study in 36 patients with mild to moderate hypertension where the antihypertensive effects of PRINIVIL alone were compared to PRINIVIL given concomitantly with indomethacin, the use of indomethacin was associated with a reduced antihypertensive effect, although the difference between the two regimens was not significant.
entities: PRINIVIL / indomethacin
ddi: null
>>> match: associate_compare
-------------
sentence: No clinically important pharmacokinetic interactions occurred when PRINIVIL was used concomitantly with propranolol or hydrochlorothiazide.
entities: PRINIVIL / propranolol
ddi: null
>>> match: occur_use
-------------
sentence: No clinically important pharmacokinetic interactions occurred when PRINIVIL was used concomitantly with propranolol or hydrochlorothiazide.
entities: PRINIVIL / hydrochlorothiazide
ddi: null
>>> match: occur_use
-------------
sentence: It is recommended that serum lithium levels be monitored frequently if PRINIVIL is administered concomitantly with lithium.
entities: lithium / PRINIVIL
ddi: null
>>> match: recommend_monitor
-------------
sentence: It is recommended that serum lithium levels be monitored frequently if PRINIVIL is administered concomitantly with lithium.
entities: lithium / lithium
ddi: null
>>> match: recommend_monitor
-------------
sentence: It is recommended that serum lithium levels be monitored frequently if PRINIVIL is administered concomitantly with lithium.
entities: PRINIVIL / lithium
ddi: advise
>>> match: monitor_administer
-------------
sentence: Since there have been conflicting results regarding the effect of digoxin levels, it is recommended that digoxin levels be monitored when initiating, adjusting, and discontinuing diltiazem hydrochloride therapy to avoid possible over- or under-digitalization.
entities: digoxin / diltiazem hydrochloride
ddi: advise
>>> match: recommend_monitor
-------------
sentence: Studies showed that diltiazem increased the AUC of midazolam and triazolam by 3-4 fold and the Cmax by 2-fold, compared to placebo.
entities: diltiazem / midazolam
ddi: mechanism
>>> match: show_increase
-------------
sentence: Studies showed that diltiazem increased the AUC of midazolam and triazolam by 3-4 fold and the Cmax by 2-fold, compared to placebo.
entities: diltiazem / triazolam
ddi: mechanism
>>> match: show_increase
-------------
sentence: Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.
entities: bosentan / norethindrone
ddi: null
>>> match: demonstrate_produce
-------------
sentence: Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.
entities: bosentan / ethinyl estradiol
ddi: null
>>> match: demonstrate_produce
-------------
sentence: Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.
entities: hormonal contraceptive / norethindrone
ddi: null
>>> match: demonstrate_produce
-------------
sentence: Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.
entities: hormonal contraceptive / ethinyl estradiol
ddi: null
>>> match: demonstrate_produce
-------------
sentence: Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.
entities: Ortho-Novum / norethindrone
ddi: null
>>> match: demonstrate_produce
-------------
sentence: Hormonal Contraceptives, Including Oral, Injectable, Transdermal, and Implantable Contraceptives: An interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive Ortho-Novum produced average decreases of norethindrone and ethinyl estradiol levels of 14% and 31%, respectively.
entities: Ortho-Novum / ethinyl estradiol
ddi: null
>>> match: demonstrate_produce
-------------
sentence: Patients using CYP3A4 metabolized statins should have cholesterol levels monitored after TRACLEER is initiated to see whether the statin dose needs adjustment.
entities: TRACLEER / statin
ddi: null
>>> match: monitor_initiate
-------------
sentence: Digoxin, Nimodipine and Losartan: Bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine, and losartan has no significant effect on plasma levels of bosentan.
entities: losartan / bosentan
ddi: null
>>> match: have_have
-------------
sentence: Allopurinol: The AUC of didanosine was increased about 4-fold when allopurinol at 300 mg/day was coadministered with a single 200-mg dose of VIDEX to two patients with renal impairment (CLcr=15 and 18 mL/min).
entities: allopurinol / VIDEX
ddi: mechanism
>>> match: increase_coadminister
-------------
sentence: Drugs Whose Absorption Can Be Affected by the Level of Acidity in the Stomach: Drugs such as ketoconazole and itraconazole should be administered at least 2 hours prior to dosing with VIDEX.
entities: ketoconazole / VIDEX
ddi: advise
>>> match: affect_administer
-------------
sentence: Drugs Whose Absorption Can Be Affected by the Level of Acidity in the Stomach: Drugs such as ketoconazole and itraconazole should be administered at least 2 hours prior to dosing with VIDEX.
entities: itraconazole / VIDEX
ddi: advise
>>> match: affect_administer
-------------
sentence: A 21 (17)% decrease in the steady-state AUC of ganciclovir was observed when VIDEX was administered 2 hours prior to ganciclovir, but not when the two drugs were administered simultaneously (n = 12).
entities: VIDEX / ganciclovir
ddi: mechanism
>>> match: observe_administer
-------------
sentence: Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, calcium, or aluminum.
entities: ciprofloxacin / antacids
ddi: null
>>> match: administer_decrease
-------------
sentence: Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, calcium, or aluminum.
entities: ciprofloxacin / magnesium
ddi: mechanism
>>> match: administer_decrease
-------------
sentence: Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, calcium, or aluminum.
entities: ciprofloxacin / calcium
ddi: mechanism
>>> match: administer_decrease
-------------
sentence: Quinolone Antibiotics: VIDEX should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium, calcium, or aluminum.
entities: ciprofloxacin / aluminum
ddi: mechanism
>>> match: administer_decrease
-------------
sentence: In eight HIV-infected patients, the steady-state AUC of ciprofloxacin was decreased an average of 26% (95% CI = 14%, 37%) when ciprofloxacin was administered 2 hours prior to a marketed chewable/dispersible tablet formulation of VIDEX.
entities: ciprofloxacin / VIDEX
ddi: mechanism
>>> match: decrease_administer
-------------
sentence: This study aimed to evaluate the in vitro activity of minocycline combined with fosfomycin against isolates of methicillin-resistant Staphylococcus aureus (MRSA).
entities: minocycline / fosfomycin
ddi: null
>>> match: aim_evaluate
-------------
sentence: This study aimed to evaluate the in vitro activity of minocycline combined with fosfomycin against isolates of methicillin-resistant Staphylococcus aureus (MRSA).
entities: minocycline / methicillin
ddi: null
>>> match: aim_evaluate
-------------
sentence: In a patient with a nonfunctioning thyroid gland who is receiving thyroid replacement therapy, free levothyroxine may be decreased when estrogens are started thus increasing thyroid requirements.
entities: estrogens / thyroid
ddi: null
>>> match: decrease_start
-------------
sentence: Blood levels of hydrodolasetron increased 24% when dolasetron was coadministered with cimetidine (nonselective inhibitor of cytochrome P-450) for 7 days, and decreased 28% with coadministration of rifampin (potent inducer of cytochrome P-450) for 7 days.
entities: dolasetron / cimetidine
ddi: mechanism
>>> match: increase_coadminister
-------------
sentence: Blood levels of hydrodolasetron increased 24% when dolasetron was coadministered with cimetidine (nonselective inhibitor of cytochrome P-450) for 7 days, and decreased 28% with coadministration of rifampin (potent inducer of cytochrome P-450) for 7 days.
entities: dolasetron / rifampin
ddi: mechanism
>>> match: increase_coadminister
-------------
sentence: Clearance of hydrodolasetron decreased by about 27% when dolasetron mesylate was administered intravenously concomitantly with atenolol.
entities: dolasetron mesylate / atenolol
ddi: mechanism
>>> match: decrease_administer
-------------
sentence: Alcohol - Although LEXAPRO did not potentiate the cognitive and motor effects of alcohol in a clinical trial, as with other psychotropic medications, the use of alcohol by patients taking LEXAPRO is not recommended.
entities: LEXAPRO / alcohol
ddi: null
>>> match: recommend_potentiate
-------------
sentence: Alcohol - Although LEXAPRO did not potentiate the cognitive and motor effects of alcohol in a clinical trial, as with other psychotropic medications, the use of alcohol by patients taking LEXAPRO is not recommended.
entities: LEXAPRO / psychotropic medications
ddi: null
>>> match: recommend_potentiate
-------------
sentence: Alcohol - Although LEXAPRO did not potentiate the cognitive and motor effects of alcohol in a clinical trial, as with other psychotropic medications, the use of alcohol by patients taking LEXAPRO is not recommended.
entities: LEXAPRO / alcohol
ddi: null
>>> match: recommend_potentiate
-------------
sentence: Alcohol - Although LEXAPRO did not potentiate the cognitive and motor effects of alcohol in a clinical trial, as with other psychotropic medications, the use of alcohol by patients taking LEXAPRO is not recommended.
entities: LEXAPRO / LEXAPRO
ddi: null
>>> match: recommend_potentiate
-------------
sentence: Alcohol - Although LEXAPRO did not potentiate the cognitive and motor effects of alcohol in a clinical trial, as with other psychotropic medications, the use of alcohol by patients taking LEXAPRO is not recommended.
entities: alcohol / psychotropic medications
ddi: null
>>> match: recommend_potentiate
-------------
sentence: Alcohol - Although LEXAPRO did not potentiate the cognitive and motor effects of alcohol in a clinical trial, as with other psychotropic medications, the use of alcohol by patients taking LEXAPRO is not recommended.
entities: alcohol / alcohol
ddi: null
>>> match: recommend_potentiate
-------------
sentence: Alcohol - Although LEXAPRO did not potentiate the cognitive and motor effects of alcohol in a clinical trial, as with other psychotropic medications, the use of alcohol by patients taking LEXAPRO is not recommended.
entities: alcohol / LEXAPRO
ddi: null
>>> match: recommend_potentiate
-------------
sentence: Alcohol - Although LEXAPRO did not potentiate the cognitive and motor effects of alcohol in a clinical trial, as with other psychotropic medications, the use of alcohol by patients taking LEXAPRO is not recommended.
entities: psychotropic medications / alcohol
ddi: null
>>> match: recommend_potentiate
-------------
sentence: Alcohol - Although LEXAPRO did not potentiate the cognitive and motor effects of alcohol in a clinical trial, as with other psychotropic medications, the use of alcohol by patients taking LEXAPRO is not recommended.
entities: psychotropic medications / LEXAPRO
ddi: advise
>>> match: recommend_potentiate
-------------
sentence: Cimetidine - In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of 400 mg/day cimetidine for 8 days resulted in an increase in citalopram AUC and Cmax of 43% and 39%, respectively.
entities: cimetidine / citalopram
ddi: null
>>> match: receive_result
-------------
sentence: Because lithium may enhance the serotonergic effects of escitalopram, caution should be exercised when LEXAPRO and lithium are coadministered.
entities: lithium / escitalopram
ddi: effect
>>> match: exercise_enhance
-------------
sentence: Insulin: A clinical study in 6 insulin-dependent diabetic patients demonstrated no effect of EXTRANEAL on insulin absorption from the peritoneal cavity or on insulin's ability to control blood glucose when insulin was administered intraperitoneally with EXTRANEAL.
entities: insulin / EXTRANEAL
ddi: null
>>> match: control_administer
-------------
sentence: It is concluded that chloral hydrate and methaqualone may be administered safely without additional caution in prothrombin test monitoring during oral anticoagulant therapy.
entities: chloral hydrate / anticoagulant
ddi: null
>>> match: conclude_administer
-------------
sentence: It is concluded that chloral hydrate and methaqualone may be administered safely without additional caution in prothrombin test monitoring during oral anticoagulant therapy.
entities: methaqualone / anticoagulant
ddi: null
>>> match: conclude_administer
-------------
sentence: It is recommended not to exceed a single 5 mg dose of Vardenafil in a 24-hour period when used in combination with erythromycin.
entities: Vardenafil / erythromycin
ddi: advise
>>> match: recommend_exceed
-------------
sentence: Since higher doses of ketoconazole (400 mg daily) may result in higher increases in Cmax and AUC, a single 2.5 mg dose of Vardenafil should not be exceeded in a 24-hour period when used in combination with ketoconazole 400 mg daily.
entities: Vardenafil / ketoconazole
ddi: advise
>>> match: result_exceed
-------------
sentence: It is recommended not to exceed a single 2.5 mg Vardenafil dose in a 24-hour period when used in combination with indinavir.
entities: Vardenafil / indinavir
ddi: advise
>>> match: recommend_exceed
-------------
sentence: Consequently, it is recommended not to exceed a single 2.5 mg Vardenafil dose in a 72-hour period when used in combination with ritonavir.
entities: Vardenafil / ritonavir
ddi: advise
>>> match: recommend_exceed
-------------
sentence: These effects were not observed when Vardenafil 20 mg was taken 24 hours before the NTG.
entities: Vardenafil / NTG
ddi: null
>>> match: observe_take
-------------
sentence: When Vardenafil dosing was separated from terazosin 10 mg by 6 hours, 7 of 28 subjects who received 20 mg of Vardenafil experienced a decrease in standing systolic blood pressure below 85 mm Hg.
entities: Vardenafil / terazosin
ddi: effect
>>> match: experience_separate
-------------
sentence: Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.
entities: ethyl alcohol / scopolamine
ddi: null
>>> match: produce_administer
-------------
sentence: Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.
entities: ethyl alcohol / lorazepam
ddi: null
>>> match: produce_administer
-------------
sentence: Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.
entities: phenothiazines / scopolamine
ddi: null
>>> match: produce_administer
-------------
sentence: Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.
entities: phenothiazines / lorazepam
ddi: null
>>> match: produce_administer
-------------
sentence: Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.
entities: barbiturates / scopolamine
ddi: null
>>> match: produce_administer
-------------
sentence: Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.
entities: barbiturates / lorazepam
ddi: null
>>> match: produce_administer
-------------
sentence: Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.
entities: MAO inhibitors / scopolamine
ddi: null
>>> match: produce_administer
-------------
sentence: Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.
entities: MAO inhibitors / lorazepam
ddi: null
>>> match: produce_administer
-------------
sentence: Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.
entities: antidepressants / scopolamine
ddi: null
>>> match: produce_administer
-------------
sentence: Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.
entities: antidepressants / lorazepam
ddi: null
>>> match: produce_administer
-------------
sentence: Injection: Lorazepam injection, like other injectable benzodiazepines, produces depression of the central nervous system when administered with ethyl alcohol, phenothiazines, barbiturates, MAO inhibitors, and other antidepressants.When scopolamine is used concomitantly with injectable lorazepam, an increased incidence of sedation, hallucinations, and irrational behavior has been observed.
entities: scopolamine / lorazepam
ddi: effect
>>> match: observe_use
-------------
sentence: No drug interaction studies have been conducted for COLAZAL, however the use of orally administered antibiotics could, theoretically, interfere with the release of mesalamine in the colon.
entities: antibiotics / mesalamine
ddi: null
>>> match: conduct_interfere
-------------
sentence: Steroids enhance the renal toxicity of edetate calcium disodium in animals. 7 Edetate calcium disodium interferes with the action of zinc insulin preparations by chelating the zinc. 7
entities: Edetate calcium disodium / zinc insulin
ddi: mechanism
>>> match: enhance_interfere
-------------
sentence: Steroids enhance the renal toxicity of edetate calcium disodium in animals. 7 Edetate calcium disodium interferes with the action of zinc insulin preparations by chelating the zinc. 7
entities: Edetate calcium disodium / zinc
ddi: null
>>> match: enhance_interfere
-------------
sentence: Steroids enhance the renal toxicity of edetate calcium disodium in animals. 7 Edetate calcium disodium interferes with the action of zinc insulin preparations by chelating the zinc. 7
entities: zinc insulin / zinc
ddi: null
>>> match: enhance_interfere
-------------
sentence: In vitro studies demonstrated that the plasma protein binding of des-ciclesonide was not affected by warfarin or salicylic acid, indicating no potential for protein binding-based drug interactions.
entities: des-ciclesonide / warfarin
ddi: null
>>> match: demonstrate_affect
-------------
sentence: In vitro studies demonstrated that the plasma protein binding of des-ciclesonide was not affected by warfarin or salicylic acid, indicating no potential for protein binding-based drug interactions.
entities: des-ciclesonide / salicylic acid
ddi: null
>>> match: demonstrate_affect
-------------
sentence: We report the case of an adolescent with altered consciousness caused by carbamazepine overdose with a positive tricyclic antidepressant level to alert clinicians to the cross-reactivity of carbamazepine with a toxicology screen for tricyclic antidepressants.
entities: carbamazepine / tricyclic antidepressants
ddi: advise
>>> match: cause_alert
-------------
sentence: In three separate controlled, parallel group clinical pharmacology studies, desloratadine at the clinical dose of 5 mg has been coadministered with azithromycin 500 mg followed by 250 mg once daily for 4 days (n=18) or with fluoxetine 20 mg once daily for 7 days after a 23 day pretreatment period with fluoxetine (n=18) or with cimetidine 600 mg every 12 hours for 14 days (n=18) under steady state conditions to normal healthy male and female volunteers.
entities: azithromycin / fluoxetine
ddi: null
>>> match: coadminister_follow
-------------
sentence: In three separate controlled, parallel group clinical pharmacology studies, desloratadine at the clinical dose of 5 mg has been coadministered with azithromycin 500 mg followed by 250 mg once daily for 4 days (n=18) or with fluoxetine 20 mg once daily for 7 days after a 23 day pretreatment period with fluoxetine (n=18) or with cimetidine 600 mg every 12 hours for 14 days (n=18) under steady state conditions to normal healthy male and female volunteers.
entities: azithromycin / fluoxetine
ddi: null
>>> match: coadminister_follow
-------------
sentence: In three separate controlled, parallel group clinical pharmacology studies, desloratadine at the clinical dose of 5 mg has been coadministered with azithromycin 500 mg followed by 250 mg once daily for 4 days (n=18) or with fluoxetine 20 mg once daily for 7 days after a 23 day pretreatment period with fluoxetine (n=18) or with cimetidine 600 mg every 12 hours for 14 days (n=18) under steady state conditions to normal healthy male and female volunteers.
entities: azithromycin / cimetidine
ddi: null
>>> match: coadminister_follow
-------------
sentence: If EVISTA is given concurrently with warfarin, prothrombin time should be monitored.
entities: EVISTA / warfarin
ddi: advise
>>> match: monitor_give
-------------
sentence: Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, naproxen, ibuprofen, diazepam, and diazoxide.
entities: EVISTA / clofibrate
ddi: advise
>>> match: use_coadminister
-------------
sentence: Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, naproxen, ibuprofen, diazepam, and diazoxide.
entities: EVISTA / indomethacin
ddi: advise
>>> match: use_coadminister
-------------
sentence: Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, naproxen, ibuprofen, diazepam, and diazoxide.
entities: EVISTA / naproxen
ddi: advise
>>> match: use_coadminister
-------------
sentence: Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, naproxen, ibuprofen, diazepam, and diazoxide.
entities: EVISTA / ibuprofen
ddi: advise
>>> match: use_coadminister
-------------
sentence: Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, naproxen, ibuprofen, diazepam, and diazoxide.
entities: EVISTA / diazepam
ddi: advise
>>> match: use_coadminister
-------------
sentence: Caution should be used when EVISTA is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, naproxen, ibuprofen, diazepam, and diazoxide.
entities: EVISTA / diazoxide
ddi: advise
>>> match: use_coadminister
-------------
sentence: In vitro binding studies with human serum proteins indicate that glipizide binds differently than tolbutamide and does not interact with salicylate or dicumarol.
entities: glipizide / tolbutamide
ddi: null
>>> match: indicate_bind
-------------
sentence: In vitro binding studies with human serum proteins indicate that glipizide binds differently than tolbutamide and does not interact with salicylate or dicumarol.
entities: glipizide / salicylate
ddi: null
>>> match: indicate_bind
-------------
sentence: In vitro binding studies with human serum proteins indicate that glipizide binds differently than tolbutamide and does not interact with salicylate or dicumarol.
entities: glipizide / dicumarol
ddi: null
>>> match: indicate_bind
-------------
sentence: In vitro binding studies with human serum proteins indicate that glipizide binds differently than tolbutamide and does not interact with salicylate or dicumarol.
entities: tolbutamide / salicylate
ddi: null
>>> match: indicate_bind
-------------
sentence: In vitro binding studies with human serum proteins indicate that glipizide binds differently than tolbutamide and does not interact with salicylate or dicumarol.
entities: tolbutamide / dicumarol
ddi: null
>>> match: indicate_bind
-------------
sentence: Since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable to avoid giving tetracycline class drugs in conjunction with penicillin.
entities: tetracycline class drugs / penicillin
ddi: advise
>>> match: avoid_give
-------------
sentence: Such occurrences have been reported when propoxyphene was administered to patients on antidepressants, anticonvulsants, or warfarin-like drugs.
entities: propoxyphene / antidepressants
ddi: null
>>> match: report_administer
-------------
sentence: Such occurrences have been reported when propoxyphene was administered to patients on antidepressants, anticonvulsants, or warfarin-like drugs.
entities: propoxyphene / anticonvulsants
ddi: null
>>> match: report_administer
-------------
sentence: Such occurrences have been reported when propoxyphene was administered to patients on antidepressants, anticonvulsants, or warfarin-like drugs.
entities: propoxyphene / warfarin
ddi: null
>>> match: report_administer
-------------
sentence: Careful observation is required when amantadine is administered concurrently with central nervous system stimulants.
entities: amantadine / central nervous system stimulants
ddi: advise
>>> match: require_administer
-------------
sentence: Therefore, when meclofenamate sodium is given to a patient receiving warfarin, the dosage of warfarin should be reduced to prevent excessive prolongation of the prothrombin time.
entities: meclofenamate sodium / warfarin
ddi: advise
>>> match: reduce_give
-------------
sentence: Drugs That Inhibit Both Aldehyde Oxidase and CYP3A4 Cimetidine: Cimetidine inhibits both aldehyde oxidase (in vitro) and CYP3A4 (in vitro and in vivo), the primary and secondary enzymes, respectively, responsible for zaleplon metabolism.
entities: Cimetidine / zaleplon
ddi: mechanism
>>> match: inhibit_inhibit
-------------
sentence: This was expected because zaleplon is primarily metabolized and renal excretion of unchanged zaleplon accounts for less than 1% of the administered dose.
entities: zaleplon / zaleplon
ddi: null
>>> match: expect_metabolize
-------------
sentence: Furosemide: When aliskiren was co-administered with furosemide, the AUC and Cmax of furosemide were reduced by about 30% and 50%, respectively.
entities: aliskiren / furosemide
ddi: mechanism
>>> match: reduce_administer
-------------
sentence: Other TNFa-blocking agents (including REMICADE) used in combination with anakinra may also result in similar toxicities.
entities: TNFa-blocking agents / anakinra
ddi: effect
>>> match: result_use
-------------
sentence: Other TNFa-blocking agents (including REMICADE) used in combination with anakinra may also result in similar toxicities.
entities: REMICADE / anakinra
ddi: effect
>>> match: result_use
-------------
sentence: Prothrombin time or other suitable anticoagulation test should be monitored if tigecycline is administered with warfarin.
entities: tigecycline / warfarin
ddi: advise
>>> match: monitor_administer
-------------
sentence: Care should be taken when using immunoanalytical methods to measure plasma phenytoin concentrations following Cerebyx administration.
entities: phenytoin / Cerebyx
ddi: null
>>> match: use_measure
-------------
sentence: These data suggest that ginsenosides are negatively coupled to three types of calcium channels in bovine chromaffin cell, including an omega-conotoxin GVIA-sensitive (N-type) channel, an omega-agatoxin IVA-sensitive (P-type) channel and nimodipine/omega-conotoxin GVIA/omega-agatoxin VIA-resistant (presumptive Q-type) channel.
entities: ginsenosides / nimodipine
ddi: null
>>> match: suggest_couple
-------------
sentence: The purpose of this study was to evaluate whether the psychostimulant drug ephedrine has any effect on dexmedetomidine-induced antinociception and locomotor inhibitor activity in mice in acute application.
entities: ephedrine / dexmedetomidine
ddi: null
>>> match: evaluate_have
-------------
sentence: We concluded that the combined administration of dexmedetomidine with ephedrine may have beneficial effects in the treatment of pain without causing sedation, which limits the use of dexmedetomidine as an analgesic in humans.
entities: dexmedetomidine / dexmedetomidine
ddi: null
>>> match: conclude_have
-------------
sentence: We concluded that the combined administration of dexmedetomidine with ephedrine may have beneficial effects in the treatment of pain without causing sedation, which limits the use of dexmedetomidine as an analgesic in humans.
entities: dexmedetomidine / analgesic
ddi: null
>>> match: conclude_have
-------------
sentence: We concluded that the combined administration of dexmedetomidine with ephedrine may have beneficial effects in the treatment of pain without causing sedation, which limits the use of dexmedetomidine as an analgesic in humans.
entities: ephedrine / dexmedetomidine
ddi: null
>>> match: conclude_have
-------------
sentence: We concluded that the combined administration of dexmedetomidine with ephedrine may have beneficial effects in the treatment of pain without causing sedation, which limits the use of dexmedetomidine as an analgesic in humans.
entities: ephedrine / analgesic
ddi: null
>>> match: conclude_have
-------------
sentence: We concluded that the combined administration of dexmedetomidine with ephedrine may have beneficial effects in the treatment of pain without causing sedation, which limits the use of dexmedetomidine as an analgesic in humans.
entities: dexmedetomidine / analgesic
ddi: null
>>> match: have_limit
-------------
sentence: Clinical studies in healthy volunteers show that the pharmacokinetics of CANCIDAS are not altered by itraconazole, amphotericin B, mycophenolate, nelfinavir, or tacrolimus.
entities: CANCIDAS / itraconazole
ddi: null
>>> match: show_alter
-------------
sentence: Clinical studies in healthy volunteers show that the pharmacokinetics of CANCIDAS are not altered by itraconazole, amphotericin B, mycophenolate, nelfinavir, or tacrolimus.
entities: CANCIDAS / amphotericin B
ddi: null
>>> match: show_alter
-------------
sentence: Clinical studies in healthy volunteers show that the pharmacokinetics of CANCIDAS are not altered by itraconazole, amphotericin B, mycophenolate, nelfinavir, or tacrolimus.
entities: CANCIDAS / mycophenolate
ddi: null
>>> match: show_alter
-------------
sentence: Clinical studies in healthy volunteers show that the pharmacokinetics of CANCIDAS are not altered by itraconazole, amphotericin B, mycophenolate, nelfinavir, or tacrolimus.
entities: CANCIDAS / nelfinavir
ddi: null
>>> match: show_alter
-------------
sentence: Clinical studies in healthy volunteers show that the pharmacokinetics of CANCIDAS are not altered by itraconazole, amphotericin B, mycophenolate, nelfinavir, or tacrolimus.
entities: CANCIDAS / tacrolimus
ddi: null
>>> match: show_alter
-------------
sentence: In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine) with CANCIDAS may result in clinically meaningful reductions in caspofungin concentrations.
entities: efavirenz / caspofungin
ddi: null
>>> match: suggest_result
-------------
sentence: In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine) with CANCIDAS may result in clinically meaningful reductions in caspofungin concentrations.
entities: nevirapine / caspofungin
ddi: null
>>> match: suggest_result
-------------
sentence: In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine) with CANCIDAS may result in clinically meaningful reductions in caspofungin concentrations.
entities: phenytoin / caspofungin
ddi: null
>>> match: suggest_result
-------------
sentence: In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine) with CANCIDAS may result in clinically meaningful reductions in caspofungin concentrations.
entities: dexamethasone / caspofungin
ddi: null
>>> match: suggest_result
-------------
sentence: In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine) with CANCIDAS may result in clinically meaningful reductions in caspofungin concentrations.
entities: carbamazepine / caspofungin
ddi: null
>>> match: suggest_result
-------------
sentence: In addition, results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance (efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine) with CANCIDAS may result in clinically meaningful reductions in caspofungin concentrations.
entities: CANCIDAS / caspofungin
ddi: null
>>> match: suggest_result
-------------
sentence: When CANCIDAS is co-administered with inducers of drug clearance, such as efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine, use of a daily dose of 70 mg of CANCIDAS should be considered
entities: CANCIDAS / efavirenz
ddi: advise
>>> match: consider_administer
-------------
sentence: When CANCIDAS is co-administered with inducers of drug clearance, such as efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine, use of a daily dose of 70 mg of CANCIDAS should be considered
entities: CANCIDAS / nevirapine
ddi: advise
>>> match: consider_administer
-------------
sentence: When CANCIDAS is co-administered with inducers of drug clearance, such as efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine, use of a daily dose of 70 mg of CANCIDAS should be considered
entities: CANCIDAS / phenytoin
ddi: advise
>>> match: consider_administer
-------------
sentence: When CANCIDAS is co-administered with inducers of drug clearance, such as efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine, use of a daily dose of 70 mg of CANCIDAS should be considered
entities: CANCIDAS / dexamethasone
ddi: advise
>>> match: consider_administer
-------------
sentence: When CANCIDAS is co-administered with inducers of drug clearance, such as efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine, use of a daily dose of 70 mg of CANCIDAS should be considered
entities: CANCIDAS / carbamazepine
ddi: advise
>>> match: consider_administer
-------------
sentence: When CANCIDAS is co-administered with inducers of drug clearance, such as efavirenz, nevirapine, phenytoin, dexamethasone, or carbamazepine, use of a daily dose of 70 mg of CANCIDAS should be considered
entities: CANCIDAS / CANCIDAS
ddi: null
>>> match: consider_administer
-------------
sentence: This could lead to decreased salicylate serum levels or increase the risk of salicylate toxicity when corticosteroid is withdrawn.
entities: salicylate / corticosteroid
ddi: effect
>>> match: lead_increase
-------------
sentence: When sympathomimetic drugs are given to patients receiving monoamine oxidase inhibitors, hypertensive reactions, including hypertensive crises, may occur.
entities: sympathomimetic drugs / monoamine oxidase inhibitors
ddi: effect
>>> match: occur_give
-------------
sentence: Increased ectopic pacemaker activity can occur when pseudoephedrine is used concomitantly with digitalis.
entities: pseudoephedrine / digitalis
ddi: effect
>>> match: occur_use
-------------
sentence: The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine.
entities: neuromuscular blocking agents / phenytoin
ddi: effect
>>> match: reduce_demonstrate
-------------
sentence: The neuromuscular blocking effect of MIVACRON may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . Resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine.
entities: neuromuscular blocking agents / carbamazepine
ddi: effect
>>> match: reduce_demonstrate
-------------
sentence: The results indicate that a spinal naloxone-sensitive endorphinergic system is involved in the production of beta-endorphin but not morphine-induced tail-flick inhibition, and suggest that intraventricular beta-endorphin and morphine elicit their pharmacological actions via the activation of different descending pain inhibitory systems;
entities: naloxone / beta-endorphin
ddi: null
>>> match: indicate_involve
-------------
sentence: The results indicate that a spinal naloxone-sensitive endorphinergic system is involved in the production of beta-endorphin but not morphine-induced tail-flick inhibition, and suggest that intraventricular beta-endorphin and morphine elicit their pharmacological actions via the activation of different descending pain inhibitory systems;
entities: naloxone / morphine
ddi: null
>>> match: indicate_involve
-------------
sentence: The results indicate that a spinal naloxone-sensitive endorphinergic system is involved in the production of beta-endorphin but not morphine-induced tail-flick inhibition, and suggest that intraventricular beta-endorphin and morphine elicit their pharmacological actions via the activation of different descending pain inhibitory systems;
entities: naloxone / beta-endorphin
ddi: null
>>> match: indicate_involve
-------------
sentence: The results indicate that a spinal naloxone-sensitive endorphinergic system is involved in the production of beta-endorphin but not morphine-induced tail-flick inhibition, and suggest that intraventricular beta-endorphin and morphine elicit their pharmacological actions via the activation of different descending pain inhibitory systems;
entities: naloxone / morphine
ddi: null
>>> match: indicate_involve
-------------
sentence: The results indicate that a spinal naloxone-sensitive endorphinergic system is involved in the production of beta-endorphin but not morphine-induced tail-flick inhibition, and suggest that intraventricular beta-endorphin and morphine elicit their pharmacological actions via the activation of different descending pain inhibitory systems;
entities: beta-endorphin / beta-endorphin
ddi: null
>>> match: indicate_involve
-------------
sentence: The results indicate that a spinal naloxone-sensitive endorphinergic system is involved in the production of beta-endorphin but not morphine-induced tail-flick inhibition, and suggest that intraventricular beta-endorphin and morphine elicit their pharmacological actions via the activation of different descending pain inhibitory systems;
entities: beta-endorphin / morphine
ddi: null
>>> match: indicate_involve
-------------
sentence: The results indicate that a spinal naloxone-sensitive endorphinergic system is involved in the production of beta-endorphin but not morphine-induced tail-flick inhibition, and suggest that intraventricular beta-endorphin and morphine elicit their pharmacological actions via the activation of different descending pain inhibitory systems;
entities: morphine / beta-endorphin
ddi: null
>>> match: indicate_involve
-------------
sentence: The results indicate that a spinal naloxone-sensitive endorphinergic system is involved in the production of beta-endorphin but not morphine-induced tail-flick inhibition, and suggest that intraventricular beta-endorphin and morphine elicit their pharmacological actions via the activation of different descending pain inhibitory systems;
entities: morphine / morphine
ddi: null
>>> match: indicate_involve
-------------
sentence: Furosemide: Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and thiazides in some patients.
entities: NSAIDs / furosemide
ddi: effect
>>> match: show_reduce
-------------
sentence: Furosemide: Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and thiazides in some patients.
entities: NSAIDs / thiazides
ddi: effect
>>> match: show_reduce
-------------
sentence: Adequate monitoring of theophylline plasma concentrations should be considered when therapy with VIOXX is initiated or changed in patients receiving theophylline.
entities: VIOXX / theophylline
ddi: advise
>>> match: consider_initiate
-------------
sentence: Although this interaction has not been reported with cinoxacin, caution should be exercised when cinoxacin is given concomitantly with caffeine-containing products.
entities: cinoxacin / caffeine
ddi: advise
>>> match: exercise_give
-------------
sentence: When methyldopa is used with other antihypertensive drugs, potentiation of antihypertensive effect may occur.
entities: methyldopa / antihypertensive drugs
ddi: effect
>>> match: occur_use
-------------
sentence: The daily dose of dexamethasone administered in clinical studies with Aprepitant reflects an approximate 50% reduction of the dose of dexamethasone.
entities: dexamethasone / Aprepitant
ddi: mechanism
>>> match: reflect_administer
-------------
sentence: The IV methylprednisolone dose should be reduced by approximately 25%, and the oral methylprednisolone dose should be reduced by approximately 50% when coadministered with Aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without Aprepitant.
entities: methylprednisolone / Aprepitant
ddi: advise
>>> match: reduce_reduce
-------------
sentence: The IV methylprednisolone dose should be reduced by approximately 25%, and the oral methylprednisolone dose should be reduced by approximately 50% when coadministered with Aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without Aprepitant.
entities: methylprednisolone / methylprednisolone
ddi: null
>>> match: reduce_reduce
-------------
sentence: The IV methylprednisolone dose should be reduced by approximately 25%, and the oral methylprednisolone dose should be reduced by approximately 50% when coadministered with Aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without Aprepitant.
entities: methylprednisolone / Aprepitant
ddi: null
>>> match: reduce_reduce
-------------
sentence: The IV methylprednisolone dose should be reduced by approximately 25%, and the oral methylprednisolone dose should be reduced by approximately 50% when coadministered with Aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without Aprepitant.
entities: Aprepitant / methylprednisolone
ddi: null
>>> match: coadminister_achieve
-------------
sentence: The IV methylprednisolone dose should be reduced by approximately 25%, and the oral methylprednisolone dose should be reduced by approximately 50% when coadministered with Aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without Aprepitant.
entities: Aprepitant / Aprepitant
ddi: null
>>> match: coadminister_achieve
-------------
sentence: Aprepitant increased the AUC of midazolam by 25% on Day 4 and decreased the AUC of midazolam by 19% on Day 8 relative to the dosing of Aprepitant on Days 1 through 3.
entities: midazolam / Aprepitant
ddi: null
>>> match: increase_decrease
-------------
sentence: Because moderate CYP3A4 inhibitors (e.g., diltiazem) result in 2-fold increase in plasma concentrations of aprepitant, concomitant administration should also be approached with caution.
entities: diltiazem / aprepitant
ddi: advise
>>> match: approach_result
-------------
sentence: Tissue culture and animal studies indicate that ELSPAR can diminish or abolish the effect of methotrexate on malignant cells.14 This effect on methotrexate activity persists as long as plasma asparagine levels are suppressed.
entities: ELSPAR / methotrexate
ddi: effect
>>> match: indicate_diminish
-------------
sentence: Studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome P450 system, such as warfarin, antipyrine, indomethacin, ibuprofen, phenytoin, propranolol, prednisone, diazepam, clarithromycin, or terfenadine in healthy subjects.
entities: lansoprazole / warfarin
ddi: null
>>> match: show_have
-------------
sentence: Studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome P450 system, such as warfarin, antipyrine, indomethacin, ibuprofen, phenytoin, propranolol, prednisone, diazepam, clarithromycin, or terfenadine in healthy subjects.
entities: lansoprazole / antipyrine
ddi: null
>>> match: show_have
-------------
sentence: Studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome P450 system, such as warfarin, antipyrine, indomethacin, ibuprofen, phenytoin, propranolol, prednisone, diazepam, clarithromycin, or terfenadine in healthy subjects.
entities: lansoprazole / indomethacin
ddi: null
>>> match: show_have
-------------
sentence: Studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome P450 system, such as warfarin, antipyrine, indomethacin, ibuprofen, phenytoin, propranolol, prednisone, diazepam, clarithromycin, or terfenadine in healthy subjects.
entities: lansoprazole / ibuprofen
ddi: null
>>> match: show_have
-------------
sentence: Studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome P450 system, such as warfarin, antipyrine, indomethacin, ibuprofen, phenytoin, propranolol, prednisone, diazepam, clarithromycin, or terfenadine in healthy subjects.
entities: lansoprazole / phenytoin
ddi: null
>>> match: show_have
-------------
sentence: Studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome P450 system, such as warfarin, antipyrine, indomethacin, ibuprofen, phenytoin, propranolol, prednisone, diazepam, clarithromycin, or terfenadine in healthy subjects.
entities: lansoprazole / propranolol
ddi: null
>>> match: show_have
-------------
sentence: Studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome P450 system, such as warfarin, antipyrine, indomethacin, ibuprofen, phenytoin, propranolol, prednisone, diazepam, clarithromycin, or terfenadine in healthy subjects.
entities: lansoprazole / prednisone
ddi: null
>>> match: show_have
-------------
sentence: Studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome P450 system, such as warfarin, antipyrine, indomethacin, ibuprofen, phenytoin, propranolol, prednisone, diazepam, clarithromycin, or terfenadine in healthy subjects.
entities: lansoprazole / diazepam
ddi: null
>>> match: show_have
-------------
sentence: Studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome P450 system, such as warfarin, antipyrine, indomethacin, ibuprofen, phenytoin, propranolol, prednisone, diazepam, clarithromycin, or terfenadine in healthy subjects.
entities: lansoprazole / clarithromycin
ddi: null
>>> match: show_have
-------------
sentence: Studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome P450 system, such as warfarin, antipyrine, indomethacin, ibuprofen, phenytoin, propranolol, prednisone, diazepam, clarithromycin, or terfenadine in healthy subjects.
entities: lansoprazole / terfenadine
ddi: null
>>> match: show_have
-------------
sentence: When lansoprazole was administered concomitantly with theophylline (CYP1A2, CYP3A), a minor increase (10%) in the clearance of theophylline was seen.
entities: lansoprazole / theophylline
ddi: mechanism
>>> match: see_administer
-------------
sentence: In a single-dose crossover study examining lansoprazole 30 mg and omeprazole 20 mg each administered alone and concomitantly with sucralfate 1 gram, absorption of the proton pump inhibitors was delayed and their bioavailability was reduced by 17% and 16%, respectively, when administered concomitantly with sucralfate.
entities: sucralfate / proton pump inhibitors
ddi: null
>>> match: administer_delay
-------------
sentence: Preliminary evidence suggests that cimetidine inhibits mebendazole metabolism and may result in an increase in plasma concentrations of mebendazole.
entities: cimetidine / mebendazole
ddi: mechanism
>>> match: suggest_inhibit
-------------
sentence: Preliminary evidence suggests that cimetidine inhibits mebendazole metabolism and may result in an increase in plasma concentrations of mebendazole.
entities: cimetidine / mebendazole
ddi: null
>>> match: suggest_inhibit
-------------
sentence: Preliminary evidence suggests that cimetidine inhibits mebendazole metabolism and may result in an increase in plasma concentrations of mebendazole.
entities: mebendazole / mebendazole
ddi: null
>>> match: suggest_inhibit
-------------
sentence: The potential for increased sedation when guanfacine is given with other CNS-depressant drug should be appreciated.
entities: guanfacine / CNS-depressant drug
ddi: effect
>>> match: appreciate_give
-------------
sentence: This study demonstrated that the potent cytochrome P450 enzyme-inducer phenytoin did indeed have a marked effect on the metabolism of quetiapine, resulting in a 5-fold increase in clearance when administered concomitantly to patients with DSM-IV-diagnosed schizophrenia, schizoaffective disorder, or bipolar disorder.
entities: phenytoin / quetiapine
ddi: mechanism
>>> match: demonstrate_have
-------------
sentence: In the present study, we tested whether the highly specific metabotropic glutamate receptor 5 antagonist, 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine, reduces dopaminergic and noradrenergic neuronal loss in monkeys rendered parkinsonian by chronic treatment with low doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
entities: 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine / 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
ddi: null
>>> match: test_reduce
-------------
sentence: When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.
entities: atropine / pralidoxime
ddi: null
>>> match: expect_use
-------------
sentence: When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.
entities: atropine / atropine
ddi: null
>>> match: expect_use
-------------
sentence: When atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine.
entities: pralidoxime / atropine
ddi: effect
>>> match: use_potentiate
-------------
sentence: Since barbiturates are potentiated by the anticholinesterases, they should be used cautiously in the treatment of convulsions.
entities: barbiturates / anticholinesterases
ddi: advise
>>> match: use_potentiate
-------------
sentence: In vitro studies indicate that, at therapeutic concentrations of salicylate (300 m g/mL), the binding of ketorolac was reduced from approximately 99.2% to 97.5%, representing a potential twofold increase in unbound ketorolac plasma levels.
entities: salicylate / ketorolac
ddi: mechanism
>>> match: indicate_reduce
-------------
sentence: In vitro studies indicate that, at therapeutic concentrations of salicylate (300 m g/mL), the binding of ketorolac was reduced from approximately 99.2% to 97.5%, representing a potential twofold increase in unbound ketorolac plasma levels.
entities: salicylate / ketorolac
ddi: null
>>> match: indicate_reduce
-------------
sentence: In vitro studies indicate that, at therapeutic concentrations of salicylate (300 m g/mL), the binding of ketorolac was reduced from approximately 99.2% to 97.5%, representing a potential twofold increase in unbound ketorolac plasma levels.
entities: ketorolac / ketorolac
ddi: null
>>> match: indicate_reduce
-------------
sentence: Methotrexate: Concomitant administration of methotrexate and some NSAIDs has been reported to reduce the clearance of methotrexate, enhancing the toxicity of methotrexate.
entities: methotrexate / methotrexate
ddi: null
>>> match: report_reduce
-------------
sentence: Psychoactive Drugs: Hallucinations have been reported when TORADOL was used in patients taking psychoactive drugs (fluoxetine, thiothixene, alprazolam).
entities: TORADOL / psychoactive drugs
ddi: effect
>>> match: report_use
-------------
sentence: Psychoactive Drugs: Hallucinations have been reported when TORADOL was used in patients taking psychoactive drugs (fluoxetine, thiothixene, alprazolam).
entities: TORADOL / fluoxetine
ddi: effect
>>> match: report_use
-------------
sentence: Psychoactive Drugs: Hallucinations have been reported when TORADOL was used in patients taking psychoactive drugs (fluoxetine, thiothixene, alprazolam).
entities: TORADOL / thiothixene
ddi: effect
>>> match: report_use
-------------
sentence: Psychoactive Drugs: Hallucinations have been reported when TORADOL was used in patients taking psychoactive drugs (fluoxetine, thiothixene, alprazolam).
entities: TORADOL / alprazolam
ddi: effect
>>> match: report_use
-------------
sentence: Omeprazole: No clinically significant changes in lomefloxacin pharmacokinetics (AUC, C max , or T max ) were observed when a single dose of lomefloxacin 400 mg was given after multiple doses of omeprazole (20 mg qd) in 13 healthy volunteers.
entities: lomefloxacin / omeprazole
ddi: null
>>> match: observe_give
-------------
sentence: These results suggest that acute dosing with clozapine would not affect behaviors most closely associated with PCP intoxication.
entities: clozapine / PCP
ddi: null
>>> match: suggest_affect
-------------
sentence: Therefore, it is recommended that Fluvoxamine Tablets not be used in combination with MAOIs, or within 14 days of discontinuing treatment with a MAOI.
entities: Fluvoxamine / MAOIs
ddi: advise
>>> match: recommend_use
-------------
sentence: Therefore, it is recommended that Fluvoxamine Tablets not be used in combination with MAOIs, or within 14 days of discontinuing treatment with a MAOI.
entities: Fluvoxamine / MAOI
ddi: advise
>>> match: recommend_use
-------------
sentence: Consequently, it is recommended that fluvoxamine not be used in combination with either terbinafine, astemizole, or cisapride.
entities: fluvoxamine / terbinafine
ddi: advise
>>> match: recommend_use
-------------
sentence: Consequently, it is recommended that fluvoxamine not be used in combination with either terbinafine, astemizole, or cisapride.
entities: fluvoxamine / astemizole
ddi: advise
>>> match: recommend_use
-------------
sentence: Consequently, it is recommended that fluvoxamine not be used in combination with either terbinafine, astemizole, or cisapride.
entities: fluvoxamine / cisapride
ddi: advise
>>> match: recommend_use
-------------
sentence: This interaction, which has not been investigated using higher doses of fluvoxamine, may be more pronounced if a 300 mg daily dose is co-administered, particularly since fluvoxamine exhibits non-linear pharmacokinetics over the dosage range 100-300 mg. If alprazolam is co-administered with Fluvoxamine Tablets, the initial alprazolam dosage should be at least halved and titration to the lowest effective dose is recommended.
entities: alprazolam / Fluvoxamine
ddi: advise
>>> match: halve_administer
-------------
sentence: Because fluvoxamine reduces the clearance of both diazepam and its active metabolite, N-desmethyldiazepam, there is a strong likelihood of substantial accumulation of both species during chronic co-administration.
entities: fluvoxamine / diazepam
ddi: mechanism
>>> match: be_reduce
-------------
sentence: Because fluvoxamine reduces the clearance of both diazepam and its active metabolite, N-desmethyldiazepam, there is a strong likelihood of substantial accumulation of both species during chronic co-administration.
entities: fluvoxamine / N-desmethyldiazepam
ddi: mechanism
>>> match: be_reduce
-------------
sentence: Therefore, if theophylline is co-administered with fluvoxamine maleate, its dose should be reduced to one third of the usual daily maintenance dose and plasma concentrations of theophylline should to monitored.
entities: theophylline / fluvoxamine maleate
ddi: advise
>>> match: reduce_administer
-------------
sentence: Warfarin: When fluvoxamine maleate (50 mg tid) was administered concomitantly with warfarin for two weeks, warfarin plasma concentrations increased by 98% and prothrombin times were prolonged.
entities: fluvoxamine maleate / warfarin
ddi: mechanism
>>> match: increase_administer
-------------
sentence: The objective of this study was to determine if there is a pharmacokinetic interaction when amprenavir is given with rifabutin or rifampin and to determine the effects of these drugs on the erythromycin breath test (ERMBT).
entities: amprenavir / rifabutin
ddi: null
>>> match: be_give
-------------
sentence: The objective of this study was to determine if there is a pharmacokinetic interaction when amprenavir is given with rifabutin or rifampin and to determine the effects of these drugs on the erythromycin breath test (ERMBT).
entities: amprenavir / rifampin
ddi: null
>>> match: be_give
-------------
sentence: Rifampin significantly decreased the AUC(ss) of amprenavir by 82%, but amprenavir had no effect on rifampin pharmacokinetics.
entities: amprenavir / rifampin
ddi: null
>>> match: decrease_have
-------------
sentence: Hypertensive crises have resulted when sympathomimetic amines have been used concomitantly within14 days following use of monoamine oxidase inhibitors.
entities: sympathomimetic amines / monoamine oxidase inhibitors
ddi: effect
>>> match: result_use
-------------
sentence: Phenytoin: In a single (400 mg) and multiple dose (400 mg TID) study of Neurontin in epileptic patients (N=8) maintained on phenytoin monotherapy for at least 2 months, gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics.
entities: gabapentin / phenytoin
ddi: null
>>> match: maintain_have
-------------
sentence: Phenytoin: In a single (400 mg) and multiple dose (400 mg TID) study of Neurontin in epileptic patients (N=8) maintained on phenytoin monotherapy for at least 2 months, gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics.
entities: gabapentin / phenytoin
ddi: null
>>> match: maintain_have
-------------
sentence: Phenytoin: In a single (400 mg) and multiple dose (400 mg TID) study of Neurontin in epileptic patients (N=8) maintained on phenytoin monotherapy for at least 2 months, gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics.
entities: gabapentin / gabapentin
ddi: null
>>> match: maintain_have
-------------
sentence: Phenytoin: In a single (400 mg) and multiple dose (400 mg TID) study of Neurontin in epileptic patients (N=8) maintained on phenytoin monotherapy for at least 2 months, gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics.
entities: phenytoin / gabapentin
ddi: null
>>> match: maintain_have
-------------
sentence: Phenytoin: In a single (400 mg) and multiple dose (400 mg TID) study of Neurontin in epileptic patients (N=8) maintained on phenytoin monotherapy for at least 2 months, gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics.
entities: phenytoin / gabapentin
ddi: null
>>> match: maintain_have
-------------
sentence: It is recommended that gabapentin be taken at least 2 hours following Maalox administration.
entities: gabapentin / Maalox
ddi: advise
>>> match: recommend_take
-------------
sentence: This indicates that gabapentin does not undergo renal tubular secretion by the pathway that is blocked by probenecid.
entities: gabapentin / probenecid
ddi: null
>>> match: indicate_undergo
-------------
sentence: Drug/Laboratory Tests Interactions Because false positive readings were reported with the Ames N-Multistix SG dipstick test for urinary protein when gabapentin was added to other antiepileptic drugs, the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein
entities: gabapentin / antiepileptic drugs
ddi: null
>>> match: report_add
-------------
sentence: Taking a rauwolfia alkaloid while you are taking or within 2 weeks of taking MAO inhibitors may increase the risk of central nervous system depression or may cause a severe high blood pressure reaction.
entities: rauwolfia alkaloid / MAO inhibitors
ddi: effect
>>> match: increase_take
-------------
sentence: Inhibitors of CYP2D6: Because CYP2D6 is involved in duloxetine metabolism, concomitant use of duloxetine with potent inhibitors of CYP2D6 may result in higher concentrations of duloxetine.
entities: duloxetine / duloxetine
ddi: null
>>> match: result_involve
-------------
sentence: Plasma TCA concentrations may need to be monitored and the dose of the TCA may need to be reduced if a TCA is co-administered with Duloxetine.
entities: TCA / TCA
ddi: null
>>> match: monitor_need
-------------
sentence: Plasma TCA concentrations may need to be monitored and the dose of the TCA may need to be reduced if a TCA is co-administered with Duloxetine.
entities: TCA / Duloxetine
ddi: null
>>> match: monitor_need
-------------
sentence: Plasma TCA concentrations may need to be monitored and the dose of the TCA may need to be reduced if a TCA is co-administered with Duloxetine.
entities: TCA / Duloxetine
ddi: advise
>>> match: reduce_administer
-------------
sentence: Duloxetine May Have a Clinically Important Interaction with the Following Other Drugs: Alcohol: When Duloxetine and ethanol were administered several hours apart so that peak concentrations of each would coincide, Duloxetine did not increase the impairment of mental and motor skills caused by alcohol.
entities: Duloxetine / alcohol
ddi: null
>>> match: coincide_increase
-------------
sentence: In a study in normal volunteers, it was found that chronic concurrent administration of 3.6 g of aspirin per day decreases indomethacin blood levels approximately 20%.
entities: aspirin / indomethacin
ddi: mechanism
>>> match: find_decrease
-------------
sentence: Clinical studies have shown that INDOCIN does not influence the hypoprothrombinemia produced by anticoagulants.
entities: INDOCIN / anticoagulants
ddi: null
>>> match: show_influence
-------------
sentence: However, when any additional drug, including INDOCIN, is added to the treatment of patients on anticoagulant therapy, the patients should be observed for alterations of the prothrombin time.
entities: INDOCIN / anticoagulant
ddi: advise
>>> match: observe_add
-------------
sentence: Caution should be used if INDOCIN is administered simultaneously with methotrexate.
entities: INDOCIN / methotrexate
ddi: advise
>>> match: use_administer
-------------
sentence: INDOCIN given concomitantly with digoxin has been reported to increase the serum concentration and prolong the half-life of digoxin.
entities: INDOCIN / digoxin
ddi: mechanism
>>> match: report_give
-------------
sentence: Results of preliminary studies in humans and rats suggest that nonabsorbable antacids given concurrently with lactulose may inhibit the desired lactulose-induced drop in colonic pH.
entities: antacids / lactulose
ddi: mechanism
>>> match: suggest_give
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: ketoconazole / SUBUTEX
ddi: null
>>> match: adjust_have
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: ketoconazole / SUBOXONE
ddi: null
>>> match: adjust_have
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: macrolide antibiotics / SUBUTEX
ddi: null
>>> match: adjust_have
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: macrolide antibiotics / SUBOXONE
ddi: null
>>> match: adjust_have
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: erythromycin / SUBUTEX
ddi: null
>>> match: adjust_have
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: erythromycin / SUBOXONE
ddi: null
>>> match: adjust_have
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: HIV protease inhibitors / SUBUTEX
ddi: null
>>> match: adjust_have
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: HIV protease inhibitors / SUBOXONE
ddi: null
>>> match: adjust_have
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: ritonavir / SUBUTEX
ddi: null
>>> match: adjust_have
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: ritonavir / SUBOXONE
ddi: null
>>> match: adjust_have
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: indinavir / SUBUTEX
ddi: null
>>> match: adjust_have
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: indinavir / SUBOXONE
ddi: null
>>> match: adjust_have
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: saquinavir / SUBUTEX
ddi: null
>>> match: adjust_have
-------------
sentence: ketoconazole), macrolide antibiotics (e.g. erythromycin), and HIV protease inhibitors (e.g. ritonavir, indinavir and saquinavir) should have their dose of SUBUTEX or SUBOXONE adjusted.
entities: saquinavir / SUBOXONE
ddi: null
>>> match: adjust_have
-------------
sentence: Acarbose has been shown to change the bioavailabillty digoxin when they are co-administered, which may require digoxin dose adjustment.
entities: digoxin / digoxin
ddi: null
>>> match: show_change
-------------
sentence: Studies in healthy volunteers have shown that Acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin, nifedipine, propranolol, or ranitidine.
entities: Acarbose / digoxin
ddi: null
>>> match: show_have
-------------
sentence: Studies in healthy volunteers have shown that Acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin, nifedipine, propranolol, or ranitidine.
entities: Acarbose / nifedipine
ddi: null
>>> match: show_have
-------------
sentence: Studies in healthy volunteers have shown that Acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin, nifedipine, propranolol, or ranitidine.
entities: Acarbose / propranolol
ddi: null
>>> match: show_have
-------------
sentence: Studies in healthy volunteers have shown that Acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin, nifedipine, propranolol, or ranitidine.
entities: Acarbose / ranitidine
ddi: null
>>> match: show_have
-------------
sentence: Acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16% (90% confidence interval: 8-23%), decrease mean C max digoxin by 26% (90% confidence interval: 16-34%) and decrease mean trough concentrations of digoxin by 9% (90% confidence limit: 19% decrease to 2% increase).
entities: digoxin / digoxin
ddi: null
>>> match: affect_require
-------------
sentence: Zidovudine should either be temporarily discontinued or decreased by 50% when coadministered with probenecid on the day of VISTIDE infusion.
entities: probenecid / VISTIDE
ddi: null
>>> match: discontinue_coadminister
-------------
sentence: We conclude that the prophylactic and antidotal properties of 4-methylpyrazole seen in animals treated with 1,3-difluoro-2-propanol derive from its capacity to inhibit the NAD+-dependent oxidation responsible for converting 1,3-difluoro-2-propanol to 1,3-difluoroacetone in the committed step of the toxic pathway.
entities: 4-methylpyrazole / 1,3-difluoro-2-propanol
ddi: null
>>> match: conclude_see
-------------
sentence: We conclude that the prophylactic and antidotal properties of 4-methylpyrazole seen in animals treated with 1,3-difluoro-2-propanol derive from its capacity to inhibit the NAD+-dependent oxidation responsible for converting 1,3-difluoro-2-propanol to 1,3-difluoroacetone in the committed step of the toxic pathway.
entities: 4-methylpyrazole / 1,3-difluoroacetone
ddi: null
>>> match: conclude_see
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Phenytoin / Live virus vaccines
ddi: null
>>> match: cause_cause
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Phenytoin / vaccine
ddi: null
>>> match: cause_cause
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Phenytoin / Mitomycin-C
ddi: null
>>> match: cause_cause
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Phenytoin / Killed virus vaccines
ddi: null
>>> match: cause_cause
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Phenytoin / vaccine
ddi: null
>>> match: cause_cause
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Live virus vaccines / vaccine
ddi: null
>>> match: cause_increase
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Live virus vaccines / Mitomycin-C
ddi: null
>>> match: cause_increase
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Live virus vaccines / Killed virus vaccines
ddi: null
>>> match: cause_increase
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Live virus vaccines / vaccine
ddi: null
>>> match: cause_increase
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: vaccine / Mitomycin-C
ddi: null
>>> match: increase_potentiate
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: vaccine / Killed virus vaccines
ddi: null
>>> match: cause_increase
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: vaccine / vaccine
ddi: null
>>> match: cause_increase
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Mitomycin-C / Killed virus vaccines
ddi: null
>>> match: cause_increase
-------------
sentence: Vindesine can interact with the drugs of the following categories:  - Blood dyscrasia: can cause unpredictable myelotoxicity - Bone marrow depressants: can cause a predictable dose-related myelotoxicity - Radiation therapy: may cause marrow depression - Neurotoxic medications: can cause neurologic toxicity - Phenytoin: can increase seizure activity - Live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - Mitomycin-C: may cause shortness of breath and bronchospasm - Killed virus vaccines: may decrease patient's response to the vaccine
entities: Mitomycin-C / vaccine
ddi: null
>>> match: cause_increase
-------------
sentence: In vitro studies indicate that bupropion is primarily metabolized to hydroxybupropion by the CYP2B6 isoenzyme.
entities: bupropion / hydroxybupropion
ddi: null
>>> match: indicate_metabolize
-------------
sentence: MAO Inhibitors: Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the MAO inhibitor phenelzine .
entities: bupropion / MAO inhibitor
ddi: null
>>> match: demonstrate_enhance
-------------
sentence: MAO Inhibitors: Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the MAO inhibitor phenelzine .
entities: bupropion / phenelzine
ddi: effect
>>> match: demonstrate_enhance
-------------
sentence: In patients who have received muscle relaxants, doxapram may temporarily mask the residual effects of muscle relaxant drugs.
entities: doxapram / muscle relaxant drugs
ddi: effect
>>> match: receive_mask
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / flupenthixol
ddi: effect
>>> match: interact_affect
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Arecoline
ddi: null
>>> match: interact_affect
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Ethanol
ddi: null
>>> match: interact_affect
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Flupenthixol
ddi: null
>>> match: interact_affect
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Ethanol
ddi: null
>>> match: interact_affect
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Tricyclic antidepressants
ddi: null
>>> match: interact_affect
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Flupenthixol
ddi: null
>>> match: interact_affect
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: MAOI / Tricyclic antidepressants
ddi: null
>>> match: interact_affect
-------------
sentence: Drug Interactions: Flupenthixol may interact with some drugs, like Monoamine oxidase inhibitors (MAOI): MAOI could theoretically affect flupenthixol pharmacodynamics - Arecoline - Eproxindine - Ethanol: Flupenthixol and Ethanol cause additive CNS depression - Tricyclic antidepressants: Flupenthixol increases the effect of Tricyclic antidepressants
entities: Flupenthixol / Tricyclic antidepressants
ddi: effect
>>> match: cause_increase
-------------
sentence: If chlorprothixene is given concomitantly with opioids, the opioid dose should be reduced (by approx. 50%), because chlorprothixene amplifies the therapeutic actions and side-effects of opioids massively.
entities: chlorprothixene / opioids
ddi: advise
>>> match: reduce_give
-------------
sentence: If chlorprothixene is given concomitantly with opioids, the opioid dose should be reduced (by approx. 50%), because chlorprothixene amplifies the therapeutic actions and side-effects of opioids massively.
entities: chlorprothixene / opioids
ddi: effect
>>> match: reduce_amplify
-------------
sentence: Consider additive sedative effects and confusional states to emerge, if chlorprothixene is given with benzodiazepines or barbituates.
entities: chlorprothixene / benzodiazepines
ddi: effect
>>> match: emerge_give
-------------
sentence: Consider additive sedative effects and confusional states to emerge, if chlorprothixene is given with benzodiazepines or barbituates.
entities: chlorprothixene / barbituates
ddi: effect
>>> match: emerge_give
-------------
sentence: Results from human in vitro metabolism studies and nonclinical studies show that REVLIMID  (lenalidomide) is neither metabolized by nor inhibits or induces the cytochrome P450 pathway suggesting that lenalidomide is not likely to cause or be subject to P450-based metabolic drug interactions in man.
entities: REVLIMID / lenalidomide
ddi: null
>>> match: show_metabolize
-------------
sentence: Results from human in vitro metabolism studies and nonclinical studies show that REVLIMID  (lenalidomide) is neither metabolized by nor inhibits or induces the cytochrome P450 pathway suggesting that lenalidomide is not likely to cause or be subject to P450-based metabolic drug interactions in man.
entities: lenalidomide / lenalidomide
ddi: null
>>> match: show_metabolize
-------------
sentence: Although this effect was noted even when cholestyramine was given 4 hours prior to fluvastatin, this regimen did not result in diminished efficacy.
entities: cholestyramine / fluvastatin
ddi: effect
>>> match: result_give
-------------
sentence: Moreover, additional interaction studies with niacin and propranolol have not demonstrated any effect on fluvastatin plasma levels, and administration to a patient population chronically receiving digoxin resulted in no difference in the extent of bioavailability of digoxin relative to control data.
entities: digoxin / digoxin
ddi: null
>>> match: demonstrate_result
-------------
sentence: Caution should be exercised when the following drugs are administered concomitantly with LODOSYN (Carbidopa) given with levodopa or carbidopa-levodopa combination products.
entities: LODOSYN / levodopa
ddi: null
>>> match: exercise_administer
-------------
sentence: Caution should be exercised when the following drugs are administered concomitantly with LODOSYN (Carbidopa) given with levodopa or carbidopa-levodopa combination products.
entities: LODOSYN / carbidopa
ddi: null
>>> match: exercise_administer
-------------
sentence: Caution should be exercised when the following drugs are administered concomitantly with LODOSYN (Carbidopa) given with levodopa or carbidopa-levodopa combination products.
entities: LODOSYN / levodopa
ddi: null
>>> match: exercise_administer
-------------
sentence: Caution should be exercised when the following drugs are administered concomitantly with LODOSYN (Carbidopa) given with levodopa or carbidopa-levodopa combination products.
entities: Carbidopa / levodopa
ddi: null
>>> match: exercise_administer
-------------
sentence: Caution should be exercised when the following drugs are administered concomitantly with LODOSYN (Carbidopa) given with levodopa or carbidopa-levodopa combination products.
entities: Carbidopa / carbidopa
ddi: null
>>> match: exercise_administer
-------------
sentence: Caution should be exercised when the following drugs are administered concomitantly with LODOSYN (Carbidopa) given with levodopa or carbidopa-levodopa combination products.
entities: Carbidopa / levodopa
ddi: null
>>> match: exercise_administer
-------------
sentence: Co-administration of BOTOX and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated.
entities: BOTOX / toxin
ddi: null
>>> match: potentiate_perform
-------------
sentence: Co-administration of BOTOX and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated.
entities: aminoglycosides / toxin
ddi: null
>>> match: potentiate_perform
-------------
sentence: Co-administration of BOTOX and aminoglycosides or other agents interfering with neuromuscular transmission (e.g., curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated.
entities: curare-like compounds / toxin
ddi: null
>>> match: potentiate_perform
-------------
sentence: METHOD: This study was a multicenter randomized double-blind study of 101 patients who were randomly assigned 1:1:1 to receive everolimus tablets at doses of 0.5 mg, 1 mg, or 2 mg twice daily with cyclosporine and prednisone.
entities: everolimus / cyclosporine
ddi: null
>>> match: assign_receive
-------------
sentence: METHOD: This study was a multicenter randomized double-blind study of 101 patients who were randomly assigned 1:1:1 to receive everolimus tablets at doses of 0.5 mg, 1 mg, or 2 mg twice daily with cyclosporine and prednisone.
entities: everolimus / prednisone
ddi: null
>>> match: assign_receive
-------------
sentence: However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  Tramadol: Although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  Chemotherapy: Tumor response to chemotherapy in the P 388 mouse leukemia model is not affected by ondansetron.
entities: ondansetron / tramadol
ddi: effect
>>> match: indicate_associate
-------------
sentence: In vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the PK properties of anagrelide, nor does anagrelide affect the PK properties of digoxin or warfarin.
entities: digoxin / anagrelide
ddi: null
>>> match: demonstrate_affect
-------------
sentence: In vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the PK properties of anagrelide, nor does anagrelide affect the PK properties of digoxin or warfarin.
entities: digoxin / anagrelide
ddi: null
>>> match: demonstrate_affect
-------------
sentence: In vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the PK properties of anagrelide, nor does anagrelide affect the PK properties of digoxin or warfarin.
entities: digoxin / digoxin
ddi: null
>>> match: demonstrate_affect
-------------
sentence: In vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the PK properties of anagrelide, nor does anagrelide affect the PK properties of digoxin or warfarin.
entities: digoxin / warfarin
ddi: null
>>> match: demonstrate_affect
-------------
sentence: In vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the PK properties of anagrelide, nor does anagrelide affect the PK properties of digoxin or warfarin.
entities: warfarin / anagrelide
ddi: null
>>> match: demonstrate_affect
-------------
sentence: In vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the PK properties of anagrelide, nor does anagrelide affect the PK properties of digoxin or warfarin.
entities: warfarin / anagrelide
ddi: null
>>> match: demonstrate_affect
-------------
sentence: In vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the PK properties of anagrelide, nor does anagrelide affect the PK properties of digoxin or warfarin.
entities: warfarin / digoxin
ddi: null
>>> match: demonstrate_affect
-------------
sentence: In vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the PK properties of anagrelide, nor does anagrelide affect the PK properties of digoxin or warfarin.
entities: warfarin / warfarin
ddi: null
>>> match: demonstrate_affect
-------------
sentence: In vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the PK properties of anagrelide, nor does anagrelide affect the PK properties of digoxin or warfarin.
entities: anagrelide / anagrelide
ddi: null
>>> match: demonstrate_affect
-------------
sentence: In vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the PK properties of anagrelide, nor does anagrelide affect the PK properties of digoxin or warfarin.
entities: anagrelide / digoxin
ddi: null
>>> match: demonstrate_affect
-------------
sentence: In vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the PK properties of anagrelide, nor does anagrelide affect the PK properties of digoxin or warfarin.
entities: anagrelide / warfarin
ddi: null
>>> match: demonstrate_affect
-------------
sentence: In vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the PK properties of anagrelide, nor does anagrelide affect the PK properties of digoxin or warfarin.
entities: anagrelide / digoxin
ddi: null
>>> match: affect_affect
-------------
sentence: In vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the PK properties of anagrelide, nor does anagrelide affect the PK properties of digoxin or warfarin.
entities: anagrelide / warfarin
ddi: null
>>> match: affect_affect
-------------
sentence: An in vivo interaction study in humans demonstrated that a single 1mg dose of anagrelide administered concomitantly with a single 900 mg dose of aspirin was generally well tolerated.
entities: anagrelide / aspirin
ddi: null
>>> match: demonstrate_administer
-------------
sentence: There is a single case report, which suggests that sucralfate may interfere with anagrelide absorption.
entities: sucralfate / anagrelide
ddi: mechanism
>>> match: suggest_interfere
-------------
sentence: Cyclosporine: Because cyclosporine can produce nephrotoxicity with decreases in creatinine clearance and rises in serum creatinine, and because renal excretion is the primary elimination route of fibrate drugs including TRICOR, there is a risk that an interaction will lead to deterioration.
entities: cyclosporine / fibrate drugs
ddi: effect
>>> match: be_produce
-------------
sentence: Cyclosporine: Because cyclosporine can produce nephrotoxicity with decreases in creatinine clearance and rises in serum creatinine, and because renal excretion is the primary elimination route of fibrate drugs including TRICOR, there is a risk that an interaction will lead to deterioration.
entities: cyclosporine / TRICOR
ddi: effect
>>> match: be_produce
-------------
sentence: In healthy volunteers, the pharmacokinetics of a 1-mg dose of butorphanol administered as STADOL NS were not affected by the coadministration of a single 6-mg subcutaneous dose of sumatriptan.
entities: STADOL NS / sumatriptan
ddi: null
>>> match: administer_affect
-------------
sentence: However, in another study in healthy volunteers, the pharmacokinetics of butorphanol were significantly altered (29% decrease in AUC and 38% decrease in Cmax) when a 1-mg dose of STADOL NS was administered 1 minute after a 20-mg dose of sumatriptan nasal spray.
entities: STADOL NS / sumatriptan
ddi: mechanism
>>> match: alter_administer
-------------
sentence: When the STADOL NS was administered 30 minutes after the sumatriptan nasal spray, the AUC of butorphanol increased 11% and Cmax decreased 18%.
entities: STADOL NS / sumatriptan
ddi: mechanism
>>> match: increase_administer
-------------
sentence: These results suggest that the analgesic effect of STADOL NS may be diminished when it is administered shortly after sumatriptan nasal spray, but by 30 minutes any such reduction in effect should be minimal.
entities: STADOL NS / sumatriptan
ddi: effect
>>> match: suggest_diminish
-------------
sentence: The pharmacokinetics of a 1-mg dose of butorphanol administered as STADOL NS were not affected by the coadministration of cimetidine (300 mg QID).
entities: STADOL NS / cimetidine
ddi: null
>>> match: administer_affect
-------------
sentence: It is not known if the effects of butorphanol are altered by concomitant medications that affect hepatic metabolism of drugs (erythromycin, etc.), but physicians should be alert to the possibility that a smaller initial dose and longer intervals between doses may be needed.
entities: butorphanol / erythromycin
ddi: advise
>>> match: know_alter
-------------
sentence: We sought to evaluate whether initiation of an antidepressant increases the risk of hospitalization for gastrointestinal bleeding in warfarin users.
entities: antidepressant / warfarin
ddi: null
>>> match: evaluate_increase
-------------
sentence: Digitalis: Immediate Release Capsules: Since there have been isolated reports of patients with elevated digoxin levels, and there is a possible interaction between digoxin and nifedipine, it is recommended that digoxin levels be monitored when initiating, adjusting, and discontinuing nifedipine to avoid possible over- or under-digitalization.
entities: digoxin / digoxin
ddi: null
>>> match: recommend_isolate
-------------
sentence: Digitalis: Immediate Release Capsules: Since there have been isolated reports of patients with elevated digoxin levels, and there is a possible interaction between digoxin and nifedipine, it is recommended that digoxin levels be monitored when initiating, adjusting, and discontinuing nifedipine to avoid possible over- or under-digitalization.
entities: digoxin / nifedipine
ddi: null
>>> match: recommend_isolate
-------------
sentence: Digitalis: Immediate Release Capsules: Since there have been isolated reports of patients with elevated digoxin levels, and there is a possible interaction between digoxin and nifedipine, it is recommended that digoxin levels be monitored when initiating, adjusting, and discontinuing nifedipine to avoid possible over- or under-digitalization.
entities: digoxin / nifedipine
ddi: advise
>>> match: recommend_monitor
-------------
sentence: Since there have been isolated reports of patients with elevated digoxin levels, it is recommended that digoxin levels be monitored when initiating, adjusting, and discontinuing nifedipine to avoid possible over- or under-digitalization.
entities: digoxin / nifedipine
ddi: advise
>>> match: recommend_monitor
-------------
sentence: Reports in the literature suggest that plasma levels of doxorubicin (and its active metabolite doxorubicinol) may be increased when paclitaxel and doxorubicin are used in combination.
entities: doxorubicin / paclitaxel
ddi: null
>>> match: suggest_increase
-------------
sentence: Reports in the literature suggest that plasma levels of doxorubicin (and its active metabolite doxorubicinol) may be increased when paclitaxel and doxorubicin are used in combination.
entities: doxorubicin / doxorubicin
ddi: null
>>> match: suggest_increase
-------------
sentence: Reports in the literature suggest that plasma levels of doxorubicin (and its active metabolite doxorubicinol) may be increased when paclitaxel and doxorubicin are used in combination.
entities: doxorubicinol / paclitaxel
ddi: null
>>> match: suggest_increase
-------------
sentence: Reports in the literature suggest that plasma levels of doxorubicin (and its active metabolite doxorubicinol) may be increased when paclitaxel and doxorubicin are used in combination.
entities: doxorubicinol / doxorubicin
ddi: null
>>> match: suggest_increase
-------------
sentence: Caution should be exercised when Methergine    (methylergonovine maleate) is used concurrently with other vasoconstrictors or ergot alkaloids.
entities: Methergine / vasoconstrictors
ddi: advise
>>> match: exercise_use
-------------
sentence: Caution should be exercised when Methergine    (methylergonovine maleate) is used concurrently with other vasoconstrictors or ergot alkaloids.
entities: Methergine / ergot alkaloids
ddi: advise
>>> match: exercise_use
-------------
sentence: Caution should be exercised when Methergine    (methylergonovine maleate) is used concurrently with other vasoconstrictors or ergot alkaloids.
entities: methylergonovine maleate / vasoconstrictors
ddi: advise
>>> match: exercise_use
-------------
sentence: Caution should be exercised when Methergine    (methylergonovine maleate) is used concurrently with other vasoconstrictors or ergot alkaloids.
entities: methylergonovine maleate / ergot alkaloids
ddi: null
>>> match: exercise_use
-------------
sentence: The results of a study of coadministration of ethambutol (50 mg/kg) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20% and 13%, respectively, suggesting that the oral absorption of ethambutol may be reduced by these antacid products.
entities: ethambutol / antacid products
ddi: null
>>> match: suggest_reduce
-------------
sentence: It is recommended to avoid concurrent administration of ethambutol with aluminum hydroxide containing antacids for at least 4 hours following ethambutol administration.
entities: ethambutol / aluminum hydroxide
ddi: advise
>>> match: recommend_avoid
-------------
sentence: It is recommended to avoid concurrent administration of ethambutol with aluminum hydroxide containing antacids for at least 4 hours following ethambutol administration.
entities: ethambutol / antacids
ddi: null
>>> match: recommend_avoid
-------------
sentence: It is recommended to avoid concurrent administration of ethambutol with aluminum hydroxide containing antacids for at least 4 hours following ethambutol administration.
entities: ethambutol / ethambutol
ddi: null
>>> match: recommend_avoid
-------------
sentence: It is recommended to avoid concurrent administration of ethambutol with aluminum hydroxide containing antacids for at least 4 hours following ethambutol administration.
entities: aluminum hydroxide / antacids
ddi: null
>>> match: avoid_contain
-------------
sentence: It is recommended to avoid concurrent administration of ethambutol with aluminum hydroxide containing antacids for at least 4 hours following ethambutol administration.
entities: aluminum hydroxide / ethambutol
ddi: null
>>> match: avoid_contain
-------------
sentence: It is recommended to avoid concurrent administration of ethambutol with aluminum hydroxide containing antacids for at least 4 hours following ethambutol administration.
entities: antacids / ethambutol
ddi: null
>>> match: avoid_contain
-------------
sentence: Antipyrine: Because atorvastatin does not affect the pharmacokinetics of antipyrine, interactions with other drugs metabolized via the same cytochrome isozymes are not expected.
entities: atorvastatin / antipyrine
ddi: null
>>> match: metabolize_affect
-------------
sentence: Caution should be exercised if an HMG-CoA reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as ketoconazole, spironolactone, and cimetidine.
entities: HMG-CoA reductase inhibitor / ketoconazole
ddi: advise
>>> match: exercise_administer
-------------
sentence: Caution should be exercised if an HMG-CoA reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as ketoconazole, spironolactone, and cimetidine.
entities: HMG-CoA reductase inhibitor / spironolactone
ddi: advise
>>> match: exercise_administer
-------------
sentence: Caution should be exercised if an HMG-CoA reductase inhibitor is administered concomitantly with drugs that may decrease the levels or activity of endogenous steroid hormones, such as ketoconazole, spironolactone, and cimetidine.
entities: HMG-CoA reductase inhibitor / cimetidine
ddi: advise
>>> match: exercise_administer
-------------
sentence: It is recommended that buspirone hydrochloride not be used concomitantly with MAO inhibitors Because the effects of concomitant administration of buspirone HCl with most other psychotropic drugs have not been studied, the concomitant use of buspirone HCl with other CNS-active drugs should be approached with caution.
entities: buspirone hydrochloride / MAO inhibitors
ddi: advise
>>> match: recommend_use
-------------
sentence: It is recommended that buspirone hydrochloride not be used concomitantly with MAO inhibitors Because the effects of concomitant administration of buspirone HCl with most other psychotropic drugs have not been studied, the concomitant use of buspirone HCl with other CNS-active drugs should be approached with caution.
entities: buspirone hydrochloride / buspirone HCl
ddi: null
>>> match: recommend_use
-------------
sentence: It is recommended that buspirone hydrochloride not be used concomitantly with MAO inhibitors Because the effects of concomitant administration of buspirone HCl with most other psychotropic drugs have not been studied, the concomitant use of buspirone HCl with other CNS-active drugs should be approached with caution.
entities: buspirone hydrochloride / psychotropic drugs
ddi: null
>>> match: recommend_use
-------------
sentence: It is recommended that buspirone hydrochloride not be used concomitantly with MAO inhibitors Because the effects of concomitant administration of buspirone HCl with most other psychotropic drugs have not been studied, the concomitant use of buspirone HCl with other CNS-active drugs should be approached with caution.
entities: buspirone hydrochloride / buspirone HCl
ddi: null
>>> match: recommend_use
-------------
sentence: It is recommended that buspirone hydrochloride not be used concomitantly with MAO inhibitors Because the effects of concomitant administration of buspirone HCl with most other psychotropic drugs have not been studied, the concomitant use of buspirone HCl with other CNS-active drugs should be approached with caution.
entities: MAO inhibitors / buspirone HCl
ddi: null
>>> match: recommend_use
-------------
sentence: It is recommended that buspirone hydrochloride not be used concomitantly with MAO inhibitors Because the effects of concomitant administration of buspirone HCl with most other psychotropic drugs have not been studied, the concomitant use of buspirone HCl with other CNS-active drugs should be approached with caution.
entities: MAO inhibitors / psychotropic drugs
ddi: null
>>> match: recommend_use
-------------
sentence: It is recommended that buspirone hydrochloride not be used concomitantly with MAO inhibitors Because the effects of concomitant administration of buspirone HCl with most other psychotropic drugs have not been studied, the concomitant use of buspirone HCl with other CNS-active drugs should be approached with caution.
entities: MAO inhibitors / buspirone HCl
ddi: null
>>> match: recommend_use
-------------
sentence: It is recommended that buspirone hydrochloride not be used concomitantly with MAO inhibitors Because the effects of concomitant administration of buspirone HCl with most other psychotropic drugs have not been studied, the concomitant use of buspirone HCl with other CNS-active drugs should be approached with caution.
entities: buspirone HCl / buspirone HCl
ddi: null
>>> match: use_study
-------------
sentence: It is recommended that buspirone hydrochloride not be used concomitantly with MAO inhibitors Because the effects of concomitant administration of buspirone HCl with most other psychotropic drugs have not been studied, the concomitant use of buspirone HCl with other CNS-active drugs should be approached with caution.
entities: psychotropic drugs / buspirone HCl
ddi: null
>>> match: use_study
-------------
sentence: MAO Inhibitors: DURAGESIC  is not recommended for use in patients who have received MAOI within 14 days because severe and unpredictable potentiation by MAO inhibitors has been reported with opioid analgesics
entities: MAO inhibitors / opioid analgesics
ddi: advise
>>> match: receive_report
-------------
sentence: These results suggest that the hepatoxicity of ethanol in alcoholic beverages is enhanced by interaction with its congeners and acetaldehyde;
entities: ethanol / acetaldehyde
ddi: effect
>>> match: suggest_enhance
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: divalproex sodium / barbiturates
ddi: null
>>> match: occur_change
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: divalproex sodium / contraceptives
ddi: null
>>> match: occur_change
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: divalproex sodium / estrogens
ddi: null
>>> match: occur_change
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: divalproex sodium / barbiturates
ddi: null
>>> match: occur_change
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: divalproex sodium / contraceptives
ddi: null
>>> match: occur_change
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: valproic acid / barbiturates
ddi: null
>>> match: occur_change
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: valproic acid / contraceptives
ddi: null
>>> match: occur_change
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: valproic acid / estrogens
ddi: null
>>> match: occur_change
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: valproic acid / barbiturates
ddi: null
>>> match: occur_change
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: valproic acid / contraceptives
ddi: null
>>> match: occur_change
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: barbiturates / contraceptives
ddi: null
>>> match: occur_change
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: barbiturates / estrogens
ddi: null
>>> match: occur_change
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: barbiturates / barbiturates
ddi: null
>>> match: occur_change
-------------
sentence: Interactions may occur with the following: adrenocorticoids (cortisone-like medicine), anticoagulants (blood thinners), carbamazepine, corticotropin (barbiturates may decrease the effects of these medicines), central nervous system (CNS) depressants (using these medicines with barbiturates may result in increased CNS depressant effects), divalproex sodium, valproic acid (using these medicines with barbiturates may change the amount of either medicine that you need to take), and oral contraceptives containing estrogens (barbiturates may decrease the effectiveness of these oral contraceptives, and you may need to change to a different type of birth control).
entities: barbiturates / contraceptives
ddi: null
>>> match: occur_change
-------------
sentence: Careful observations on hepatotoxicity are suggested when acetaminophen is prescribed with caffeine.
entities: acetaminophen / caffeine
ddi: effect
>>> match: suggest_prescribe
-------------
sentence: Caution should be used if TOLECTIN is administered concomitantly with methotrexate.
entities: TOLECTIN / methotrexate
ddi: advise
>>> match: use_administer
-------------
sentence: TOLECTIN and other nonsteroidal anti-inflammatory drugs have been reported to reduce the tubular secretion of methotrexate in an animal model, possibly enhancing the toxicity of methotrexate.
entities: methotrexate / methotrexate
ddi: null
>>> match: report_reduce
-------------
sentence: Furthermore it has been proposed that isoniazid resulted In induction of P-450IIE1 in the patients liver which, in turn, resulted in a greater proportion of the ingested acetaminophen being converted to the toxic metabolites.
entities: isoniazid / acetaminophen
ddi: mechanism
>>> match: propose_result
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: Isoniazid / carbamazepine
ddi: mechanism
>>> match: make_know
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: Isoniazid / Carbamazepine
ddi: null
>>> match: make_know
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: Isoniazid / isoniazid
ddi: null
>>> match: make_know
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: Isoniazid / carbamazepine
ddi: null
>>> match: make_know
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: Isoniazid / anticonvulsant
ddi: null
>>> match: make_know
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: carbamazepine / Carbamazepine
ddi: null
>>> match: know_slow
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: carbamazepine / isoniazid
ddi: null
>>> match: make_know
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: carbamazepine / carbamazepine
ddi: null
>>> match: make_know
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: carbamazepine / anticonvulsant
ddi: null
>>> match: make_know
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: Carbamazepine / isoniazid
ddi: advise
>>> match: make_know
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: Carbamazepine / carbamazepine
ddi: null
>>> match: make_know
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: Carbamazepine / anticonvulsant
ddi: null
>>> match: make_know
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: isoniazid / anticonvulsant
ddi: null
>>> match: make_know
-------------
sentence: Carbamazepine: Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely, and appropriate dosage adjustment of the anticonvulsant should be made.
entities: carbamazepine / anticonvulsant
ddi: null
>>> match: make_know
-------------
sentence: Therophylline: A recent study has shown that concomitan administration of isoniazid and theophylline may cause elevated plasma levels of theophylline, and in some instances a slight decrease in the elimination of isoniazid.
entities: isoniazid / theophylline
ddi: null
>>> match: show_cause
-------------
sentence: Therophylline: A recent study has shown that concomitan administration of isoniazid and theophylline may cause elevated plasma levels of theophylline, and in some instances a slight decrease in the elimination of isoniazid.
entities: theophylline / theophylline
ddi: null
>>> match: show_cause
-------------
sentence: Plasma valproate concentration should be monitored when isoniazid and valproate are co administered, and appropriate dosage adjustments of valproate should be made.
entities: isoniazid / valproate
ddi: null
>>> match: monitor_administer
-------------
sentence: Plasma valproate concentration should be monitored when isoniazid and valproate are co administered, and appropriate dosage adjustments of valproate should be made.
entities: valproate / valproate
ddi: null
>>> match: monitor_administer
-------------
sentence: To determine whether injection of thiosulfate would permit larger doses of cisplatin to be administered, a fixed 9.9-g/m2 dose of thiosulfate was given intravenously over three hours concurrently with escalating doses of cisplatin.
entities: thiosulfate / cisplatin
ddi: null
>>> match: determine_permit
-------------
sentence: This may occur because diflunisal competitively displaces coumarins from protein binding sites.
entities: diflunisal / coumarins
ddi: mechanism
>>> match: occur_displace
-------------
sentence: Accordingly, when diflunisal is administered with oral anticoagulants, the prothrombin time should be closely monitored during and for several days after concomitant drug administration.
entities: diflunisal / anticoagulants
ddi: advise
>>> match: monitor_administer
-------------
sentence: Methotrexate: Caution should be used if diflunisal is administered concomitantly with methotrexate.
entities: diflunisal / methotrexate
ddi: advise
>>> match: use_administer
-------------
sentence: The data presented here demonstrate that with serial pharmacokinetic dosing of gentamicin, the iatrogenic alteration caused by gentamicin therapy can be avoided.
entities: gentamicin / gentamicin
ddi: null
>>> match: demonstrate_cause
-------------
sentence: Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.
entities: Selective serotonin reuptake inhibitors / sumatriptan
ddi: effect
>>> match: contraindicate_report
-------------
sentence: Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.
entities: SSRIs / sumatriptan
ddi: effect
>>> match: contraindicate_report
-------------
sentence: Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.
entities: fluoxetine / sumatriptan
ddi: effect
>>> match: contraindicate_report
-------------
sentence: Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.
entities: fluvoxamine / sumatriptan
ddi: effect
>>> match: contraindicate_report
-------------
sentence: Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.
entities: paroxetine / sumatriptan
ddi: effect
>>> match: contraindicate_report
-------------
sentence: Therefore, the use of sumatriptan succinate tablets in patients receiving MAO-A inhibitors is contraindicated . Selective serotonin reuptake inhibitors (SSRIs) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.
entities: sertraline / sumatriptan
ddi: effect
>>> match: contraindicate_report
-------------
sentence: Based on this experience, we suggest that low-dose ketamine added to propofol may be associated with prevention of EA in children with a history of EA with propofol TIVA.
entities: ketamine / propofol
ddi: effect
>>> match: suggest_add
-------------
sentence: Based on this experience, we suggest that low-dose ketamine added to propofol may be associated with prevention of EA in children with a history of EA with propofol TIVA.
entities: ketamine / propofol
ddi: null
>>> match: suggest_add
-------------
sentence: Based on this experience, we suggest that low-dose ketamine added to propofol may be associated with prevention of EA in children with a history of EA with propofol TIVA.
entities: propofol / propofol
ddi: null
>>> match: suggest_add
-------------
sentence: Mitotane has been reported to accelerate the metabolism of warfarin by the mechanism of hepatic microsomal enzyme induction, leading to an increase in dosage requirements for warfarin.
entities: warfarin / warfarin
ddi: null
>>> match: report_accelerate
-------------
sentence: Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.
entities: metoclopramide / alcohol
ddi: effect
>>> match: occur_give
-------------
sentence: Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.
entities: metoclopramide / sedatives
ddi: effect
>>> match: occur_give
-------------
sentence: Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.
entities: metoclopramide / hypnotics
ddi: effect
>>> match: occur_give
-------------
sentence: Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.
entities: metoclopramide / narcotics
ddi: effect
>>> match: occur_give
-------------
sentence: Additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.
entities: metoclopramide / tranquilizers
ddi: effect
>>> match: occur_give
-------------
sentence: Animal experience indicates that clorazepate dipotassium prolongs the sleeping time after hexobarbital or after ethyl alcohol, increases the inhibitory effects of chlorpromazine, but does not exhibit monoamine oxidase inhibition.
entities: clorazepate dipotassium / hexobarbital
ddi: effect
>>> match: indicate_prolong
-------------
sentence: Animal experience indicates that clorazepate dipotassium prolongs the sleeping time after hexobarbital or after ethyl alcohol, increases the inhibitory effects of chlorpromazine, but does not exhibit monoamine oxidase inhibition.
entities: clorazepate dipotassium / ethyl alcohol
ddi: effect
>>> match: indicate_prolong
-------------
sentence: Animal experience indicates that clorazepate dipotassium prolongs the sleeping time after hexobarbital or after ethyl alcohol, increases the inhibitory effects of chlorpromazine, but does not exhibit monoamine oxidase inhibition.
entities: clorazepate dipotassium / chlorpromazine
ddi: effect
>>> match: indicate_prolong
-------------
sentence: Animal experience indicates that clorazepate dipotassium prolongs the sleeping time after hexobarbital or after ethyl alcohol, increases the inhibitory effects of chlorpromazine, but does not exhibit monoamine oxidase inhibition.
entities: hexobarbital / chlorpromazine
ddi: null
>>> match: prolong_increase
-------------
sentence: Animal experience indicates that clorazepate dipotassium prolongs the sleeping time after hexobarbital or after ethyl alcohol, increases the inhibitory effects of chlorpromazine, but does not exhibit monoamine oxidase inhibition.
entities: ethyl alcohol / chlorpromazine
ddi: null
>>> match: prolong_increase
-------------
sentence: It has been reported that results of studies in animals indicate that dopamine-induced ventricular arrhythmias during anesthesia can be reversed by propranolol.
entities: dopamine / propranolol
ddi: effect
>>> match: indicate_reverse
-------------
sentence: It is suggested that in patients receiving dopamine HCl, alternatives to phenytoin should be used if anticonvulsant therapy is needed.
entities: dopamine HCl / phenytoin
ddi: advise
>>> match: suggest_use
-------------
sentence: It is suggested that in patients receiving dopamine HCl, alternatives to phenytoin should be used if anticonvulsant therapy is needed.
entities: dopamine HCl / anticonvulsant
ddi: null
>>> match: suggest_use
-------------
sentence: It is suggested that in patients receiving dopamine HCl, alternatives to phenytoin should be used if anticonvulsant therapy is needed.
entities: phenytoin / anticonvulsant
ddi: null
>>> match: suggest_use
-------------
sentence: Pharmacokinetic studies indicate that administration of disulfiram or diazepam does not affect the pharmacokinetics of acamprosate.
entities: disulfiram / acamprosate
ddi: null
>>> match: indicate_affect
-------------
sentence: Pharmacokinetic studies indicate that administration of disulfiram or diazepam does not affect the pharmacokinetics of acamprosate.
entities: diazepam / acamprosate
ddi: null
>>> match: indicate_affect
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: desipramine hydrochloride / psychotropic agents
ddi: effect
>>> match: give_combine
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: desipramine hydrochloride / tranquilizers
ddi: effect
>>> match: give_combine
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: desipramine hydrochloride / sedative
ddi: effect
>>> match: give_combine
-------------
sentence: If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive.
entities: desipramine hydrochloride / hypnotics
ddi: effect
>>> match: give_combine
-------------
sentence: Although the clinical significance is not known, it is not recommended that cefditoren pivoxil be taken concomitantly with antacids.
entities: cefditoren pivoxil / antacids
ddi: advise
>>> match: recommend_take
-------------
sentence: Although the clinical significance is not known, it is not recommended that cefditoren pivoxil be taken concomitantly with H2 receptor antagonists.
entities: cefditoren pivoxil / H2 receptor antagonists
ddi: null
>>> match: recommend_take
-------------
sentence: A study of interaction between BREVIBLOC and warfarin showed that concomitant administration of BREVIBLOC and warfarin does not alter warfarin plasma levels.
entities: BREVIBLOC / warfarin
ddi: null
>>> match: show_alter
-------------
sentence: A study of interaction between BREVIBLOC and warfarin showed that concomitant administration of BREVIBLOC and warfarin does not alter warfarin plasma levels.
entities: warfarin / warfarin
ddi: null
>>> match: show_alter
-------------
sentence: When intravenous morphine and BREVIBLOC were concomitantly administered in normal subjects, no effect on morphine blood levels was seen, but BREVIBLOC steady-state blood levels were increased by 46% in the presence of morphine.
entities: BREVIBLOC / morphine
ddi: mechanism
>>> match: see_increase
-------------
sentence: Although the interactions observed in these studies do not appear to be of major clinical importance, BREVIBLOC should be titrated with caution in patients being treated concurrently with digoxin, morphine, succinylcholine or warfarin.
entities: BREVIBLOC / digoxin
ddi: advise
>>> match: appear_titrate
-------------
sentence: Although the interactions observed in these studies do not appear to be of major clinical importance, BREVIBLOC should be titrated with caution in patients being treated concurrently with digoxin, morphine, succinylcholine or warfarin.
entities: BREVIBLOC / morphine
ddi: advise
>>> match: appear_titrate
-------------
sentence: Although the interactions observed in these studies do not appear to be of major clinical importance, BREVIBLOC should be titrated with caution in patients being treated concurrently with digoxin, morphine, succinylcholine or warfarin.
entities: BREVIBLOC / succinylcholine
ddi: advise
>>> match: appear_titrate
-------------
sentence: Although the interactions observed in these studies do not appear to be of major clinical importance, BREVIBLOC should be titrated with caution in patients being treated concurrently with digoxin, morphine, succinylcholine or warfarin.
entities: BREVIBLOC / warfarin
ddi: advise
>>> match: appear_titrate
-------------
sentence: and disulfiram When amitriptyline HCl is given with anticholinergic agents or sympathomimetic drugs, including epinephrine combined with local anesthetics, close supervision and careful adjustment of dosages are required.
entities: amitriptyline HCl / anticholinergic
ddi: null
>>> match: require_give
-------------
sentence: and disulfiram When amitriptyline HCl is given with anticholinergic agents or sympathomimetic drugs, including epinephrine combined with local anesthetics, close supervision and careful adjustment of dosages are required.
entities: amitriptyline HCl / sympathomimetic
ddi: null
>>> match: require_give
-------------
sentence: and disulfiram When amitriptyline HCl is given with anticholinergic agents or sympathomimetic drugs, including epinephrine combined with local anesthetics, close supervision and careful adjustment of dosages are required.
entities: amitriptyline HCl / epinephrine
ddi: null
>>> match: require_give
-------------
sentence: and disulfiram When amitriptyline HCl is given with anticholinergic agents or sympathomimetic drugs, including epinephrine combined with local anesthetics, close supervision and careful adjustment of dosages are required.
entities: amitriptyline HCl / anesthetics
ddi: null
>>> match: require_give
-------------
sentence: Hyperpyrexia has been reported when amitriptyline HCl is administered with anticholinergic agents or with neuroleptic drugs, particularly during hot weather.
entities: amitriptyline HCl / anticholinergic
ddi: effect
>>> match: report_administer
-------------
sentence: Hyperpyrexia has been reported when amitriptyline HCl is administered with anticholinergic agents or with neuroleptic drugs, particularly during hot weather.
entities: amitriptyline HCl / neuroleptic
ddi: null
>>> match: report_administer
-------------
sentence: Hyperpyrexia has been reported when amitriptyline HCl is administered with anticholinergic agents or with neuroleptic drugs, particularly during hot weather.
entities: anticholinergic / neuroleptic
ddi: null
>>> match: report_administer
-------------
sentence: Cimetidine is reported to reduce hepatic metabolism of certain tricyclic antidepressants, thereby delaying elimination and increasing steady-state concentrations of these drugs.
entities: tricyclic antidepressants / drugs
ddi: null
>>> match: report_reduce
-------------
sentence: Increases in plasma levels of tricyclic antidepressants, and in the frequency and severity of side effects, particularly anticholinergic, have been reported when cimetidine was added to the drug regimen.
entities: anticholinergic / cimetidine
ddi: null
>>> match: increase_report
-------------
sentence: Increases in plasma levels of tricyclic antidepressants, and in the frequency and severity of side effects, particularly anticholinergic, have been reported when cimetidine was added to the drug regimen.
entities: anticholinergic / drug
ddi: null
>>> match: increase_report
-------------
sentence: Increases in plasma levels of tricyclic antidepressants, and in the frequency and severity of side effects, particularly anticholinergic, have been reported when cimetidine was added to the drug regimen.
entities: cimetidine / drug
ddi: null
>>> match: report_add
-------------
sentence: Ethanol:Clinical evidence has shown that etretinate can be formed with concurrent ingestion of acitretin and ethanol.
entities: etretinate / acitretin
ddi: null
>>> match: show_form
-------------
sentence: Ethanol:Clinical evidence has shown that etretinate can be formed with concurrent ingestion of acitretin and ethanol.
entities: etretinate / ethanol
ddi: null
>>> match: show_form
-------------
sentence: However, it has been established that acitretin interferes with the contraceptive effect of microdosed progestin minipill preparations.
entities: acitretin / progestin
ddi: effect
>>> match: establish_interfere
-------------
sentence: Phenytoin: If acitretin is given concurrently with phenytoin, the protein binding of phenytoin may be reduced.
entities: acitretin / phenytoin
ddi: mechanism
>>> match: reduce_give
-------------
sentence: In vitro studies have shown that precipitation occurs when eye drops containing thimerosal are mixed with latanoprost.
entities: thimerosal / latanoprost
ddi: null
>>> match: drop_mix
-------------
sentence: Exemestane is extensively metabolized by CYP 3A4, but coadministration of ketoconazole, a potent inhibitor of CYP 3A4, has no significant effect on exemestane pharmacokinetics.
entities: ketoconazole / exemestane
ddi: null
>>> match: metabolize_have
-------------
sentence: Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.
entities: glucocorticoids / PROLEUKIN
ddi: effect
>>> match: reduce_show
-------------
sentence: Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.
entities: glucocorticoids / PROLEUKIN
ddi: null
>>> match: reduce_show
-------------
sentence: Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.
entities: Beta-blockers / PROLEUKIN
ddi: effect
>>> match: avoid_potentiate
-------------
sentence: Although glucocorticoids have been shown to reduce PROLEUKIN-induced side effects including fever, renal insufficiency, hyperbilirubinemia, confusion, and dyspnea, concomitant administration of these agents with PROLEUKIN may reduce the antitumor effectiveness of PROLEUKIN and thus should be avoided. 12 Beta-blockers and other antihypertensives may potentiate the hypotension seen with PROLEUKIN.
entities: antihypertensives / PROLEUKIN
ddi: effect
>>> match: avoid_potentiate
-------------
sentence: However, interactions may be expected, and UROXATRAL should NOT be used in combination with other alpha-blockers.
entities: UROXATRAL / alpha-blockers
ddi: advise
>>> match: expect_use
-------------
sentence: These studies indicate that ketoconazole or erythromycin co-administration enhances fexofenadine gastrointestinal absorption.
entities: ketoconazole / fexofenadine
ddi: mechanism
>>> match: indicate_enhance
-------------
sentence: These studies indicate that ketoconazole or erythromycin co-administration enhances fexofenadine gastrointestinal absorption.
entities: erythromycin / fexofenadine
ddi: mechanism
>>> match: indicate_enhance
-------------
sentence: This observed increase in the bioavailability of fexofenadine may be due to transport-related effects, such as p-glycoprotein. in vivo animal studies also suggest that in addition to enhancing absorption, ketoconazole decreases fexofenadine gastrointestinal secretion, while erythromycin may also decrease biliary excretion.
entities: ketoconazole / fexofenadine
ddi: mechanism
>>> match: suggest_decrease
-------------
sentence: This observed increase in the bioavailability of fexofenadine may be due to transport-related effects, such as p-glycoprotein. in vivo animal studies also suggest that in addition to enhancing absorption, ketoconazole decreases fexofenadine gastrointestinal secretion, while erythromycin may also decrease biliary excretion.
entities: ketoconazole / erythromycin
ddi: null
>>> match: suggest_decrease
-------------
sentence: This observed increase in the bioavailability of fexofenadine may be due to transport-related effects, such as p-glycoprotein. in vivo animal studies also suggest that in addition to enhancing absorption, ketoconazole decreases fexofenadine gastrointestinal secretion, while erythromycin may also decrease biliary excretion.
entities: fexofenadine / erythromycin
ddi: null
>>> match: suggest_decrease
-------------
sentence: Tetracycline, a bacteriostatic antibiotic, may antagonize the bactericidal effect of penicillin and concurrent use of these drugs should be avoided.
entities: Tetracycline / penicillin
ddi: effect
>>> match: avoid_antagonize
-------------
sentence: Tetracycline, a bacteriostatic antibiotic, may antagonize the bactericidal effect of penicillin and concurrent use of these drugs should be avoided.
entities: bacteriostatic antibiotic / penicillin
ddi: null
>>> match: avoid_antagonize
-------------
sentence: Single dose pharmacokinetic studies demonstrated that the metabolism of rivastigmine is not significantly affected by concurrent administration of digoxin, warfarin, diazepam, or fluoxetine.
entities: rivastigmine / digoxin
ddi: null
>>> match: demonstrate_affect
-------------
sentence: Single dose pharmacokinetic studies demonstrated that the metabolism of rivastigmine is not significantly affected by concurrent administration of digoxin, warfarin, diazepam, or fluoxetine.
entities: rivastigmine / warfarin
ddi: null
>>> match: demonstrate_affect
-------------
sentence: Single dose pharmacokinetic studies demonstrated that the metabolism of rivastigmine is not significantly affected by concurrent administration of digoxin, warfarin, diazepam, or fluoxetine.
entities: rivastigmine / diazepam
ddi: null
>>> match: demonstrate_affect
-------------
sentence: Single dose pharmacokinetic studies demonstrated that the metabolism of rivastigmine is not significantly affected by concurrent administration of digoxin, warfarin, diazepam, or fluoxetine.
entities: rivastigmine / fluoxetine
ddi: null
>>> match: demonstrate_affect
-------------
sentence: Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).
entities: rivastigmine / antacids
ddi: null
>>> match: show_influence
-------------
sentence: Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).
entities: rivastigmine / antihypertensives
ddi: null
>>> match: show_influence
-------------
sentence: Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).
entities: rivastigmine / calcium channel blockers
ddi: null
>>> match: show_influence
-------------
sentence: Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).
entities: rivastigmine / antidiabetics
ddi: null
>>> match: show_influence
-------------
sentence: Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).
entities: rivastigmine / nonsteroidal anti-inflammatory drugs
ddi: null
>>> match: show_influence
-------------
sentence: Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).
entities: rivastigmine / estrogens
ddi: null
>>> match: show_influence
-------------
sentence: Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).
entities: rivastigmine / salicylate analgesics
ddi: null
>>> match: show_influence
-------------
sentence: Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).
entities: rivastigmine / antianginals
ddi: null
>>> match: show_influence
-------------
sentence: Population PK analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).
entities: rivastigmine / antihistamines
ddi: null
>>> match: show_influence
-------------
sentence: Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar neuromuscular blocking agents or cholinergic agonists such as bethanechol.
entities: cholinesterase inhibitors / succinylcholine
ddi: effect
>>> match: expect_give
-------------
sentence: Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar neuromuscular blocking agents or cholinergic agonists such as bethanechol.
entities: cholinesterase inhibitors / neuromuscular blocking agents
ddi: effect
>>> match: expect_give
-------------
sentence: Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar neuromuscular blocking agents or cholinergic agonists such as bethanechol.
entities: cholinesterase inhibitors / cholinergic agonists
ddi: effect
>>> match: expect_give
-------------
sentence: Use with Cholinomimetics and Other Cholinesterase Inhibitors: A synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar neuromuscular blocking agents or cholinergic agonists such as bethanechol.
entities: cholinesterase inhibitors / bethanechol
ddi: effect
>>> match: expect_give
-------------
sentence: For example, when vitamin K antagonists are administered concomitantly with nilutamide, prothrombin time should be carefully monitored and if necessary, the dosage of vitamin K antagonists should be reduced.
entities: vitamin K antagonists / nilutamide
ddi: advise
>>> match: monitor_administer
-------------
sentence: In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that ZEBETA be discontinued for several days before the withdrawal of clonidine.
entities: ZEBETA / clonidine
ddi: advise
>>> match: suggest_discontinue
-------------
sentence: When Bezalip or Bezalip retard is used at the same time as other medicines or substances the following interactions must be taken into account: - Bezalip and Bezalip retard may enhance the action of anticoagulants of the coumarin type.
entities: Bezalip / Bezalip retard
ddi: null
>>> match: use_retard
-------------
sentence: When Bezalip or Bezalip retard is used at the same time as other medicines or substances the following interactions must be taken into account: - Bezalip and Bezalip retard may enhance the action of anticoagulants of the coumarin type.
entities: Bezalip / anticoagulants of the coumarin type
ddi: effect
>>> match: take_enhance
-------------
sentence: - When Bezalip or Bezalip retard is used concurrently with anion-exchange resins (e.g. cholestryramine), an interval of at least 2 hours should be maintained between the two medicines, since the absorption of Bezalip or Bezalip retard is impaired
entities: Bezalip / Bezalip retard
ddi: null
>>> match: use_retard
-------------
sentence: Because antacids may interfere with the absorption of anticholinergic agents, simultaneous use of these drugs should be avoided.
entities: antacids / anticholinergic agents
ddi: mechanism
>>> match: avoid_interfere
-------------
sentence: Clinical trials have indicated that Pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral, inhaled and/or parenteral antibiotics, bronchodilators, enzyme supplements, vitamins, oral or inhaled corticosteroids, and analgesics.
entities: Pulmozyme / antibiotics
ddi: null
>>> match: indicate_use
-------------
sentence: Clinical trials have indicated that Pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral, inhaled and/or parenteral antibiotics, bronchodilators, enzyme supplements, vitamins, oral or inhaled corticosteroids, and analgesics.
entities: Pulmozyme / bronchodilators
ddi: null
>>> match: indicate_use
-------------
sentence: Clinical trials have indicated that Pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral, inhaled and/or parenteral antibiotics, bronchodilators, enzyme supplements, vitamins, oral or inhaled corticosteroids, and analgesics.
entities: Pulmozyme / vitamins
ddi: null
>>> match: indicate_use
-------------
sentence: Clinical trials have indicated that Pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral, inhaled and/or parenteral antibiotics, bronchodilators, enzyme supplements, vitamins, oral or inhaled corticosteroids, and analgesics.
entities: Pulmozyme / corticosteroids
ddi: null
>>> match: indicate_use
-------------
sentence: Clinical trials have indicated that Pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral, inhaled and/or parenteral antibiotics, bronchodilators, enzyme supplements, vitamins, oral or inhaled corticosteroids, and analgesics.
entities: Pulmozyme / analgesics
ddi: null
>>> match: indicate_use
-------------
sentence: The safety and efficacy of anakinra used in combination with HUMIRA has not been studied.
entities: anakinra / HUMIRA
ddi: null
>>> match: study_use
-------------
sentence: 1- nc denotes a mean change of less than 10% 2- Pediatrics 3- Mean increase in adults at high Trileptal doses In vivo, the plasma levels of phenytoin increased by up to 40%, when Trileptal was given at doses above 1200 mg/day.
entities: phenytoin / Trileptal
ddi: mechanism
>>> match: denote_increase
-------------
sentence: Treatment with entacapone coadministered with levodopa/dopa decarboxylase inhibitor does not change these effects.
entities: entacapone / levodopa
ddi: null
>>> match: change_coadminister
-------------
sentence: Treatment with entacapone coadministered with levodopa/dopa decarboxylase inhibitor does not change these effects.
entities: entacapone / dopa decarboxylase inhibitor
ddi: null
>>> match: change_coadminister
-------------
sentence: No interaction was noted with the MAO-B inhibitor selegiline in two multiple-dose interaction studies when entacapone was coadministered with a levodopa/dopa decarboxylase inhibitor (n=29).
entities: entacapone / levodopa
ddi: null
>>> match: note_coadminister
-------------
sentence: No interaction was noted with the MAO-B inhibitor selegiline in two multiple-dose interaction studies when entacapone was coadministered with a levodopa/dopa decarboxylase inhibitor (n=29).
entities: entacapone / dopa decarboxylase inhibitor
ddi: null
>>> match: note_coadminister
-------------
sentence: Serum lithium levels should be monitored frequently if INSPRA is administered concomitantly with lithium.
entities: INSPRA / lithium
ddi: advise
>>> match: monitor_administer
-------------
sentence: When paroxetine, a potent inhibitor of CYP2D6, was co-administered with BROVANA at steady-state, exposure to either drug was not altered.
entities: paroxetine / BROVANA
ddi: null
>>> match: alter_administer
-------------
sentence: Accordingly, patients should be advised to avoid alcohol while taking REMERON SolTab. Diazepam: Concomitant administration of diazepam (15 mg) had a minimal effect on plasma levels of mirtazapine (15 mg) in 12 healthy subjects.
entities: alcohol / REMERON SolTab
ddi: advise
>>> match: advise_avoid
-------------
sentence: Accordingly, patients should be advised to avoid diazepam and other similar drugs while taking REMERON SolTab.
entities: diazepam / REMERON SolTab
ddi: advise
>>> match: advise_avoid
-------------
sentence: The risk of using bromocriptine mesylate in combination with other drugs has not been systematically evaluated, but alcohol may potentiate the side effects of bromocriptine mesylate.
entities: alcohol / bromocriptine mesylate
ddi: effect
>>> match: evaluate_potentiate
-------------
sentence: Although a dose adjustment of azithromycin is not recommended when administered in combination with nelfinavir, close monitoring for known side effects of azithromycin, such as liver enzyme abnormalities and hearing impairment, is warranted.
entities: azithromycin / nelfinavir
ddi: advise
>>> match: warrant_recommend
-------------
sentence: Until further data are developed regarding drug interactions when azithromycin and these drugs are used concomitantly, careful monitoring of patients is advised: Digoxin elevated digoxin concentrations.
entities: azithromycin / Digoxin
ddi: null
>>> match: develop_advise
-------------
sentence: Until further data are developed regarding drug interactions when azithromycin and these drugs are used concomitantly, careful monitoring of patients is advised: Digoxin elevated digoxin concentrations.
entities: azithromycin / digoxin
ddi: null
>>> match: develop_advise
-------------
sentence: There are no significant effects on cefdinir pharmacokinetics if the antacid is administered 2 hours before or 2 hours after cefdinir.
entities: antacid / cefdinir
ddi: null
>>> match: be_administer
-------------
sentence: If antacids are required during OMNICEF therapy, OMNICEF should be taken at least 2 hours before or after the antacid.
entities: antacids / OMNICEF
ddi: null
>>> match: take_require
-------------
sentence: If iron supplements are required during OMNICEF therapy, OMNICEF should be taken at least 2 hours before or after the supplement.
entities: iron supplements / OMNICEF
ddi: null
>>> match: take_require
-------------
sentence: In particular, convulsions have been reported when ethionamide is administered with cycloserine and special care should be taken when the treatment regimen includes both of these drugs.
entities: ethionamide / cycloserine
ddi: effect
>>> match: report_administer
-------------
sentence: Because of its primary CNS effect, caution should be used when EQUETROTM is taken with other centrally acting drugs and alcohol.
entities: EQUETROTM / centrally acting drugs
ddi: advise
>>> match: use_take
-------------
sentence: Because of its primary CNS effect, caution should be used when EQUETROTM is taken with other centrally acting drugs and alcohol.
entities: EQUETROTM / alcohol
ddi: advise
>>> match: use_take
-------------
sentence: Dicumarol: It has been reported that allopurinol prolongs the half-life of the anticoagulant, dicumarol.
entities: allopurinol / anticoagulant
ddi: null
>>> match: report_prolong
-------------
sentence: Dicumarol: It has been reported that allopurinol prolongs the half-life of the anticoagulant, dicumarol.
entities: allopurinol / dicumarol
ddi: mechanism
>>> match: report_prolong
-------------
sentence: The clinical basis of this drug interaction has not been established but should be noted when allopurinol is given to patients already on dicumarol therapy.
entities: allopurinol / dicumarol
ddi: null
>>> match: note_give
-------------
sentence: Cyclosporin: Reports indicate that cyclosporine levels may be increased during concomitant treatment with allopurinol sodium for injection.
entities: cyclosporine / allopurinol sodium
ddi: mechanism
>>> match: indicate_increase
-------------
sentence: Close supervision and careful adjustment of the dosage are required when nortriptyline hydrochloride is used with other anticholinergic drugs or sympathomimetic drugs.
entities: nortriptyline hydrochloride / anticholinergic drugs
ddi: advise
>>> match: require_use
-------------
sentence: Close supervision and careful adjustment of the dosage are required when nortriptyline hydrochloride is used with other anticholinergic drugs or sympathomimetic drugs.
entities: nortriptyline hydrochloride / sympathomimetic drugs
ddi: advise
>>> match: require_use
-------------
sentence: When ouabain was applied to the muscle in the presence of phentolamine, both first and second contractile responses to PTX were abolished.
entities: ouabain / phentolamine
ddi: effect
>>> match: abolish_apply
-------------
sentence: Additive CNS depression may occur when antihistamines are administered concomitantly with other CNS depressants including barbiturates, tranquilizers, and alcohol.
entities: antihistamines / CNS depressants
ddi: effect
>>> match: occur_administer
-------------
sentence: Additive CNS depression may occur when antihistamines are administered concomitantly with other CNS depressants including barbiturates, tranquilizers, and alcohol.
entities: antihistamines / barbiturates
ddi: effect
>>> match: occur_administer
-------------
sentence: Additive CNS depression may occur when antihistamines are administered concomitantly with other CNS depressants including barbiturates, tranquilizers, and alcohol.
entities: antihistamines / tranquilizers
ddi: effect
>>> match: occur_administer
-------------
sentence: Additive CNS depression may occur when antihistamines are administered concomitantly with other CNS depressants including barbiturates, tranquilizers, and alcohol.
entities: antihistamines / alcohol
ddi: effect
>>> match: occur_administer
-------------
sentence: There is a significant increase in exposure to imatinib when Gleevec is coadministered with ketoconazole (CYP3A4 inhibitor).
entities: Gleevec / ketoconazole
ddi: mechanism
>>> match: be_coadminister
-------------
sentence: Particular caution is recommended when administering Gleevec with CYP3A4 substrates that have a narrow therapeutic window (e.g., cyclosporine or pimozide).
entities: Gleevec / cyclosporine
ddi: advise
>>> match: recommend_have
-------------
sentence: Particular caution is recommended when administering Gleevec with CYP3A4 substrates that have a narrow therapeutic window (e.g., cyclosporine or pimozide).
entities: Gleevec / pimozide
ddi: advise
>>> match: recommend_have
-------------
sentence: Both 18-MC and ibogaine are sequestered in fat and, like ibogaine, 18-MC probably has an active metabolite.
entities: ibogaine / 18-MC
ddi: null
>>> match: sequester_have
-------------
sentence: The data suggest that 18-MC has a narrower spectrum of actions and will have a substantially greater therapeutic index than ibogaine.
entities: 18-MC / ibogaine
ddi: null
>>> match: suggest_have
-------------
sentence: Aspirin: Concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.
entities: diclofenac / aspirin
ddi: mechanism
>>> match: recommend_displace
-------------
sentence: Anticoagulants: While studies have not shown diclofenac to interact with anticoagulants of the warfarin type, caution should be exercised, nonetheless, since interactions have been seen with other NSAIDs.
entities: diclofenac / anticoagulants of the warfarin type
ddi: null
>>> match: exercise_show
-------------
sentence: Patients who begin taking diclofenac or who increase their diclofenac dose or any other NSAID while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.
entities: diclofenac / diclofenac
ddi: null
>>> match: begin_take
-------------
sentence: Patients who begin taking diclofenac or who increase their diclofenac dose or any other NSAID while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.
entities: diclofenac / NSAID
ddi: null
>>> match: begin_take
-------------
sentence: Patients who begin taking diclofenac or who increase their diclofenac dose or any other NSAID while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.
entities: diclofenac / digoxin
ddi: effect
>>> match: begin_take
-------------
sentence: Patients who begin taking diclofenac or who increase their diclofenac dose or any other NSAID while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.
entities: diclofenac / methotrexate
ddi: effect
>>> match: begin_take
-------------
sentence: Patients who begin taking diclofenac or who increase their diclofenac dose or any other NSAID while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.
entities: diclofenac / cyclosporine
ddi: effect
>>> match: begin_take
-------------
sentence: Patients who begin taking diclofenac or who increase their diclofenac dose or any other NSAID while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.
entities: diclofenac / digoxin
ddi: null
>>> match: take_increase
-------------
sentence: Patients who begin taking diclofenac or who increase their diclofenac dose or any other NSAID while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.
entities: diclofenac / methotrexate
ddi: null
>>> match: take_increase
-------------
sentence: Patients who begin taking diclofenac or who increase their diclofenac dose or any other NSAID while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.
entities: diclofenac / cyclosporine
ddi: null
>>> match: take_increase
-------------
sentence: Patients who begin taking diclofenac or who increase their diclofenac dose or any other NSAID while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.
entities: NSAID / digoxin
ddi: effect
>>> match: take_increase
-------------
sentence: Patients who begin taking diclofenac or who increase their diclofenac dose or any other NSAID while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.
entities: NSAID / methotrexate
ddi: effect
>>> match: take_increase
-------------
sentence: Patients who begin taking diclofenac or who increase their diclofenac dose or any other NSAID while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs.
entities: NSAID / cyclosporine
ddi: effect
>>> match: take_increase
-------------
sentence: Phenobarbital toxicity has been reported to have occurred in a patient on chronic phenobarbital treatment following the initiation of diclofenac therapy.
entities: phenobarbital / diclofenac
ddi: effect
>>> match: report_occur
-------------
sentence: Another study showed that alosetron had no clinically significant effect on plasma concentrations of the oral contraceptive agents ethinyl estradiol and levonorgestrel (CYP3A4 substrates).
entities: alosetron / contraceptive agents
ddi: null
>>> match: show_have
-------------
sentence: Another study showed that alosetron had no clinically significant effect on plasma concentrations of the oral contraceptive agents ethinyl estradiol and levonorgestrel (CYP3A4 substrates).
entities: alosetron / ethinyl estradiol
ddi: null
>>> match: show_have
-------------
sentence: Another study showed that alosetron had no clinically significant effect on plasma concentrations of the oral contraceptive agents ethinyl estradiol and levonorgestrel (CYP3A4 substrates).
entities: alosetron / levonorgestrel
ddi: null
>>> match: show_have
-------------
sentence: Another study showed that alosetron had no clinically significant effect on plasma concentrations of the oral contraceptive agents ethinyl estradiol and levonorgestrel (CYP3A4 substrates).
entities: contraceptive agents / ethinyl estradiol
ddi: null
>>> match: show_have
-------------
sentence: Another study showed that alosetron had no clinically significant effect on plasma concentrations of the oral contraceptive agents ethinyl estradiol and levonorgestrel (CYP3A4 substrates).
entities: contraceptive agents / levonorgestrel
ddi: null
>>> match: show_have
-------------
sentence: There have been isolated reports of patients experiencing increases in their prothrombin times when etidronate was added to warfarin therapy.
entities: etidronate / warfarin
ddi: effect
>>> match: isolate_add
-------------
sentence: The incremental LDL-C reduction due to adding ezetimibe to cholestyramine may be reduced by this interaction.
entities: ezetimibe / cholestyramine
ddi: effect
>>> match: reduce_add
-------------
sentence: HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, simvastatin, pravastatin, lovastatin, or fluvastatin.
entities: ezetimibe / atorvastatin
ddi: null
>>> match: see_administer
-------------
sentence: HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, simvastatin, pravastatin, lovastatin, or fluvastatin.
entities: ezetimibe / simvastatin
ddi: null
>>> match: see_administer
-------------
sentence: HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, simvastatin, pravastatin, lovastatin, or fluvastatin.
entities: ezetimibe / pravastatin
ddi: null
>>> match: see_administer
-------------
sentence: HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, simvastatin, pravastatin, lovastatin, or fluvastatin.
entities: ezetimibe / lovastatin
ddi: null
>>> match: see_administer
-------------
sentence: HMG-CoA reductase inhibitors: No clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, simvastatin, pravastatin, lovastatin, or fluvastatin.
entities: ezetimibe / fluvastatin
ddi: null
>>> match: see_administer
-------------
sentence: Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, gelusil, erythromycin and multi minerals.
entities: moxifloxacin / fluoroquinolones
ddi: null
>>> match: be_fluoroquinolone
-------------
sentence: Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, gelusil, erythromycin and multi minerals.
entities: moxifloxacin / sucralfate
ddi: null
>>> match: be_fluoroquinolone
-------------
sentence: Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, gelusil, erythromycin and multi minerals.
entities: moxifloxacin / gelusil
ddi: null
>>> match: be_fluoroquinolone
-------------
sentence: Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, gelusil, erythromycin and multi minerals.
entities: moxifloxacin / erythromycin
ddi: null
>>> match: be_fluoroquinolone
-------------
sentence: Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, gelusil, erythromycin and multi minerals.
entities: moxifloxacin / multi minerals
ddi: null
>>> match: be_fluoroquinolone
-------------
sentence: Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, gelusil, erythromycin and multi minerals.
entities: fluoroquinolones / sucralfate
ddi: null
>>> match: be_fluoroquinolone
-------------
sentence: Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, gelusil, erythromycin and multi minerals.
entities: fluoroquinolones / gelusil
ddi: null
>>> match: be_fluoroquinolone
-------------
sentence: Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, gelusil, erythromycin and multi minerals.
entities: fluoroquinolones / erythromycin
ddi: null
>>> match: be_fluoroquinolone
-------------
sentence: Being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, gelusil, erythromycin and multi minerals.
entities: fluoroquinolones / multi minerals
ddi: null
>>> match: be_fluoroquinolone
-------------
sentence: Prolonged recovery time may occur if barbiturates and/or narcotics are used concurrently with ketamine.
entities: barbiturates / ketamine
ddi: effect
>>> match: occur_use
-------------
sentence: Prolonged recovery time may occur if barbiturates and/or narcotics are used concurrently with ketamine.
entities: narcotics / ketamine
ddi: effect
>>> match: occur_use
-------------
sentence: In vitro data indicate that the phosphorylation of stavudine is also inhibited at relevant concentrations by doxorubicin and ribavirin.
entities: stavudine / doxorubicin
ddi: effect
>>> match: indicate_inhibit
-------------
sentence: In vitro data indicate that the phosphorylation of stavudine is also inhibited at relevant concentrations by doxorubicin and ribavirin.
entities: stavudine / ribavirin
ddi: effect
>>> match: indicate_inhibit
-------------
sentence: Among the risk factors studied, two appear to increase the risk of ARE: the prescription of thiabendazole to treat strongyloidiasis during the melarsoprol cure and the bad general clinical conditions of patients.
entities: thiabendazole / melarsoprol
ddi: effect
>>> match: appear_treat
-------------
sentence: Synergism was also noted when methylglyoxal was combined with carbenicillin and amikacin.
entities: methylglyoxal / carbenicillin
ddi: effect
>>> match: note_combine
-------------
sentence: Synergism was also noted when methylglyoxal was combined with carbenicillin and amikacin.
entities: methylglyoxal / amikacin
ddi: effect
>>> match: note_combine
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: salicylates / sulfonamides
ddi: null
>>> match: potentiate_bind
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: salicylates / chloramphenicol
ddi: null
>>> match: potentiate_bind
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: salicylates / probenecid
ddi: null
>>> match: potentiate_bind
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: salicylates / coumarins
ddi: null
>>> match: potentiate_bind
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: salicylates / monoamine oxidase inhibitors
ddi: null
>>> match: potentiate_bind
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: salicylates / beta adrenergic blocking agents
ddi: null
>>> match: potentiate_bind
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonamides / chloramphenicol
ddi: null
>>> match: potentiate_bind
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonamides / probenecid
ddi: null
>>> match: potentiate_bind
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonamides / coumarins
ddi: null
>>> match: potentiate_bind
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonamides / monoamine oxidase inhibitors
ddi: null
>>> match: potentiate_bind
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: sulfonamides / beta adrenergic blocking agents
ddi: null
>>> match: potentiate_bind
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: chloramphenicol / probenecid
ddi: null
>>> match: potentiate_bind
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: chloramphenicol / coumarins
ddi: null
>>> match: potentiate_bind
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: chloramphenicol / monoamine oxidase inhibitors
ddi: null
>>> match: potentiate_bind
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: chloramphenicol / beta adrenergic blocking agents
ddi: null
>>> match: potentiate_bind
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: probenecid / coumarins
ddi: null
>>> match: potentiate_bind
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: probenecid / monoamine oxidase inhibitors
ddi: null
>>> match: potentiate_bind
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: probenecid / beta adrenergic blocking agents
ddi: null
>>> match: potentiate_bind
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: coumarins / monoamine oxidase inhibitors
ddi: null
>>> match: potentiate_bind
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: coumarins / beta adrenergic blocking agents
ddi: null
>>> match: potentiate_bind
-------------
sentence: The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, and beta adrenergic blocking agents.
entities: monoamine oxidase inhibitors / beta adrenergic blocking agents
ddi: null
>>> match: potentiate_bind
-------------
sentence: We conclude that ADL 8-2698 prevents morphine-induced increases in gastrointestinal transit time by means of selective peripheral opioid anitagonism without affecting central opioid analgesia.
entities: ADL 8-2698 / morphine
ddi: effect
>>> match: conclude_prevent
-------------
sentence: Caution is advised when beginning, discontinuing, or changing the dose of DIAMOX in patients receiving primidone.
entities: DIAMOX / primidone
ddi: advise
>>> match: discontinue_change
-------------
sentence: Acetazolamide increases lithium excretion and the lithium may be decreased.
entities: Acetazolamide / lithium
ddi: mechanism
>>> match: decrease_increase
-------------
sentence: Acetazolamide increases lithium excretion and the lithium may be decreased.
entities: Acetazolamide / lithium
ddi: null
>>> match: decrease_increase
-------------
sentence: Nicardipine HCl usually does not alter the plasma levels of digoxin, however, serum digoxin levels should be evaluated after concomitant therapy with nicardipine HCl is initiated.
entities: digoxin / nicardipine HCl
ddi: advise
>>> match: alter_evaluate
-------------
sentence: It has been reported that the incidence of bradycardia was increased when oxymorphone was combined with propofol for induction of anesthesia.
entities: oxymorphone / propofol
ddi: effect
>>> match: increase_combine
-------------
sentence: Tetracycline, a bacteriostatic antibiotic, may antagonize the bactercidal effect of penicillin and concurrent use of these drugs should be avoided.
entities: Tetracycline / penicillin
ddi: effect
>>> match: avoid_antagonize
-------------
sentence: Tetracycline, a bacteriostatic antibiotic, may antagonize the bactercidal effect of penicillin and concurrent use of these drugs should be avoided.
entities: bacteriostatic antibiotic / penicillin
ddi: null
>>> match: avoid_antagonize
-------------
sentence: The plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decrease by concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and adjustment of the dosage of imipramine may therefore be necessary.
entities: cimetidine / imipramine
ddi: null
>>> match: increase_give
-------------
sentence: The plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decrease by concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and adjustment of the dosage of imipramine may therefore be necessary.
entities: fluoxetine / imipramine
ddi: null
>>> match: increase_give
-------------
sentence: The plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decrease by concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and adjustment of the dosage of imipramine may therefore be necessary.
entities: barbiturates / imipramine
ddi: null
>>> match: increase_give
-------------
sentence: The plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decrease by concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and adjustment of the dosage of imipramine may therefore be necessary.
entities: phenytoin / imipramine
ddi: null
>>> match: increase_give
-------------
sentence: Caution should be observed when anileridine is coadministered with other opioids, sedatives, phenothiazines, or anesthetics, as these agents may increase respiratory and circulatory depression.
entities: anileridine / opioids
ddi: advise
>>> match: observe_coadminister
-------------
sentence: Caution should be observed when anileridine is coadministered with other opioids, sedatives, phenothiazines, or anesthetics, as these agents may increase respiratory and circulatory depression.
entities: anileridine / sedatives
ddi: advise
>>> match: observe_coadminister
-------------
sentence: Caution should be observed when anileridine is coadministered with other opioids, sedatives, phenothiazines, or anesthetics, as these agents may increase respiratory and circulatory depression.
entities: anileridine / phenothiazines
ddi: advise
>>> match: observe_coadminister
-------------
sentence: Caution should be observed when anileridine is coadministered with other opioids, sedatives, phenothiazines, or anesthetics, as these agents may increase respiratory and circulatory depression.
entities: anileridine / anesthetics
ddi: advise
>>> match: observe_coadminister
-------------
sentence: Close supervision and careful adjustment of dosage are required when Anafranil is administered with anticholinergic or sympathomimetic drugs.
entities: Anafranil / anticholinergic
ddi: advise
>>> match: require_administer
-------------
sentence: Close supervision and careful adjustment of dosage are required when Anafranil is administered with anticholinergic or sympathomimetic drugs.
entities: Anafranil / sympathomimetic drugs
ddi: advise
>>> match: require_administer
-------------
sentence: Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants.
entities: CMI / tricyclic antidepressants
ddi: null
>>> match: report_anticipate
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: methylphenidate / cimetidine
ddi: null
>>> match: report_increase
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: methylphenidate / fluoxetine
ddi: null
>>> match: report_increase
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: methylphenidate / barbiturates
ddi: null
>>> match: report_increase
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: methylphenidate / phenytoin
ddi: null
>>> match: report_increase
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: methylphenidate / CMI
ddi: mechanism
>>> match: report_increase
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: cimetidine / barbiturates
ddi: null
>>> match: report_increase
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: cimetidine / phenytoin
ddi: null
>>> match: report_increase
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: cimetidine / CMI
ddi: mechanism
>>> match: report_increase
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: fluoxetine / barbiturates
ddi: null
>>> match: report_increase
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: fluoxetine / phenytoin
ddi: null
>>> match: report_increase
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: fluoxetine / CMI
ddi: mechanism
>>> match: report_increase
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: barbiturates / CMI
ddi: mechanism
>>> match: report_increase
-------------
sentence: plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well.
entities: phenytoin / CMI
ddi: mechanism
>>> match: report_increase
-------------
sentence: Caution is advised when TRISENOX is coadministered with other medications that can prolong the QT interval (e.g. certain antiarrhythmics or thioridazine) or lead to electrolyte abnormalities (such as diuretics or amphotericin B).
entities: TRISENOX / antiarrhythmics
ddi: advise
>>> match: advise_coadminister
-------------
sentence: Caution is advised when TRISENOX is coadministered with other medications that can prolong the QT interval (e.g. certain antiarrhythmics or thioridazine) or lead to electrolyte abnormalities (such as diuretics or amphotericin B).
entities: TRISENOX / thioridazine
ddi: advise
>>> match: advise_coadminister
-------------
sentence: Caution is advised when TRISENOX is coadministered with other medications that can prolong the QT interval (e.g. certain antiarrhythmics or thioridazine) or lead to electrolyte abnormalities (such as diuretics or amphotericin B).
entities: TRISENOX / diuretics
ddi: advise
>>> match: advise_coadminister
-------------
sentence: Caution is advised when TRISENOX is coadministered with other medications that can prolong the QT interval (e.g. certain antiarrhythmics or thioridazine) or lead to electrolyte abnormalities (such as diuretics or amphotericin B).
entities: TRISENOX / amphotericin B
ddi: advise
>>> match: advise_coadminister
-------------
sentence: Patients with Congenital or Acquired QT Prolongation In a study of the effect of solifenacin on the QT interval in 76 healthy women, the QT prolonging effect appeared less with solifenacin 10 mg than with 30 mg (three times the maximum recommended dose), and the effect of solifenacin 30 mg did not appear as large as that of the positive control moxifloxacin at its therapeutic dose.
entities: solifenacin / moxifloxacin
ddi: null
>>> match: appear_appear
-------------
sentence: Although studies designed to examine drug interactions have not been done, it was noted that corticosteroid or ACTH treatment of relapses for periods of up to 28 days has been administered to patients (N=180) receiving Betaseron.
entities: corticosteroid / Betaseron
ddi: null
>>> match: note_administer
-------------
sentence: Although studies designed to examine drug interactions have not been done, it was noted that corticosteroid or ACTH treatment of relapses for periods of up to 28 days has been administered to patients (N=180) receiving Betaseron.
entities: ACTH / Betaseron
ddi: null
>>> match: note_administer
-------------
sentence: however, no deleterious interactions were seen when ROMAZICON was administered after narcotics, inhalational anesthetics, muscle relaxants and muscle relaxant antagonists administered in conjunction with sedation or anesthesia.
entities: ROMAZICON / narcotics
ddi: null
>>> match: see_administer
-------------
sentence: however, no deleterious interactions were seen when ROMAZICON was administered after narcotics, inhalational anesthetics, muscle relaxants and muscle relaxant antagonists administered in conjunction with sedation or anesthesia.
entities: ROMAZICON / anesthetics
ddi: null
>>> match: see_administer
-------------
sentence: however, no deleterious interactions were seen when ROMAZICON was administered after narcotics, inhalational anesthetics, muscle relaxants and muscle relaxant antagonists administered in conjunction with sedation or anesthesia.
entities: ROMAZICON / muscle relaxants
ddi: null
>>> match: see_administer
-------------
sentence: Particular caution is necessary when using ROMAZICON in cases of mixed drug overdosage since the toxic effects (such as convulsions and cardiac dysrhythmias) of other drugs taken in overdose (especially cyclic antidepressants) may emerge with the reversal of the benzodiazepine effect by flumazenil.
entities: ROMAZICON / cyclic antidepressants
ddi: effect
>>> match: emerge_use
-------------
sentence: Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of Nalfon and salicylates is not recommended.
entities: Nalfon / aspirin
ddi: null
>>> match: recommend_show
-------------
sentence: Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of Nalfon and salicylates is not recommended.
entities: Nalfon / aspirin
ddi: null
>>> match: recommend_show
-------------
sentence: Because Nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of Nalfon, the concomitant use of Nalfon and salicylates is not recommended.
entities: Nalfon / Nalfon
ddi: null
>>> match: recommend_show
-------------
sentence: Concurrent administration of HEXALEN and antidepressants of the MAO inhibitor class may cause severe orthostatic hypotension.Cimetidine, an inhibitor of microsomal drug metabolism, increased altretamine's half-life and toxicity in a rat model.
entities: Cimetidine / altretamine
ddi: mechanism
>>> match: cause_increase
-------------
sentence: however, it adversely affected response duration suggesting that pyridoxine should not be administered with HEXALEN and/or cisplatin.1
entities: pyridoxine / HEXALEN
ddi: advise
>>> match: suggest_administer
-------------
sentence: however, it adversely affected response duration suggesting that pyridoxine should not be administered with HEXALEN and/or cisplatin.1
entities: pyridoxine / cisplatin
ddi: advise
>>> match: suggest_administer
-------------
sentence: Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.
entities: LEVSIN / antimuscarinics
ddi: effect
>>> match: occur_administer
-------------
sentence: Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.
entities: LEVSIN / amantadine
ddi: effect
>>> match: occur_administer
-------------
sentence: Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.
entities: LEVSIN / haloperidol
ddi: effect
>>> match: occur_administer
-------------
sentence: Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.
entities: LEVSIN / phenothiazines
ddi: effect
>>> match: occur_administer
-------------
sentence: Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.
entities: LEVSIN / monoamine oxidase (MAO) inhibitors
ddi: effect
>>> match: occur_administer
-------------
sentence: Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.
entities: LEVSIN / tricyclic antidepressants
ddi: effect
>>> match: occur_administer
-------------
sentence: Additive adverse effects resulting from cholinergic blockade may occur when LEVSIN is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.
entities: LEVSIN / antihistamines
ddi: effect
>>> match: occur_administer
-------------
sentence: A study published in 2002 found that vigabatrin causes a statistically significant increase in plasma clearance of carbamazepine.
entities: vigabatrin / carbamazepine
ddi: mechanism
>>> match: find_cause
-------------
sentence: In 1984, Drs Rimmer and Richens at the University of Wales reported that administering vigabatrin with phenytoin lowered the serum phenytoin concentration in patients with treatment-resistant epilepsy.
entities: vigabatrin / phenytoin
ddi: null
>>> match: report_lower
-------------
sentence: In 1984, Drs Rimmer and Richens at the University of Wales reported that administering vigabatrin with phenytoin lowered the serum phenytoin concentration in patients with treatment-resistant epilepsy.
entities: phenytoin / phenytoin
ddi: null
>>> match: report_lower
-------------
sentence: Caution should be taken when ENABLEX is used concomitantly with medications that are predominantly metabolized by CYP2D6 and which have a narrow therapeutic window, such as flecainide, thioridazine and tricyclic antidepressants (see CLINICAL PHARMACOLOGY).
entities: ENABLEX / flecainide
ddi: advise
>>> match: take_use
-------------
sentence: Caution should be taken when ENABLEX is used concomitantly with medications that are predominantly metabolized by CYP2D6 and which have a narrow therapeutic window, such as flecainide, thioridazine and tricyclic antidepressants (see CLINICAL PHARMACOLOGY).
entities: ENABLEX / thioridazine
ddi: advise
>>> match: take_use
-------------
sentence: Caution should be taken when ENABLEX is used concomitantly with medications that are predominantly metabolized by CYP2D6 and which have a narrow therapeutic window, such as flecainide, thioridazine and tricyclic antidepressants (see CLINICAL PHARMACOLOGY).
entities: ENABLEX / tricyclic antidepressants
ddi: advise
>>> match: take_use
-------------
sentence: Caution should be used when CYP3A4 inhibitors are co-administered with felodipine.
entities: CYP3A4 / felodipine
ddi: null
>>> match: use_administer
-------------
sentence: The following specific interactions have been reported: Itraconazole Co-administration of another extended release formulation of felodipine with itraconazole resulted in approximately 8-fold increase in the AUC, more than 6- fold increase in the Cmax, and 2-fold prolongation in the half- life of felodipine.
entities: felodipine / felodipine
ddi: null
>>> match: report_result
-------------
sentence: The following specific interactions have been reported: Itraconazole Co-administration of another extended release formulation of felodipine with itraconazole resulted in approximately 8-fold increase in the AUC, more than 6- fold increase in the Cmax, and 2-fold prolongation in the half- life of felodipine.
entities: itraconazole / felodipine
ddi: null
>>> match: report_result
-------------
sentence: Other Concomitant Therapy  In healthy subjects there were no clinically significant interactions when felodipine was given concomitantly with indomethacin or spironolactone.
entities: felodipine / indomethacin
ddi: null
>>> match: be_give
-------------
sentence: Other Concomitant Therapy  In healthy subjects there were no clinically significant interactions when felodipine was given concomitantly with indomethacin or spironolactone.
entities: felodipine / spironolactone
ddi: null
>>> match: be_give
-------------
sentence: May interact with the following: beta-adrenergic blocking agents (these medicines may make your condition worse and prevent the adrenergic bronchodilators from working properly) and disopyramide, quinidine, phenothiazines, and procainamide (these medicines may increase the risk of heart problems).
entities: adrenergic bronchodilators / disopyramide
ddi: null
>>> match: make_prevent
-------------
sentence: May interact with the following: beta-adrenergic blocking agents (these medicines may make your condition worse and prevent the adrenergic bronchodilators from working properly) and disopyramide, quinidine, phenothiazines, and procainamide (these medicines may increase the risk of heart problems).
entities: adrenergic bronchodilators / quinidine
ddi: null
>>> match: make_prevent
-------------
sentence: May interact with the following: beta-adrenergic blocking agents (these medicines may make your condition worse and prevent the adrenergic bronchodilators from working properly) and disopyramide, quinidine, phenothiazines, and procainamide (these medicines may increase the risk of heart problems).
entities: adrenergic bronchodilators / phenothiazines
ddi: null
>>> match: make_prevent
-------------
sentence: May interact with the following: beta-adrenergic blocking agents (these medicines may make your condition worse and prevent the adrenergic bronchodilators from working properly) and disopyramide, quinidine, phenothiazines, and procainamide (these medicines may increase the risk of heart problems).
entities: adrenergic bronchodilators / procainamide
ddi: null
>>> match: make_prevent
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / acetaminophen
ddi: int
>>> match: affect_interact
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / Tylenol
ddi: int
>>> match: affect_interact
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / chloramphenicol
ddi: int
>>> match: affect_interact
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / Chloromycetin
ddi: int
>>> match: affect_interact
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / anesthetics
ddi: int
>>> match: affect_interact
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / benzocaine
ddi: int
>>> match: affect_interact
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / lidocaine
ddi: int
>>> match: affect_interact
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / para-aminobenzoic acid
ddi: int
>>> match: affect_interact
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / PABA
ddi: int
>>> match: affect_interact
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / multivitamins
ddi: int
>>> match: affect_interact
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / procainamide
ddi: int
>>> match: affect_interact
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / Pronestyl
ddi: int
>>> match: affect_interact
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / sulfonamides
ddi: int
>>> match: affect_interact
-------------
sentence: Bentiromide may interact with acetaminophen (e.g., Tylenol), chloramphenicol (e.g., Chloromycetin), local anesthetics (e.g., benzocaine and lidocaine), para-aminobenzoic acid (PABA)-containing preparations (e.g., sunscreens and some multivitamins), procainamide (e.g., Pronestyl), sulfonamides (sulfa medicines), thiazide diuretics (use of these medicines during the test period will affect the test results), and pancreatic supplements (use of pancreatic supplements may give false test results).
entities: Bentiromide / thiazide diuretics
ddi: int
>>> match: affect_interact
-------------
sentence: Since PLETAL is extensively metabolized by cytochrome P-450 isoenzymes, caution should be exercised when PLETAL is coadministered with inhibitors of C.P.A. such as ketoconazole and erythromycin or inhibitors of CYP2C19 such as omeprazole.
entities: PLETAL / ketoconazole
ddi: advise
>>> match: exercise_coadminister
-------------
sentence: Since PLETAL is extensively metabolized by cytochrome P-450 isoenzymes, caution should be exercised when PLETAL is coadministered with inhibitors of C.P.A. such as ketoconazole and erythromycin or inhibitors of CYP2C19 such as omeprazole.
entities: PLETAL / erythromycin
ddi: advise
>>> match: exercise_coadminister
-------------
sentence: Since PLETAL is extensively metabolized by cytochrome P-450 isoenzymes, caution should be exercised when PLETAL is coadministered with inhibitors of C.P.A. such as ketoconazole and erythromycin or inhibitors of CYP2C19 such as omeprazole.
entities: PLETAL / omeprazole
ddi: advise
>>> match: exercise_coadminister
-------------
sentence: Pharmacokinetic studies have demonstrated that omeprazole and erythromycin significantly increased the systemic exposure of cilostazol and/or its major metabolites.
entities: omeprazole / cilostazol
ddi: mechanism
>>> match: demonstrate_increase
-------------
sentence: Pharmacokinetic studies have demonstrated that omeprazole and erythromycin significantly increased the systemic exposure of cilostazol and/or its major metabolites.
entities: erythromycin / cilostazol
ddi: mechanism
>>> match: demonstrate_increase
-------------
sentence: It was shown that neurotensin antagonized evidently the antinociceptive effect of enkephalins and their analogue.
entities: neurotensin / enkephalins
ddi: effect
>>> match: show_antagonize
-------------
sentence: It is concluded that neurotensin modulates in an opposite way the function of the enkephalinergic neurons and the central action of tuftsin.
entities: neurotensin / tuftsin
ddi: effect
>>> match: conclude_modulate
-------------
sentence: Other Antihypertensives: When MYKROX Tablets are used with other antihypertensive drugs, care must be taken, especially during initial therapy.
entities: MYKROX / antihypertensive drugs
ddi: advise
>>> match: take_use
-------------
sentence: Caution should be used when NSAIDs are administered concomitantly with methotrexate.
entities: NSAIDs / methotrexate
ddi: advise
>>> match: use_administer
-------------
sentence: ACE inhibitors: Reports suggest that NSAIDs may diminish the antihypertensive effect of ACE inhibitors.
entities: NSAIDs / ACE inhibitors
ddi: effect
>>> match: suggest_diminish
-------------
sentence: Furosemide: Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and thiazides in some patients.
entities: NSAIDs / furosemide
ddi: effect
>>> match: show_reduce
-------------
sentence: Furosemide: Clinical studies, as well as post-marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and thiazides in some patients.
entities: NSAIDs / thiazides
ddi: effect
>>> match: show_reduce
-------------
sentence: A drug interaction study was performed in which ERBITUX was administered in combination with irinotecan.
entities: ERBITUX / irinotecan
ddi: null
>>> match: perform_administer
-------------
sentence: When ertapenem is co-administered with probenecid (500 mg p.o. every 6 hours), probenecid competes for active tubular secretion and reduces the renal clearance of ertapenem.
entities: ertapenem / probenecid
ddi: null
>>> match: compete_administer
-------------
sentence: In vitro studies indicate that ertapenem does not inhibit P-glycoprotein-mediated transport of digoxin or vinblastine and that ertapenem is not a substrate for P-glycoprotein-mediated transport.
entities: ertapenem / digoxin
ddi: null
>>> match: indicate_inhibit
-------------
sentence: In vitro studies indicate that ertapenem does not inhibit P-glycoprotein-mediated transport of digoxin or vinblastine and that ertapenem is not a substrate for P-glycoprotein-mediated transport.
entities: ertapenem / vinblastine
ddi: null
>>> match: indicate_inhibit
-------------
sentence: In vitro studies indicate that ertapenem does not inhibit P-glycoprotein-mediated transport of digoxin or vinblastine and that ertapenem is not a substrate for P-glycoprotein-mediated transport.
entities: ertapenem / ertapenem
ddi: null
>>> match: indicate_inhibit
-------------
sentence: In vitro studies indicate that ertapenem does not inhibit P-glycoprotein-mediated transport of digoxin or vinblastine and that ertapenem is not a substrate for P-glycoprotein-mediated transport.
entities: digoxin / ertapenem
ddi: null
>>> match: indicate_inhibit
-------------
sentence: In vitro studies indicate that ertapenem does not inhibit P-glycoprotein-mediated transport of digoxin or vinblastine and that ertapenem is not a substrate for P-glycoprotein-mediated transport.
entities: vinblastine / ertapenem
ddi: null
>>> match: indicate_inhibit
-------------
sentence: Serious toxicity may result if dextromethorphan is coadministered with monoamine oxidase inhibitors (MAOIs).
entities: dextromethorphan / monoamine oxidase inhibitors
ddi: effect
>>> match: result_coadminister
-------------
sentence: Serious toxicity may result if dextromethorphan is coadministered with monoamine oxidase inhibitors (MAOIs).
entities: dextromethorphan / MAOIs
ddi: effect
>>> match: result_coadminister
----------------------
1028 matches found
----------------------
P(mechanism|ANY) = 91/1028 = 0.08852140077821012
P(effect|ANY) = 174/1028 = 0.16926070038910507
P(int|ANY) = 14/1028 = 0.013618677042801557
P(advise|ANY) = 126/1028 = 0.122568093385214
P(null|ANY) = 623/1028 = 0.6060311284046692
----------------------
P(advise|recommend_administer) = 1/1 = 1.0
P(effect|indicate_exacerbate) = 1/1 = 1.0
P(effect|suggest_potentiate) = 1/1 = 1.0
P(null|indicate_have) = 1/1 = 1.0
P(mechanism|indicate_increase) = 1/2 = 0.5
P(null|indicate_increase) = 1/2 = 0.5
P(mechanism|show_inhibit) = 10/14 = 0.7142857142857143
P(null|show_inhibit) = 4/14 = 0.2857142857142857
P(null|show_affect) = 3/3 = 1.0
P(advise|advise_administer) = 4/4 = 1.0
P(null|induce_preconstrict) = 1/1 = 1.0
P(mechanism|decrease_increase) = 2/4 = 0.5
P(null|decrease_increase) = 2/4 = 0.5
P(mechanism|have_decrease) = 1/2 = 0.5
P(null|have_decrease) = 1/2 = 0.5
P(null|indicate_cause) = 1/1 = 1.0
P(null|report_identify) = 2/2 = 1.0
P(null|show_elevate) = 9/9 = 1.0
P(effect|increase_use) = 2/2 = 1.0
P(advise|recommend_determine) = 1/1 = 1.0
P(null|conclude_coadminister) = 2/2 = 1.0
P(advise|avoid_give) = 2/2 = 1.0
P(effect|be_evaluate) = 3/3 = 1.0
P(advise|monitor_initiate) = 1/2 = 0.5
P(null|monitor_initiate) = 1/2 = 0.5
P(null|achieve_monitor) = 2/2 = 1.0
P(effect|minimize_discontinue) = 3/7 = 0.42857142857142855
P(advise|minimize_discontinue) = 1/7 = 0.14285714285714285
P(null|minimize_discontinue) = 3/7 = 0.42857142857142855
P(null|show_coadminister) = 3/3 = 1.0
P(null|be_warrant) = 2/2 = 1.0
P(advise|monitor_administer) = 7/9 = 0.7777777777777778
P(null|monitor_administer) = 2/9 = 0.2222222222222222
P(null|reduce_beadminister) = 4/4 = 1.0
P(advise|decrease_maintain) = 1/1 = 1.0
P(advise|monitor_start) = 1/1 = 1.0
P(advise|recommend_monitor) = 5/8 = 0.625
P(null|recommend_monitor) = 3/8 = 0.375
P(effect|occur_administer) = 19/27 = 0.7037037037037037
P(null|occur_administer) = 8/27 = 0.2962962962962963
P(mechanism|indicate_inhibit) = 2/16 = 0.125
P(effect|indicate_inhibit) = 3/16 = 0.1875
P(null|indicate_inhibit) = 11/16 = 0.6875
P(mechanism|suggest_inhibit) = 2/5 = 0.4
P(effect|suggest_inhibit) = 1/5 = 0.2
P(null|suggest_inhibit) = 2/5 = 0.4
P(mechanism|report_coadminister) = 2/3 = 0.6666666666666666
P(null|report_coadminister) = 1/3 = 0.3333333333333333
P(null|advise_monitor) = 1/1 = 1.0
P(effect|report_enhance) = 1/1 = 1.0
P(effect|monitor_report) = 1/1 = 1.0
P(null|reveal_influence) = 4/4 = 1.0
P(advise|be_administer) = 1/4 = 0.25
P(null|be_administer) = 3/4 = 0.75
P(mechanism|suggest_impair) = 1/1 = 1.0
P(mechanism|increase_add) = 1/1 = 1.0
P(null|inhibit_increase) = 1/1 = 1.0
P(null|eliminate_conduct) = 8/8 = 1.0
P(mechanism|conduct_have) = 7/7 = 1.0
P(null|determine_investigate) = 8/8 = 1.0
P(effect|observe_combine) = 1/1 = 1.0
P(effect|report_diminish) = 24/24 = 1.0
P(mechanism|occur_interfere) = 1/1 = 1.0
P(null|interact_result) = 48/48 = 1.0
P(null|result_interfere) = 5/5 = 1.0
P(null|evaluate_conjugate) = 16/16 = 1.0
P(null|show_enter) = 1/1 = 1.0
P(effect|observe_use) = 2/3 = 0.6666666666666666
P(null|observe_use) = 1/3 = 0.3333333333333333
P(mechanism|result_inhibit) = 1/1 = 1.0
P(null|allow_initiate) = 1/1 = 1.0
P(null|use_control) = 6/6 = 1.0
P(advise|avoid_prescribe) = 3/3 = 1.0
P(null|involve_metabolize) = 3/3 = 1.0
P(mechanism|metabolize_inhibit) = 1/2 = 0.5
P(null|metabolize_inhibit) = 1/2 = 0.5
P(null|require_give) = 7/7 = 1.0
P(null|administer_have) = 1/1 = 1.0
P(mechanism|administer_report) = 2/2 = 1.0
P(mechanism|demonstrate_double) = 1/3 = 0.3333333333333333
P(null|demonstrate_double) = 2/3 = 0.6666666666666666
P(null|double_know) = 2/2 = 1.0
P(null|know_metabolize) = 1/1 = 1.0
P(mechanism|report_prolong) = 1/4 = 0.25
P(effect|report_prolong) = 1/4 = 0.25
P(null|report_prolong) = 2/4 = 0.5
P(null|draw_mix) = 1/1 = 1.0
P(effect|report_reduce) = 1/5 = 0.2
P(null|report_reduce) = 4/5 = 0.8
P(mechanism|alter_administer) = 1/3 = 0.3333333333333333
P(null|alter_administer) = 2/3 = 0.6666666666666666
P(advise|use_administer) = 5/7 = 0.7142857142857143
P(null|use_administer) = 2/7 = 0.2857142857142857
P(advise|avoid_take) = 1/1 = 1.0
P(null|observe_reverse) = 2/2 = 1.0
P(mechanism|recommend_displace) = 1/2 = 0.5
P(advise|recommend_displace) = 1/2 = 0.5
P(null|indicate_influence) = 5/5 = 1.0
P(null|influence_influence) = 1/1 = 1.0
P(advise|recommend_have) = 2/6 = 0.3333333333333333
P(null|recommend_have) = 4/6 = 0.6666666666666666
P(advise|give_administer) = 1/1 = 1.0
P(mechanism|use_occur) = 1/1 = 1.0
P(effect|suggest_alter) = 1/1 = 1.0
P(null|modify_affect) = 2/2 = 1.0
P(effect|suggest_regulate) = 8/8 = 1.0
P(mechanism|observe_administer) = 1/6 = 0.16666666666666666
P(advise|observe_administer) = 2/6 = 0.3333333333333333
P(null|observe_administer) = 3/6 = 0.5
P(null|report_decrease) = 1/1 = 1.0
P(effect|exclude_take) = 1/1 = 1.0
P(effect|suggest_result) = 2/8 = 0.25
P(null|suggest_result) = 6/8 = 0.75
P(effect|show_attenuate) = 1/1 = 1.0
P(mechanism|interfere_pose) = 1/6 = 0.16666666666666666
P(null|interfere_pose) = 5/6 = 0.8333333333333334
P(null|pose_filtrate) = 2/2 = 1.0
P(null|decrease_have) = 2/2 = 1.0
P(null|administer_prolong) = 1/1 = 1.0
P(mechanism|lower_take) = 3/3 = 1.0
P(null|use_treat) = 1/1 = 1.0
P(mechanism|observe_return) = 1/3 = 0.3333333333333333
P(null|observe_return) = 2/3 = 0.6666666666666666
P(null|observe_monitor) = 5/5 = 1.0
P(mechanism|be_cause) = 1/1 = 1.0
P(effect|observe_add) = 1/2 = 0.5
P(advise|observe_add) = 1/2 = 0.5
P(mechanism|indicate_reduce) = 1/4 = 0.25
P(advise|indicate_reduce) = 1/4 = 0.25
P(null|indicate_reduce) = 2/4 = 0.5
P(effect|suggest_diminish) = 4/4 = 1.0
P(null|associate_compare) = 2/2 = 1.0
P(effect|occur_use) = 4/6 = 0.6666666666666666
P(null|occur_use) = 2/6 = 0.3333333333333333
P(mechanism|show_increase) = 2/2 = 1.0
P(null|demonstrate_produce) = 6/6 = 1.0
P(null|have_have) = 1/1 = 1.0
P(mechanism|increase_coadminister) = 3/3 = 1.0
P(advise|affect_administer) = 2/2 = 1.0
P(mechanism|administer_decrease) = 3/4 = 0.75
P(null|administer_decrease) = 1/4 = 0.25
P(mechanism|decrease_administer) = 2/2 = 1.0
P(null|aim_evaluate) = 2/2 = 1.0
P(null|decrease_start) = 1/1 = 1.0
P(advise|recommend_potentiate) = 1/9 = 0.1111111111111111
P(null|recommend_potentiate) = 8/9 = 0.8888888888888888
P(null|receive_result) = 1/1 = 1.0
P(effect|exercise_enhance) = 1/1 = 1.0
P(null|control_administer) = 1/1 = 1.0
P(null|conclude_administer) = 2/2 = 1.0
P(advise|recommend_exceed) = 3/3 = 1.0
P(advise|result_exceed) = 1/1 = 1.0
P(null|observe_take) = 1/1 = 1.0
P(effect|experience_separate) = 1/1 = 1.0
P(null|produce_administer) = 10/10 = 1.0
P(null|conduct_interfere) = 1/1 = 1.0
P(mechanism|enhance_interfere) = 1/3 = 0.3333333333333333
P(null|enhance_interfere) = 2/3 = 0.6666666666666666
P(null|demonstrate_affect) = 17/17 = 1.0
P(advise|cause_alert) = 1/1 = 1.0
P(null|coadminister_follow) = 3/3 = 1.0
P(advise|monitor_give) = 1/1 = 1.0
P(advise|use_coadminister) = 6/6 = 1.0
P(null|indicate_bind) = 5/5 = 1.0
P(effect|report_administer) = 2/7 = 0.2857142857142857
P(null|report_administer) = 5/7 = 0.7142857142857143
P(advise|require_administer) = 3/3 = 1.0
P(mechanism|reduce_give) = 1/3 = 0.3333333333333333
P(advise|reduce_give) = 2/3 = 0.6666666666666666
P(mechanism|inhibit_inhibit) = 1/1 = 1.0
P(null|expect_metabolize) = 1/1 = 1.0
P(mechanism|reduce_administer) = 1/3 = 0.3333333333333333
P(advise|reduce_administer) = 2/3 = 0.6666666666666666
P(effect|result_use) = 3/3 = 1.0
P(null|use_measure) = 1/1 = 1.0
P(null|suggest_couple) = 1/1 = 1.0
P(null|evaluate_have) = 1/1 = 1.0
P(null|conclude_have) = 4/4 = 1.0
P(null|have_limit) = 1/1 = 1.0
P(null|show_alter) = 7/7 = 1.0
P(advise|consider_administer) = 5/6 = 0.8333333333333334
P(null|consider_administer) = 1/6 = 0.16666666666666666
P(effect|lead_increase) = 1/1 = 1.0
P(effect|occur_give) = 6/6 = 1.0
P(effect|reduce_demonstrate) = 2/2 = 1.0
P(null|indicate_involve) = 8/8 = 1.0
P(effect|show_reduce) = 4/4 = 1.0
P(advise|consider_initiate) = 1/1 = 1.0
P(advise|exercise_give) = 1/1 = 1.0
P(mechanism|reflect_administer) = 1/1 = 1.0
P(advise|reduce_reduce) = 1/3 = 0.3333333333333333
P(null|reduce_reduce) = 2/3 = 0.6666666666666666
P(null|coadminister_achieve) = 2/2 = 1.0
P(null|increase_decrease) = 1/1 = 1.0
P(advise|approach_result) = 1/1 = 1.0
P(effect|indicate_diminish) = 1/1 = 1.0
P(null|show_have) = 19/19 = 1.0
P(mechanism|see_administer) = 1/9 = 0.1111111111111111
P(null|see_administer) = 8/9 = 0.8888888888888888
P(null|administer_delay) = 1/1 = 1.0
P(effect|appreciate_give) = 1/1 = 1.0
P(mechanism|demonstrate_have) = 1/1 = 1.0
P(null|test_reduce) = 1/1 = 1.0
P(advise|expect_use) = 1/3 = 0.3333333333333333
P(null|expect_use) = 2/3 = 0.6666666666666666
P(effect|use_potentiate) = 1/2 = 0.5
P(advise|use_potentiate) = 1/2 = 0.5
P(effect|report_use) = 4/4 = 1.0
P(null|observe_give) = 1/1 = 1.0
P(null|suggest_affect) = 1/1 = 1.0
P(advise|recommend_use) = 6/12 = 0.5
P(null|recommend_use) = 6/12 = 0.5
P(advise|halve_administer) = 1/1 = 1.0
P(mechanism|be_reduce) = 2/2 = 1.0
P(mechanism|increase_administer) = 2/2 = 1.0
P(null|be_give) = 4/4 = 1.0
P(null|maintain_have) = 5/5 = 1.0
P(advise|recommend_take) = 2/3 = 0.6666666666666666
P(null|recommend_take) = 1/3 = 0.3333333333333333
P(null|indicate_undergo) = 1/1 = 1.0
P(null|report_add) = 2/2 = 1.0
P(effect|increase_take) = 1/1 = 1.0
P(null|result_involve) = 1/1 = 1.0
P(null|monitor_need) = 2/2 = 1.0
P(null|coincide_increase) = 1/1 = 1.0
P(mechanism|find_decrease) = 1/1 = 1.0
P(null|show_influence) = 10/10 = 1.0
P(mechanism|report_give) = 1/1 = 1.0
P(mechanism|suggest_give) = 1/1 = 1.0
P(null|adjust_have) = 14/14 = 1.0
P(null|show_change) = 1/1 = 1.0
P(null|affect_require) = 1/1 = 1.0
P(null|discontinue_coadminister) = 1/1 = 1.0
P(null|conclude_see) = 2/2 = 1.0
P(null|cause_cause) = 5/5 = 1.0
P(mechanism|cause_increase) = 1/10 = 0.1
P(effect|cause_increase) = 1/10 = 0.1
P(null|cause_increase) = 8/10 = 0.8
P(null|increase_potentiate) = 1/1 = 1.0
P(null|indicate_metabolize) = 1/1 = 1.0
P(effect|demonstrate_enhance) = 1/2 = 0.5
P(null|demonstrate_enhance) = 1/2 = 0.5
P(effect|receive_mask) = 1/1 = 1.0
P(effect|interact_affect) = 1/8 = 0.125
P(null|interact_affect) = 7/8 = 0.875
P(effect|reduce_amplify) = 1/1 = 1.0
P(effect|emerge_give) = 2/2 = 1.0
P(null|show_metabolize) = 2/2 = 1.0
P(effect|result_give) = 1/1 = 1.0
P(null|demonstrate_result) = 1/1 = 1.0
P(advise|exercise_administer) = 3/9 = 0.3333333333333333
P(null|exercise_administer) = 6/9 = 0.6666666666666666
P(null|potentiate_perform) = 3/3 = 1.0
P(null|assign_receive) = 2/2 = 1.0
P(effect|indicate_associate) = 1/1 = 1.0
P(null|affect_affect) = 2/2 = 1.0
P(null|demonstrate_administer) = 1/1 = 1.0
P(mechanism|suggest_interfere) = 1/1 = 1.0
P(effect|be_produce) = 2/2 = 1.0
P(null|administer_affect) = 2/2 = 1.0
P(advise|know_alter) = 1/1 = 1.0
P(null|evaluate_increase) = 1/1 = 1.0
P(null|recommend_isolate) = 2/2 = 1.0
P(null|suggest_increase) = 4/4 = 1.0
P(advise|exercise_use) = 3/4 = 0.75
P(null|exercise_use) = 1/4 = 0.25
P(null|suggest_reduce) = 1/1 = 1.0
P(advise|recommend_avoid) = 1/3 = 0.3333333333333333
P(null|recommend_avoid) = 2/3 = 0.6666666666666666
P(null|avoid_contain) = 3/3 = 1.0
P(null|metabolize_affect) = 1/1 = 1.0
P(null|use_study) = 2/2 = 1.0
P(advise|receive_report) = 1/1 = 1.0
P(effect|suggest_enhance) = 1/1 = 1.0
P(null|occur_change) = 14/14 = 1.0
P(effect|suggest_prescribe) = 1/1 = 1.0
P(mechanism|propose_result) = 1/1 = 1.0
P(mechanism|make_know) = 1/13 = 0.07692307692307693
P(advise|make_know) = 1/13 = 0.07692307692307693
P(null|make_know) = 11/13 = 0.8461538461538461
P(null|know_slow) = 1/1 = 1.0
P(null|show_cause) = 2/2 = 1.0
P(null|determine_permit) = 1/1 = 1.0
P(mechanism|occur_displace) = 1/1 = 1.0
P(null|demonstrate_cause) = 1/1 = 1.0
P(effect|contraindicate_report) = 6/6 = 1.0
P(effect|suggest_add) = 1/3 = 0.3333333333333333
P(null|suggest_add) = 2/3 = 0.6666666666666666
P(null|report_accelerate) = 1/1 = 1.0
P(effect|indicate_prolong) = 3/3 = 1.0
P(null|prolong_increase) = 2/2 = 1.0
P(effect|indicate_reverse) = 1/1 = 1.0
P(advise|suggest_use) = 1/3 = 0.3333333333333333
P(null|suggest_use) = 2/3 = 0.6666666666666666
P(null|indicate_affect) = 2/2 = 1.0
P(effect|give_combine) = 4/4 = 1.0
P(mechanism|see_increase) = 1/1 = 1.0
P(advise|appear_titrate) = 4/4 = 1.0
P(null|increase_report) = 2/2 = 1.0
P(null|show_form) = 2/2 = 1.0
P(effect|establish_interfere) = 1/1 = 1.0
P(null|drop_mix) = 1/1 = 1.0
P(null|metabolize_have) = 1/1 = 1.0
P(effect|reduce_show) = 1/2 = 0.5
P(null|reduce_show) = 1/2 = 0.5
P(effect|avoid_potentiate) = 2/2 = 1.0
P(mechanism|indicate_enhance) = 2/2 = 1.0
P(mechanism|suggest_decrease) = 1/3 = 0.3333333333333333
P(null|suggest_decrease) = 2/3 = 0.6666666666666666
P(effect|avoid_antagonize) = 2/4 = 0.5
P(null|avoid_antagonize) = 2/4 = 0.5
P(effect|expect_give) = 4/4 = 1.0
P(advise|suggest_discontinue) = 1/1 = 1.0
P(null|use_retard) = 2/2 = 1.0
P(effect|take_enhance) = 1/1 = 1.0
P(mechanism|avoid_interfere) = 1/1 = 1.0
P(null|indicate_use) = 5/5 = 1.0
P(null|study_use) = 1/1 = 1.0
P(mechanism|denote_increase) = 1/1 = 1.0
P(null|change_coadminister) = 2/2 = 1.0
P(null|note_coadminister) = 2/2 = 1.0
P(advise|advise_avoid) = 2/2 = 1.0
P(effect|evaluate_potentiate) = 1/1 = 1.0
P(advise|warrant_recommend) = 1/1 = 1.0
P(null|develop_advise) = 2/2 = 1.0
P(null|take_require) = 2/2 = 1.0
P(advise|use_take) = 2/2 = 1.0
P(null|note_give) = 1/1 = 1.0
P(advise|require_use) = 2/2 = 1.0
P(effect|abolish_apply) = 1/1 = 1.0
P(mechanism|be_coadminister) = 1/1 = 1.0
P(null|sequester_have) = 1/1 = 1.0
P(null|suggest_have) = 1/1 = 1.0
P(null|exercise_show) = 1/1 = 1.0
P(effect|begin_take) = 3/5 = 0.6
P(null|begin_take) = 2/5 = 0.4
P(effect|take_increase) = 3/6 = 0.5
P(null|take_increase) = 3/6 = 0.5
P(effect|report_occur) = 1/1 = 1.0
P(effect|isolate_add) = 1/1 = 1.0
P(effect|reduce_add) = 1/1 = 1.0
P(null|be_fluoroquinolone) = 9/9 = 1.0
P(effect|appear_treat) = 1/1 = 1.0
P(effect|note_combine) = 2/2 = 1.0
P(null|potentiate_bind) = 21/21 = 1.0
P(effect|conclude_prevent) = 1/1 = 1.0
P(advise|discontinue_change) = 1/1 = 1.0
P(advise|alter_evaluate) = 1/1 = 1.0
P(effect|increase_combine) = 1/1 = 1.0
P(null|increase_give) = 4/4 = 1.0
P(advise|observe_coadminister) = 4/4 = 1.0
P(null|report_anticipate) = 1/1 = 1.0
P(mechanism|report_increase) = 5/13 = 0.38461538461538464
P(null|report_increase) = 8/13 = 0.6153846153846154
P(advise|advise_coadminister) = 4/4 = 1.0
P(null|appear_appear) = 1/1 = 1.0
P(null|note_administer) = 2/2 = 1.0
P(effect|emerge_use) = 1/1 = 1.0
P(null|recommend_show) = 3/3 = 1.0
P(advise|suggest_administer) = 2/2 = 1.0
P(mechanism|find_cause) = 1/1 = 1.0
P(null|report_lower) = 2/2 = 1.0
P(advise|take_use) = 4/4 = 1.0
P(null|report_result) = 2/2 = 1.0
P(null|make_prevent) = 4/4 = 1.0
P(int|affect_interact) = 14/14 = 1.0
P(advise|exercise_coadminister) = 3/3 = 1.0
P(mechanism|demonstrate_increase) = 2/2 = 1.0
P(effect|show_antagonize) = 1/1 = 1.0
P(effect|conclude_modulate) = 1/1 = 1.0
P(null|perform_administer) = 1/1 = 1.0
P(null|compete_administer) = 1/1 = 1.0
P(effect|result_coadminister) = 2/2 = 1.0
